BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97:934-959. [PMID: 12569593 DOI: 10.1002/cncr.11105] [Cited by in Crossref: 1671] [Cited by in F6Publishing: 1425] [Article Influence: 87.9] [Reference Citation Analysis]
Number Citing Articles
1 Pape UF, Perren A, Niederle B, Gross D, Gress T, Costa F, Arnold R, Denecke T, Plöckinger U, Salazar R. ENETS Consensus Guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas. Neuroendocrinology. 2012;95:135-156. [PMID: 22262080 DOI: 10.1159/000335629] [Cited by in Crossref: 294] [Cited by in F6Publishing: 210] [Article Influence: 29.4] [Reference Citation Analysis]
2 Wang GG, Yao JC, Worah S, White JA, Luna R, Wu TT, Hamilton SR, Rashid A. Comparison of genetic alterations in neuroendocrine tumors: frequent loss of chromosome 18 in ileal carcinoid tumors. Mod Pathol 2005;18:1079-87. [PMID: 15920555 DOI: 10.1038/modpathol.3800389] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 3.1] [Reference Citation Analysis]
3 Gellissen J, Kapsimalakou S, Begum N, Krueger A, Stoeckelhuber BM, Lubienski A, Helmberger T. Bildgebungsverfahren bei neuroendokrinen und mesenchymalen Tumoren des Gastrointestinaltrakts. Visc Med 2007;23:119-26. [DOI: 10.1159/000102019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Chiappetta M, Lococo F, Sperduti I, Cusumano G, Terminella A, Fournel L, Guerrera F, Filosso P, Tabacco D, Nicosia S, Alifano M, Gallina F, Facciolo F, Margaritora S. Lymphadenectomy for lung carcinoids: Which factors may predict nodal upstaging? A multi centric, retrospective study. J Surg Oncol 2022. [PMID: 35522364 DOI: 10.1002/jso.26912] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Widmeier E, Füllgraf H, Waller CF. Complete remission of Cdx-2 positive primary testicular carcinoid tumor: 10-years follow-up and literature review. BMC Urol 2020;20:197. [PMID: 33317491 DOI: 10.1186/s12894-020-00768-2] [Reference Citation Analysis]
6 Son J, Park IJ, Yang DH, Kim J, Kim KJ, Byeon JS, Hong SM, Kim YI, Kim JB, Lim SB, Yu CS, Kim JC. Oncological outcomes according to the treatment modality based on the size of rectal neuroendocrine tumors: a single-center retrospective study. Surg Endosc 2021. [PMID: 34009477 DOI: 10.1007/s00464-021-08527-6] [Reference Citation Analysis]
7 Zanger P, Habscheid W, Kremsner PG, Dahm HH. Schistosoma japonicum infection and rectal carcinoid tumour: underreported coincidence or neglected association? Epidemiol Infect 2010;138:1289-91. [PMID: 20056016 DOI: 10.1017/S095026880999152X] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
8 Chao G, Zhang S, Si J. Comparing endoscopic mucosal resection with endoscopic submucosal dissection: the different endoscopic techniques for colorectal tumors. J Surg Res. 2016;202:204-215. [PMID: 27083968 DOI: 10.1016/j.jss.2015.12.027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
9 Wang AY, Ahmad NA. Rectal carcinoids. Curr Opin Gastroenterol. 2006;22:529-535. [PMID: 16891885 DOI: 10.1097/01.mog.0000239868.27328.1d] [Cited by in Crossref: 43] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
10 Modlin IM, Shapiro MD, Kidd M. An analysis of rare carcinoid tumors: clarifying these clinical conundrums. World J Surg. 2005;29:92-101. [PMID: 15599742 DOI: 10.1007/s00268-004-7443-z] [Cited by in Crossref: 116] [Cited by in F6Publishing: 85] [Article Influence: 6.8] [Reference Citation Analysis]
11 Kidd M, Modlin IM, Black JW, Boyce M, Culler M. A comparison of the effects of gastrin, somatostatin and dopamine receptor ligands on rat gastric enterochromaffin-like cell secretion and proliferation. Regul Pept. 2007;143:109-117. [PMID: 17531331 DOI: 10.1016/j.regpep.2007.04.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
12 Lawrence B, Kidd M, Svejda B, Modlin I. A clinical perspective on gastric neuroendocrine neoplasia. Curr Gastroenterol Rep 2011;13:101-9. [PMID: 21080245 DOI: 10.1007/s11894-010-0158-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
13 Cao F, Sada DM, Lai S, Sada YH. Stereotactic Radiosurgery for Carcinoid Brain Metastasis: A Case Report. Cureus 2019;11:e5509. [PMID: 31667042 DOI: 10.7759/cureus.5509] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Jensen KH, Hilsted L, Jensen C, Mynster T, Rehfeld JF, Knigge U. Chromogranin A is a sensitive marker of progression or regression in ileo-cecal neuroendocrine tumors. Scand J Gastroenterol. 2013;48:70-77. [PMID: 23094948 DOI: 10.3109/00365521.2012.733953] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
15 Helland SK, Prøsch AM, Viste A. Carcinoid Tumours in the Gastrointestinal Tract — A Population-Based Study from Western Norway. Scand J Surg 2006;95:158-61. [DOI: 10.1177/145749690609500305] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
16 Gabriel M, Oberauer A, Dobrozemsky G, Decristoforo C, Putzer D, Kendler D, Uprimny C, Kovacs P, Bale R, Virgolini IJ. 68 Ga-DOTA-Tyr 3 -Octreotide PET for Assessing Response to Somatostatin-Receptor–Mediated Radionuclide Therapy. J Nucl Med 2009;50:1427-34. [DOI: 10.2967/jnumed.108.053421] [Cited by in Crossref: 116] [Cited by in F6Publishing: 106] [Article Influence: 8.9] [Reference Citation Analysis]
17 Jamali M, Chetty R. Predicting prognosis in gastroentero-pancreatic neuroendocrine tumors: an overview and the value of Ki-67 immunostaining. Endocr Pathol 2008;19:282-8. [PMID: 18931958 DOI: 10.1007/s12022-008-9044-0] [Cited by in Crossref: 73] [Cited by in F6Publishing: 66] [Article Influence: 5.6] [Reference Citation Analysis]
18 Zhang J, Yu Q, He Y, Hu T, Chen K, Yang Z, Zhang X, Cheng D, He Z. The Cancers-Specific Survival of Metastatic Pulmonary Carcinoids and Sites of Distant Metastasis: A Population-Based Study. Technol Cancer Res Treat 2021;20:15330338211036528. [PMID: 34378452 DOI: 10.1177/15330338211036528] [Reference Citation Analysis]
19 Machairas N, Daskalakis K, Felekouras E, Alexandraki KI, Kaltsas G, Sotiropoulos GC. Currently available treatment options for neuroendocrine liver metastases. Ann Gastroenterol 2021;34:130-41. [PMID: 33654350 DOI: 10.20524/aog.2021.0574] [Reference Citation Analysis]
20 Kim MS, Hur H, Min BS, Baik SH, Lee KY, Kim NK. Clinical outcomes for rectal carcinoid tumors according to a new (AJCC 7th edition) TNM staging system: a single institutional analysis of 122 patients. J Surg Oncol. 2013;107:835-841. [PMID: 23505038 DOI: 10.1002/jso.23327] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
21 Buil-Bruna N, Dehez M, Manon A, Nguyen TX, Trocóniz IF. Establishing the Quantitative Relationship Between Lanreotide Autogel®, Chromogranin A, and Progression-Free Survival in Patients with Nonfunctioning Gastroenteropancreatic Neuroendocrine Tumors. AAPS J 2016;18:703-12. [PMID: 26908127 DOI: 10.1208/s12248-016-9884-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
22 Şentürk M, Acar B, Yildirim MA, Çakir M, Küçükkartallar T, Vatansev C. Clinicopathological Characteristics of Gastroenteropancreatic Neuroendocrine Tumors: 10 Years of Experience From a Single Center. Pancreas 2022;51:159-63. [DOI: 10.1097/mpa.0000000000001981] [Reference Citation Analysis]
23 Bi Y, Deng Y, Li S, Zhou X, Chen Y, Ma D, Mao X, Guan Y, Chen J, Meng Y. Immunophenotypic and prognostic analysis of PAX8 and TTF-1 expressions in neuroendocrine carcinomas of thymic origin: A comparative study with their pulmonary counterparts. J Surg Oncol 2016;114:697-702. [PMID: 27761900 DOI: 10.1002/jso.24393] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
24 Olpin J, Fine GC, Shaaban A. Imaging of Gastrointestinal Neuroendocrine Tumors. Curr Radiol Rep 2020;8. [DOI: 10.1007/s40134-020-00371-1] [Reference Citation Analysis]
25 Georgescu TA, Bohiltea RE, Munteanu O, Furtunescu F, Lisievici AC, Grigoriu C, Gherghiceanu F, Vlădăreanu EM, Berceanu C, Ducu I, Iordache AM. Emerging Therapeutic Concepts and Latest Diagnostic Advancements Regarding Neuroendocrine Tumors of the Gynecologic Tract. Medicina (Kaunas) 2021;57:1338. [PMID: 34946283 DOI: 10.3390/medicina57121338] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Varker KA, Martin EW, Klemanski D, Palmer B, Shah MH, Bloomston M. Repeat transarterial chemoembolization (TACE) for progressive hepatic carcinoid metastases provides results similar to first TACE. J Gastrointest Surg 2007;11:1680-5. [PMID: 17899303 DOI: 10.1007/s11605-007-0235-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
27 Landry CS, Mcmasters KM, Scoggins CR, Martin RC. Proposed Staging System for Gastrointestinal Carcinoid Tumors. The American Surgeon 2008;74:418-22. [DOI: 10.1177/000313480807400511] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
28 Ramage JK, Davies AH, Ardill J, Bax N, Caplin M, Grossman A, Hawkins R, McNicol AM, Reed N, Sutton R, Thakker R, Aylwin S, Breen D, Britton K, Buchanan K, Corrie P, Gillams A, Lewington V, McCance D, Meeran K, Watkinson A; UKNETwork for Neuroendocrine Tumours. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut 2005;54 Suppl 4:iv1-16. [PMID: 15888809 DOI: 10.1136/gut.2004.053314] [Cited by in Crossref: 180] [Cited by in F6Publishing: 195] [Article Influence: 10.6] [Reference Citation Analysis]
29 Lee SH, Moon D, Lee HS, Lee CK, Jeon YD, Park JH, Kim H, Lee SK. Multicentric Type 3 Gastric Neuroendocrine Tumors. Clin Endosc 2015;48:431-5. [PMID: 26473128 DOI: 10.5946/ce.2015.48.5.431] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
30 Kim HY, Choi SI, Kim YH. Neuroendocrine tumor of unknown primary accompanied with stomach adenocarcinoma. J Gastric Cancer. 2011;11:234-238. [PMID: 22324016 DOI: 10.5230/jgc.2011.11.4.234] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
31 Franko J, Feng W, Yip L, Genovese E, Moser AJ. Non-functional neuroendocrine carcinoma of the pancreas: incidence, tumor biology, and outcomes in 2,158 patients. J Gastrointest Surg. 2010;14:541-548. [PMID: 19997980 DOI: 10.1007/s11605-009-1115-0] [Cited by in Crossref: 171] [Cited by in F6Publishing: 150] [Article Influence: 13.2] [Reference Citation Analysis]
32 Dayer N, Fasquelle F, Salati E, Dietrich G. Multiple primary malignancies: synchronous lymphoma, pancreatic neuroendocrine tumour and colorectal cancer. BMJ Case Rep 2021;14:e241938. [PMID: 34088689 DOI: 10.1136/bcr-2021-241938] [Reference Citation Analysis]
33 Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current Status of Gastrointestinal Carcinoids. Gastroenterology 2005;128:1717-51. [DOI: 10.1053/j.gastro.2005.03.038] [Reference Citation Analysis]
34 Wang Y, Beyer DT, Hall M. Obturator Canal Lymph Node Metastasis from Rectal Carcinoid Tumors: Total Mesorectal Excision May Be Insufficient. J Gastrointest Surg 2016;20:1247-52. [DOI: 10.1007/s11605-016-3128-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
35 Jabaji R, Kern T, Shen D, Chu W, Merchant M. Primary Renal Carcinoid Tumor: Report of Two Cases. Perm J 2020;24. [PMID: 32240087 DOI: 10.7812/TPP/19.147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Narayanan M, Serban D, Tender GC. Primary cervical spine carcinoid tumor in a woman with arm paresthesias and weakness: a case report. J Med Case Rep 2013;7:214. [PMID: 23972315 DOI: 10.1186/1752-1947-7-214] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
37 Salyers WJ, Vega KJ, Munoz JC, Trotman BW, Tanev SS. Neuroendocrine tumors of the gastrointestinal tract: Case reports and literature review. World J Gastrointest Oncol 2014; 6(8): 301-310 [PMID: 25132927 DOI: 10.4251/wjgo.v6.i8.301] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
38 O’Donnell ME, Badger SA, Beattie GC, Carson J, Garstin WI. Malignant neoplasms of the appendix. Int J Colorectal Dis. 2007;22:1239-1248. [PMID: 17447078 DOI: 10.1007/s00384-007-0304-0] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 3.5] [Reference Citation Analysis]
39 Tshori S, Bocher M, Yuzefovich B, Rubinstein R, Gross DJ, Fraenkel M, Krausz Y. Diagnostic Computed Tomography Coregistration With In-111-DTPA-Octreotide Single Photon Emission Tomography/Low-Dose Computed Tomography. J Comput Assist Tomogr 2017;41:499-504. [PMID: 27879526 DOI: 10.1097/RCT.0000000000000527] [Reference Citation Analysis]
40 Megdanova-Chipeva VG, Lamarca A, Backen A, McNamara MG, Barriuso J, Sergieva S, Gocheva L, Mansoor W, Manoharan P, Valle JW. Systemic Treatment Selection for Patients with Advanced Pancreatic Neuroendocrine Tumours (PanNETs). Cancers (Basel) 2020;12:E1988. [PMID: 32708210 DOI: 10.3390/cancers12071988] [Reference Citation Analysis]
41 Pedicone R, Adham M, Hervieu V, Lombard-Bohas C, Guibal A, Scoazec JY, Chayvialle JA, Partensky C. Long-term survival after pancreaticoduodenectomy for endocrine tumors of the ampulla of Vater and minor papilla. Pancreas. 2009;38:638-643. [PMID: 19531971 DOI: 10.1097/MPA.0b013e3181a9d41f] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
42 Levy AD, Taylor LD, Abbott RM, Sobin LH. Duodenal carcinoids: imaging features with clinical-pathologic comparison. Radiology. 2005;237:967-972. [PMID: 16237144 DOI: 10.1148/radiol.2373041863] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
43 Fujii Y, Tzeng CW, Chiang YJ, Halperin DM, Dasari A, Kim MP, Katz MHG, Lee JE, Ikoma N. Incidence of Lymph Node Metastases and Impact of Radical Surgery for Duodenal Neuroendocrine Tumors. J Surg Res 2021;268:419-31. [PMID: 34416414 DOI: 10.1016/j.jss.2021.06.085] [Reference Citation Analysis]
44 Watson GA, Ahmed Y, Picardo S, Chew S, Cobbe S, Mahony C, Crotty J, Wallis F, Shelly MJ, Kiely P, Ipadeola OB, Healy V, Osman N, Gupta RK. Unusual Sites of High-Grade Neuroendocrine Carcinomas: A Case Series and Review of the Literature. Am J Case Rep. 2018;19:710-723. [PMID: 29915166 DOI: 10.12659/ajcr.908953] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
45 Özaslan E, Karaca H, Koca S, Sevinç A, Hacioğlu B, Özkan M, Özçelik M, Duran AO, Hacibekiroğlu İ, Yildiz Y, Tanriverdi Ö, Menekşe S, Aksoy A, Bozkurt O, Urvay S, Uysal M, Demir H, Çiltaş A, Dane F. Comparison of survival with somatostatin analog and chemotherapy and prognostic factors for treatment in 165 advanced neuroendocrine tumor patients with Ki-67 20% or less. Anticancer Drugs 2017;28:222-9. [PMID: 27768606 DOI: 10.1097/CAD.0000000000000445] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
46 Milanetto AC, Fassan M, David A, Pasquali C. Serotonin-Secreting Neuroendocrine Tumours of the Pancreas. J Clin Med 2020;9:E1363. [PMID: 32384679 DOI: 10.3390/jcm9051363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
47 Prakash L, Bhosale P, Cloyd J, Kim M, Parker N, Yao J, Dasari A, Halperin D, Aloia T, Lee JE, Vauthey JN, Fleming JB, Katz MHG. Role of Fluorouracil, Doxorubicin, and Streptozocin Therapy in the Preoperative Treatment of Localized Pancreatic Neuroendocrine Tumors. J Gastrointest Surg 2017;21:155-63. [DOI: 10.1007/s11605-016-3270-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
48 Sugimoto S, Hotta K, Shimoda T, Imai K, Yamaguchi Y, Nakajima T, Oishi T, Mori K, Takizawa K, Kakushima N, Tanaka M, Kawata N, Matsubayashi H, Ono H. The Ki-67 labeling index and lymphatic/venous permeation predict the metastatic potential of rectal neuroendocrine tumors. Surg Endosc 2016;30:4239-48. [DOI: 10.1007/s00464-015-4735-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
49 Wulfert S, Kratochwil C, Choyke PL, Afshar-Oromieh A, Mier W, Kauczor HU, Schenk JP, Haberkorn U, Giesel FL. Multimodal imaging for early functional response assessment of (90)Y-/ (177)Lu-DOTATOC peptide receptor targeted radiotherapy with DW-MRI and (68)Ga-DOTATOC-PET/CT. Mol Imaging Biol 2014;16:586-94. [PMID: 24526358 DOI: 10.1007/s11307-014-0722-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
50 Gregersen T, Brock C, Haase AM, Laurberg S, Drewes AM, Grønbæk H, Krogh K. Rectal Mechano-sensory Function in Patients with Carcinoid Diarrhea. J Neurogastroenterol Motil 2016;22:264-71. [PMID: 26690884 DOI: 10.5056/jnm15113] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
51 Altmayer S, Verma N, Francisco MZ, Almeida RF, Mohammed TL, Hochhegger B. Classification and Imaging Findings of Lung Neoplasms. Semin Roentgenol 2020;55:41-50. [PMID: 31964479 DOI: 10.1053/j.ro.2019.10.002] [Reference Citation Analysis]
52 Gaba RC, Mendoza-Elias N, Morrison JD, Valeshabad AK, Lipnik AJ. Decision Making for Selection of Transarterial Locoregional Therapy of Metastatic Neuroendocrine Tumors. Semin Intervent Radiol 2017;34:101-8. [PMID: 28579677 DOI: 10.1055/s-0037-1602590] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
53 Zhai LR, Zhang XW, Yu T, Jiang ZD, Huang DW, Jia Y, Cui MH. Primary ovarian carcinoid: Two cases report and review of literature. Medicine (Baltimore) 2020;99:e21109. [PMID: 33019380 DOI: 10.1097/MD.0000000000021109] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Callahan AF, White M, Ituarte P, Gagandeep S, Woo Y, Fong Y, Melstrom L. Surgical Intervention in Gastric Carcinoid is Associated With Improved Survival in Local and Regional Disease. Am J Clin Oncol 2018;41:882-7. [PMID: 28763328 DOI: 10.1097/COC.0000000000000392] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
55 Fernández Catalina P, Lorenzo Solar M, Sánchez Sobrino P, Alvarez Álvarez C. [Goblet cell carcinoid of the appendix]. Endocrinol Nutr 2013;60:e5-6. [PMID: 23415545 DOI: 10.1016/j.endonu.2012.10.008] [Reference Citation Analysis]
56 Gupta S, Engstrom PF, Cohen SJ. Emerging therapies for advanced gastroenteropancreatic neuroendocrine tumors. Clin Colorectal Cancer 2011;10:298-309. [PMID: 21813338 DOI: 10.1016/j.clcc.2011.06.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
57 Nakamura K, Osada M, Goto A, Iwasa T, Takahashi S, Takizawa N, Akahoshi K, Ochiai T, Nakamura N, Akiho H. Short- and long-term outcomes of endoscopic resection of rectal neuroendocrine tumours: analyses according to the WHO 2010 classification. Scand J Gastroenterol. 2016;51:448-455. [PMID: 26540372 DOI: 10.3109/00365521.2015.1107752] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
58 Scherübl H, Jensen RT, Cadiot G, Stölzel U, Klöppel G. Neuroendocrine tumors of the small bowels are on the rise: Early aspects and management. World J Gastrointest Endosc 2010; 2(10): 325-334 [PMID: 21160582 DOI: 10.4253/wjge.v2.i10.325] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 50] [Article Influence: 5.3] [Reference Citation Analysis]
59 Koenig A, Krug S, Mueller D, Barth PJ, Koenig U, Scharf M, Ellenrieder V, Michl P, Moll R, Homayunfar K, Kann PH, Stroebel P, Gress TM, Rinke A. Clinicopathological hallmarks and biomarkers of colorectal neuroendocrine neoplasms. PLoS One 2017;12:e0188876. [PMID: 29232390 DOI: 10.1371/journal.pone.0188876] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
60 Eggenberger JC. Carcinoid and other neuroendocrine tumors of the colon and rectum. Clin Colon Rectal Surg 2011;24:129-34. [PMID: 22942794 DOI: 10.1055/s-0031-1285996] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
61 Binderup T, Knigge U, Loft A, Mortensen J, Pfeifer A, Federspiel B, Hansen CP, Højgaard L, Kjaer A. Functional imaging of neuroendocrine tumors: a head-to-head comparison of somatostatin receptor scintigraphy, 123I-MIBG scintigraphy, and 18F-FDG PET. J Nucl Med. 2010;51:704-712. [PMID: 20395333 DOI: 10.2967/jnumed.109.069765] [Cited by in Crossref: 186] [Cited by in F6Publishing: 140] [Article Influence: 15.5] [Reference Citation Analysis]
62 Dakin GF, Warner RR, Pomp A, Salky B, Inabnet WB. Presentation, treatment, and outcome of type 1 gastric carcinoid tumors. J Surg Oncol. 2006;93:368-372. [PMID: 16550587 DOI: 10.1002/jso.20468] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 3.3] [Reference Citation Analysis]
63 Massironi S, Sciola V, Peracchi M, Ciafardini C, Spampatti MP, Conte D. Neuroendocrine tumors of the gastro-entero-pancreatic system. World J Gastroenterol 2008; 14(35): 5377-5384 [PMID: 18803349 DOI: 10.3748/wjg.14.5377] [Cited by in CrossRef: 103] [Cited by in F6Publishing: 94] [Article Influence: 7.4] [Reference Citation Analysis]
64 Wang ZD, Jiao XX, Peng XQ, Liu L, Zhang LF, Zhou L. Clinicopathological characteristics and prognosis of gastric neuroendocrine neoplasms of different clinical classifications. Shijie Huaren Xiaohua Zazhi 2019; 27(4): 267-275 [DOI: 10.11569/wcjd.v27.i4.267] [Reference Citation Analysis]
65 Jhawar S, Lakhotia R, Suzuki M, Welch J, Agarwal SK, Sharretts J, Merino M, Ahlman M, Blau JE, Simonds WF, Del Rivero J. Clinical presentation and management of primary ovarian neuroendocrine tumor in multiple endocrine neoplasia type 1. Endocrinol Diabetes Metab Case Rep 2019;2019:EDM190040. [PMID: 31480016 DOI: 10.1530/EDM-19-0040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
66 Hallet J, Law CH, Cukier M, Saskin R, Liu N, Singh S. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes. Cancer. 2015;121:589-597. [PMID: 25312765 DOI: 10.1002/cncr.29099] [Cited by in Crossref: 337] [Cited by in F6Publishing: 301] [Article Influence: 42.1] [Reference Citation Analysis]
67 Yang X, Cao Y, Chen C, Liu L, Wang C, Liu S. Primary neuroendocrine breast carcinomas: a retrospective analysis and review of literature. Onco Targets Ther 2017;10:397-407. [PMID: 28176908 DOI: 10.2147/OTT.S113736] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
68 Eick J, Steinberg J, Schwertner C, Ring W, Scherübl H. [Rectal neuroendocrine tumors: endoscopic therapy]. Chirurg 2016;87:288-91. [PMID: 26801755 DOI: 10.1007/s00104-015-0141-6] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
69 Alexandraki KI, Kaltsas GA, Grozinsky-Glasberg S, Chatzellis E, Grossman AB. Appendiceal neuroendocrine neoplasms: diagnosis and management. Endocr Relat Cancer. 2016;23:R27-R41. [PMID: 26483424 DOI: 10.1530/erc-15-0310] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
70 Khan MS, Luong TV, Watkins J, Toumpanakis C, Caplin ME, Meyer T. A comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasms. Br J Cancer. 2013;108:1838-1845. [PMID: 23579216 DOI: 10.1038/bjc.2013.156] [Cited by in Crossref: 83] [Cited by in F6Publishing: 70] [Article Influence: 9.2] [Reference Citation Analysis]
71 Bohman E, Sahlin S, Seregard S. Carcinoid presenting as extrinsic eye muscle metastasis. Acta Ophthalmol 2009;87:916-7. [PMID: 19432847 DOI: 10.1111/j.1755-3768.2008.01470.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
72 Bisambar C, Collier A, Duthie F, Meney C. Non-functional duodenal neuroendocrine carcinoma: a rare cause of diabetes mellitus. Endocrinol Diabetes Metab Case Rep 2018;2018:18-0061. [PMID: 30159144 DOI: 10.1530/EDM-18-0061] [Reference Citation Analysis]
73 Walsh KM, Choi M, Oberg K, Kulke MH, Yao JC, Wu C, Jurkiewicz M, Hsu LI, Hooshmand SM, Hassan M, Janson ET, Cunningham JL, Vosburgh E, Sackler RS, Lifton RP, Dewan AT, Hoh J. A pilot genome-wide association study shows genomic variants enriched in the non-tumor cells of patients with well-differentiated neuroendocrine tumors of the ileum. Endocr Relat Cancer 2011;18:171-80. [PMID: 21139019 DOI: 10.1677/ERC-10-0248] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
74 Spolverato G, Bagante F, Aldrighetti L, Poultsides GA, Bauer TW, Fields RC, Maithel SK, Marques HP, Weiss M, Pawlik TM. Management and outcomes of patients with recurrent neuroendocrine liver metastasis after curative surgery: An international multi-institutional analysis. J Surg Oncol 2017;116:298-306. [DOI: 10.1002/jso.24670] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
75 Ploenes T, Börner N, Kirkpatrick CJ, Heintz A. Neuroendocrine tumour, mucinous adenocarcinoma and signet-ring cell carcinoma of the appendix: three cases and review of literature. Indian J Surg. 2013;75:299-302. [PMID: 24426597 DOI: 10.1007/s12262-012-0704-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
76 Spolverato G, Bagante F, Aldrighetti L, Poultsides G, Bauer TW, Field RC, Marques HP, Weiss M, Maithel SK, Pawlik TM. Neuroendocrine Liver Metastasis: Prognostic Implications of Primary Tumor Site on Patients Undergoing Curative Intent Liver Surgery. J Gastrointest Surg 2017;21:2039-47. [PMID: 28744737 DOI: 10.1007/s11605-017-3491-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
77 Mahoney B, Scheler J. Somatostatin Receptor Scintigraphy of Neuroendocrine Tumors of the Abdomen and Pelvis. Semin Roentgenol 2016;51:112-22. [PMID: 27105966 DOI: 10.1053/j.ro.2016.02.008] [Reference Citation Analysis]
78 Weber M, Kessler L, Schaarschmidt B, Fendler WP, Lahner H, Antoch G, Umutlu L, Herrmann K, Rischpler C. Treatment-related changes in neuroendocrine tumors as assessed by textural features derived from 68Ga-DOTATOC PET/MRI with simultaneous acquisition of apparent diffusion coefficient. BMC Cancer 2020;20:326. [PMID: 32299391 DOI: 10.1186/s12885-020-06836-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
79 Levy AD, Sobin LH. Gastrointestinal Carcinoids: Imaging Features with Clinicopathologic Comparison. RadioGraphics 2007;27:237-57. [DOI: 10.1148/rg.271065169] [Cited by in Crossref: 95] [Cited by in F6Publishing: 64] [Article Influence: 6.3] [Reference Citation Analysis]
80 Liu Q, Polydorides AD. Diagnosis and prognostic significance of extramural venous invasion in neuroendocrine tumors of the small intestine. Mod Pathol 2020;33:2318-29. [PMID: 32514164 DOI: 10.1038/s41379-020-0585-1] [Reference Citation Analysis]
81 Okada H, Uchida Y, Matsuzaki N, Goto T, Nishimura S, Kurita A, Nishimura T, Yazumi S, Terajima H. A case of neuroendocrine carcinoma in the hepatic hilar lymph nodes concomitant with an adenocarcinoma of the gallbladder. World J Surg Oncol 2016;14:284. [PMID: 27842605 DOI: 10.1186/s12957-016-1039-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
82 Lee L, Igarashi H, Fujimori N, Hijioka M, Kawabe K, Oda Y, Jensen RT, Ito T. Long-term outcomes and prognostic factors in 78 Japanese patients with advanced pancreatic neuroendocrine neoplasms: a single-center retrospective study. Jpn J Clin Oncol 2015;45:1131-8. [PMID: 26378090 DOI: 10.1093/jjco/hyv143] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
83 Rotondi M, Ercolino T, Fonte R, Lagonigro MS, Leporati P, Villani L, La Manna L, Mannelli M, Chiovato L. Occurrence of medullary thyroid carcinoma, bronchial carcinoid tumor, and papillary thyroid carcinoma in a family bearing the RET G691S polymorphism. J Endocrinol Invest 2009;32:115-8. [PMID: 19411807 DOI: 10.1007/BF03345698] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
84 Ramachandran A, Madhusudhan KS. Advances in the imaging of gastroenteropancreatic neuroendocrine neoplasms. World J Gastroenterol 2022; 28(26): 3008-3026 [DOI: 10.3748/wjg.v28.i26.3008] [Reference Citation Analysis]
85 Cavalcoli F, Rausa E, Conte D, Nicolini AF, Massironi S. Is there still a role for the hepatic locoregional treatment of metastatic neuroendocrine tumors in the era of systemic targeted therapies? World J Gastroenterol 2017; 23(15): 2640-2650 [PMID: 28487601 DOI: 10.3748/wjg.v23.i15.2640] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
86 Ferolla P, Daddi N, Urbani M, Semeraro A, Ribacchi R, Giovenali P, Ascani S, De Angelis V, Crinò L, Puma F, Daddi G; Regional Multidisciplinary Group for the Diagnosis and Treatment of Neuroendocrine Tumors, CRO, Umbria Region Cancer Network, Italy. Tumorlets, multicentric carcinoids, lymph-nodal metastases, and long-term behavior in bronchial carcinoids. J Thorac Oncol 2009;4:383-7. [PMID: 19247084 DOI: 10.1097/JTO.0b013e318197f2e7] [Cited by in Crossref: 51] [Cited by in F6Publishing: 12] [Article Influence: 3.9] [Reference Citation Analysis]
87 Hafeez U, Joshi A, Bhatt M, Kelly J, Sabesan S, Vangaveti V. Clinical profile and treatment outcomes of advanced neuroendocrine tumours in rural and regional patients: a retrospective study from a regional cancer centre in North Queensland, Australia. Intern Med J 2017;47:284-90. [PMID: 27860085 DOI: 10.1111/imj.13333] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
88 Jeffreys M, Rachet B, Mcdowell S, Habib AG, Lepage C, Coleman MP. Survival from rectal and anal cancers in England and Wales, 1986–2001. European Journal of Cancer 2006;42:1434-40. [DOI: 10.1016/j.ejca.2006.01.019] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
89 Koraitim M, Spedding AV, Bradley K, Brennan PA. Widespread metachronous carcinoid tumour metastases to the head and neck: a unique presentation. British Journal of Oral and Maxillofacial Surgery 2016;54:1022-4. [DOI: 10.1016/j.bjoms.2016.01.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
90 Okubo Y, Kasajima R, Suzuki M, Miyagi Y, Motohashi O, Shiozawa M, Yoshioka E, Washimi K, Kawachi K, Kameda Y, Yokose T. Risk factors associated with the progression and metastases of hindgut neuroendocrine tumors: a retrospective study. BMC Cancer. 2017;17:769. [PMID: 29145818 DOI: 10.1186/s12885-017-3769-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
91 Joskin J, de Baere T, Auperin A, Tselikas L, Guiu B, Farouil G, Boige V, Malka D, Leboulleux S, Ducreux M, Baudin E, Deschamps F. Predisposing Factors of Liver Necrosis after Transcatheter Arterial Chemoembolization in Liver Metastases from Neuroendocrine Tumor. Cardiovasc Intervent Radiol 2015;38:372-80. [DOI: 10.1007/s00270-014-0914-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
92 Sewpaul A, Bargiela D, James A, Johnson SJ, French JJ. Spontaneous Regression of a Carcinoid Tumor following Pregnancy. Case Rep Endocrinol. 2014;2014:481823. [PMID: 25587468 DOI: 10.1155/2014/481823] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
93 Wang YH, Lin Y, Xue L, Wang JH, Chen MH, Chen J. Relationship between clinical characteristics and survival of gastroenteropancreatic neuroendocrine neoplasms: A single-institution analysis (1995-2012) in South China. BMC Endocr Disord. 2012;12:30. [PMID: 23194346 DOI: 10.1186/1472 -6823-12-30] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
94 Liu F, Li Y, Ying D, Qiu S, He Y, Li M, Liu Y, Zhang Y, Zhu Q, Hu Y, Liu L, Li G, Pan W, Jin W, Mu J, Cao Y, Liu Y. Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder. Signal Transduct Target Ther 2021;6:55. [PMID: 33563892 DOI: 10.1038/s41392-020-00412-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
95 Dronamraju SS, Joypaul VB. Management of gastrointestinal carcinoid tumours - 10 years experience at a district general hospital. J Gastrointest Oncol 2012;3:120-9. [PMID: 22811879 DOI: 10.3978/j.issn.2078-6891.2011.039] [Reference Citation Analysis]
96 Delle Fave G, Capurso G, Milione M, Panzuto F. Endocrine tumours of the stomach. Best Pract Res Clin Gastroenterol. 2005;19:659-673. [PMID: 16253892 DOI: 10.1016/j.bpg.2005.05.002] [Cited by in Crossref: 57] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
97 Shen A, Haghighi A, Liang T, Lee O, Gange W, Deboer C, Akhter M, Saber MS, Patel VR, Berry JL, Gokoffski KK. Metastatic neuroendocrine tumors mimicking as primary ocular disease. American Journal of Ophthalmology Case Reports 2022;26:101425. [DOI: 10.1016/j.ajoc.2022.101425] [Reference Citation Analysis]
98 Gagliardi I, Tarquini M, Ambrosio MR, Giannetta E, Borges de Souza P, Gafà R, Carnevale A, Franceschetti P, Zatelli MC. NEP-Score Thresholds Predict Survival of Patients With Bronchial Carcinoids. Front Endocrinol (Lausanne) 2020;11:621557. [PMID: 33628200 DOI: 10.3389/fendo.2020.621557] [Reference Citation Analysis]
99 Sugimoto S, Hotta K, Shimoda T, Imai K, Ito S, Yamaguchi Y, Takizawa K, Kakushima N, Tanaka M, Kawata N, Yoshida M, Ishiwatari H, Matsubayashi H, Ono H. Can the Ki-67 Labeling Index in Biopsy Specimens Predict the World Health Organization Grade of Rectal Neuroendocrine Tumors? Dig Dis 2018;36:118-22. [DOI: 10.1159/000484083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
100 Tsang ES, McConnell YJ, Schaeffer DF, Yin Y, Speers CH, Kennecke HF. Prognostic Factors for Locoregional Recurrence in Neuroendocrine Tumors of the Rectum. Dis Colon Rectum 2018;61:187-92. [PMID: 29337773 DOI: 10.1097/DCR.0000000000000996] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
101 Ambrosini V, Tomassetti P, Rubello D, Campana D, Nanni C, Castellucci P, Farsad M, Montini G, Al-Nahhas A, Franchi R, Fanti S. Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours. Nucl Med Commun 2007;28:473-7. [PMID: 17460538 DOI: 10.1097/MNM.0b013e328182d606] [Cited by in Crossref: 39] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
102 Naswa N, Sharma P, Kumar A, Nazar AH, Kumar R, Chumber S, Bal C. Gallium-68-DOTA-NOC PET/CT of Patients With Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Single-Center Study. American Journal of Roentgenology 2011;197:1221-8. [DOI: 10.2214/ajr.11.7298] [Cited by in Crossref: 85] [Cited by in F6Publishing: 30] [Article Influence: 7.7] [Reference Citation Analysis]
103 Akerström G, Hellman P. Surgery on neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab 2007;21:87-109. [PMID: 17382267 DOI: 10.1016/j.beem.2006.12.004] [Cited by in Crossref: 110] [Cited by in F6Publishing: 83] [Article Influence: 7.3] [Reference Citation Analysis]
104 Chen Y, Ohki R. p53-PHLDA3-Akt Network: The Key Regulators of Neuroendocrine Tumorigenesis. Int J Mol Sci 2020;21:E4098. [PMID: 32521808 DOI: 10.3390/ijms21114098] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
105 Kang H, O'Connell JB, Leonardi MJ, Maggard MA, McGory ML, Ko CY. Rare tumors of the colon and rectum: a national review. Int J Colorectal Dis. 2007;22:183-189. [PMID: 16845516 DOI: 10.1007/s00384-006-0145-2] [Cited by in Crossref: 86] [Cited by in F6Publishing: 63] [Article Influence: 5.4] [Reference Citation Analysis]
106 Clin B, Andujar P, Abd Al Samad I, Azpitarte C, Le Pimpec-Barthes F, Billon-Galland MA, Danel C, Galateau-Salle F, Housset B, Legrand-Cattan K, Matrat M, Monnet I, Riquet M, Pairon JC. Pulmonary carcinoid tumors and asbestos exposure. Ann Occup Hyg 2012;56:789-95. [PMID: 22562831 DOI: 10.1093/annhyg/mes017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
107 Hsu C, Rashid A, Xing Y, Chiang YJ, Chagpar RB, Fournier KF, Chang GJ, You YN, Feig BW, Cormier JN. Varying malignant potential of appendiceal neuroendocrine tumors: importance of histologic subtype. J Surg Oncol. 2013;107:136-143. [PMID: 22767417 DOI: 10.1002/jso.23205] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
108 Liu DM, Kennedy A, Turner D, Rose SC, Kee ST, Whiting S, Murthy R, Nutting C, Heran M, Lewandowski R. Minimally invasive techniques in management of hepatic neuroendocrine metastatic disease. Am J Clin Oncol. 2009;32:200-215. [PMID: 19346815 DOI: 10.1097/coc.0b013e318172b3b6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
109 Howe JR, Cardona K, Fraker DL, Kebebew E, Untch BR, Wang YZ, Law CH, Liu EH, Kim MK, Menda Y, Morse BG, Bergsland EK, Strosberg JR, Nakakura EK, Pommier RF. The Surgical Management of Small Bowel Neuroendocrine Tumors: Consensus Guidelines of the North American Neuroendocrine Tumor Society. Pancreas. 2017;46:715-731. [PMID: 28609357 DOI: 10.1097/mpa.0000000000000846] [Cited by in Crossref: 173] [Cited by in F6Publishing: 94] [Article Influence: 43.3] [Reference Citation Analysis]
110 Elsayes KM, Menias CO, Bowerson M, Osman OM, Alkharouby AM, Hillen TJ. Imaging of carcinoid tumors: spectrum of findings with pathologic and clinical correlation. J Comput Assist Tomogr. 2011;35:72-80. [PMID: 21245692 DOI: 10.1097/rct.0b013e3181fd2044] [Cited by in Crossref: 22] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
111 Fan KY, Wild AT, Halappa VG, Kumar R, Ellsworth S, Ziegler M, Garg T, Rosati LM, Su Z, Hacker-Prietz A, Pawlik TM, Cosgrove DP, Hong KK, Kamel IR, Geschwind JF, Herman JM. Neuroendocrine tumor liver metastases treated with yttrium-90 radioembolization. Contemp Clin Trials 2016;50:143-9. [PMID: 27520932 DOI: 10.1016/j.cct.2016.08.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
112 Wang CH. Clinical features of neuroendocrine tumors in digestive system. Shijie Huaren Xiaohua Zazhi 2008; 16(24): 2788-2791 [DOI: 10.11569/wcjd.v16.i24.2788] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
113 Kinoshita T, Oshiro T, Urita T, Yoshida Y, Ooshiro M, Okazumi S, Katoh R, Sasai D, Hiruta N. Sporadic gastric carcinoid tumor successfully treated by two-stage laparoscopic surgery: A case report. World J Gastrointest Surg 2010; 2(11): 385-388 [PMID: 21160902 DOI: 10.4240/wjgs.v2.i11.385] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
114 Gladdy RA, Strong VE, Coit D, Allen PJ, Gerdes H, Shia J, Klimstra DS, Brennan MF, Tang LH. Defining Surgical Indications for Type I Gastric Carcinoid Tumor. Ann Surg Oncol 2009;16:3154-60. [DOI: 10.1245/s10434-009-0687-y] [Cited by in Crossref: 59] [Cited by in F6Publishing: 51] [Article Influence: 4.5] [Reference Citation Analysis]
115 Boch M, Rinke A, Rexin P, Seipelt M, Brödje D, Schober M, Gress TM, Michl P, Krug S. Paraneoplastic brainstem encephalitis in a patient with exceptionally long course of a metastasized neuroendocrine rectum neoplasm. BMC Cancer 2014;14:691. [PMID: 25244967 DOI: 10.1186/1471-2407-14-691] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
116 Saund MS, Al Natour RH, Sharma AM, Huang Q, Boosalis VA, Gold JS. Tumor size and depth predict rate of lymph node metastasis and utilization of lymph node sampling in surgically managed gastric carcinoids. Ann Surg Oncol. 2011;18:2826-2832. [PMID: 21455598 DOI: 10.1245/s10434-011-1652-0] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 3.6] [Reference Citation Analysis]
117 Kaifi JT, Kayser G, Ruf J, Passlick B. The Diagnosis and Treatment of Bronchopulmonary Carcinoid. Dtsch Arztebl Int 2015;112:479-85. [PMID: 26214234 DOI: 10.3238/arztebl.2015.0479] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
118 Stinner B, Rothmund M. Neuroendocrine tumours (carcinoids) of the appendix. Best Pract Res Clin Gastroenterol. 2005;19:729-738. [PMID: 16253897 DOI: 10.1016/j.bpg.2005.06.003] [Cited by in Crossref: 58] [Cited by in F6Publishing: 46] [Article Influence: 3.6] [Reference Citation Analysis]
119 Pitt SC, Chen H, Kunnimalaiyaan M. Inhibition of phosphatidylinositol 3-kinase/Akt signaling suppresses tumor cell proliferation and neuroendocrine marker expression in GI carcinoid tumors. Ann Surg Oncol 2009;16:2936-42. [PMID: 19588205 DOI: 10.1245/s10434-009-0591-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
120 Lehrman ED, Fidelman N. Liver-Directed Therapy for Neuroendocrine Tumor Liver Metastases in the Era of Peptide Receptor Radionuclide Therapy. Semin Intervent Radiol 2020;37:499-507. [PMID: 33328706 DOI: 10.1055/s-0040-1720951] [Reference Citation Analysis]
121 Tchana-Sato V, Detry O, Polus M, Thiry A, Detroz B, Maweja S, Hamoir E, Defechereux T, Coimbra C, Roover AD, Meurisse M, Honoré P. Carcinoid tumor of the appendix: A consecutive series from 1237 appendectomies. World J Gastroenterol 2006; 12(41): 6699-6701 [PMID: 17075987 DOI: 10.3748/wjg.v12.i41.6699] [Cited by in CrossRef: 77] [Cited by in F6Publishing: 55] [Article Influence: 4.8] [Reference Citation Analysis]
122 Filosso PL, Steering Committee, Asamura H, Brunelli A, Filosso PL, Garcia-yuste M, Lim E, Papagiannopoulos K, Sarkaria I, Thomas P; The European Society of Thoracic Surgeons (ESTS), Neuroendocrine Tumors of the Lung Working-Group. Knowledge of Pulmonary Neuroendocrine Tumors: Where Are We Now? Thoracic Surgery Clinics 2014;24:ix-xii. [DOI: 10.1016/j.thorsurg.2014.05.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
123 Sänger PW, Freesmeyer M. Early Dynamic 68Ga-DOTA-D-Phe1-Tyr3-Octreotide PET/CT in Patients With Hepatic Metastases of Neuroendocrine Tumors. Clin Nucl Med 2016;41:447-53. [PMID: 26859210 DOI: 10.1097/RLU.0000000000001154] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
124 Mezi S, Petrozza V, Schillaci O, La Torre V, Cimadon B, Leopizzi M, Orsi E, La Torre F. Neuroendocrine tumors of the gallbladder: a case report and review of the literature. J Med Case Rep. 2011;5:334. [PMID: 21801379 DOI: 10.1186/1752-1947-5-334] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
125 Wang YZ, Chauhan A, Hall MA. Adjuvant intraoperative post-dissectional tumor bed chemotherapy-A novel approach in treating midgut neuroendocrine tumors. J Gastrointest Oncol 2015;6:254-8. [PMID: 26029451 DOI: 10.3978/j.issn.2078-6891.2015.008] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
126 Yumoto S, Miyamoto Y, Akiyama T, Kiyozumi Y, Eto K, Hiyoshi Y, Nagai Y, Iwatsuki M, Baba Y, Iwagami S, Yoshida N, Baba H. Synchronous NET and colorectal cancer development: a case report. Surg Case Rep 2020;6:10. [PMID: 31919616 DOI: 10.1186/s40792-020-0777-4] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
127 Lepage C, Ciccolallo L, De Angelis R, Bouvier AM, Faivre J, Gatta G; EUROCARE working group. European disparities in malignant digestive endocrine tumours survival. Int J Cancer 2010;126:2928-34. [PMID: 19569047 DOI: 10.1002/ijc.24698] [Cited by in Crossref: 7] [Cited by in F6Publishing: 20] [Article Influence: 0.6] [Reference Citation Analysis]
128 Dincer HE, Podgaetz E, Andrade RS. Pulmonary Neuroendocrine Tumors: Part I. Spectrum and Characteristics of Tumors. J Bronchology Interv Pulmonol 2015;22:267-73. [PMID: 26165900 DOI: 10.1097/LBR.0000000000000157] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
129 Chen R, Liu X, Sun S, Wang S, Ge N, Wang G, Guo J. Comparison of Endoscopic Mucosal Resection With Circumferential Incision and Endoscopic Submucosal Dissection for Rectal Carcinoid Tumor. Surg Laparosc Endosc Percutan Tech. 2016;26:e56-e61. [PMID: 27213787 DOI: 10.1097/sle.0000000000000266] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
130 Borgonovi Christiano A, Gullo CE, Angelo Palmejani M, de Vita Marques AM, Pires Barbosa A, Pandolfi Basso M, Cernaglia Aureliano de Lima LG, Gomes Netinho J. Neuroendocrine tumor of the anal canal. GE Jornal Português de Gastrenterologia 2012;19:267-9. [DOI: 10.1016/j.jpg.2011.06.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
131 Franchi G, Manzoni MF. Cytological Ki-67 in pancreatic endocrine tumors: a new "must"? Gland Surg 2014;3:219-21. [PMID: 25493251 DOI: 10.3978/j.issn.2227-684X.2014.08.02] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
132 Stallone G, Infante B, Cormio L, Macarini L, Grandaliano G. Rapamycin Treatment for Benign Multicystic Peritoneal Mesothelioma: A Rare Disease with a Difficult Management. Am J Case Rep 2017;18:632-6. [PMID: 28579603 DOI: 10.12659/AJCR.903548] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
133 Gupta A, Lubner MG, Wertz RM, Foley E, Loeffler A, Pickhardt PJ. CT detection of primary and metastatic ileal carcinoid tumor: rates of missed findings and associated delay in clinical diagnosis. Abdom Radiol (NY) 2019;44:2721-8. [PMID: 31016344 DOI: 10.1007/s00261-019-01945-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
134 Bahra M, Jacob D, Pascher A, Plockinger U, Kristiansen G, Neuhaus P, Langrehr JM. Surgical strategies and predictors of outcome for malignant neuroendocrine tumors of the pancreas. J Gastroenterol Hepatol 2007;22:930-5. [DOI: 10.1111/j.1440-1746.2007.04893.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
135 Venkitaraman B, Karunanithi S, Kumar A, Khilnani GC, Kumar R. Role of 68Ga-DOTATOC PET/CT in initial evaluation of patients with suspected bronchopulmonary carcinoid. Eur J Nucl Med Mol Imaging 2014;41:856-64. [PMID: 24435773 DOI: 10.1007/s00259-013-2659-5] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
136 Yong JN, Lim XC, Nistala KRY, Lim LKE, Lim GEH, Quek J, Tham HY, Wong NW, Tan KK, Chong CS. Endoscopic submucosal dissection versus endoscopic mucosal resection for rectal carcinoid tumor. A meta-analysis and meta-regression with single-arm analysis. J Dig Dis 2021;22:562-71. [PMID: 34472210 DOI: 10.1111/1751-2980.13048] [Reference Citation Analysis]
137 Hughes MS, Azoury SC, Assadipour Y, Straughan DM, Trivedi AN, Lim RM, Joy G, Voellinger MT, Tang DM, Venkatesan AM. Prospective evaluation and treatment of familial carcinoid small intestine neuroendocrine tumors (SI-NETs). Surgery. 2016;159:350-356. [PMID: 26454678 DOI: 10.1016/j.surg.2015.05.041] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
138 Grozinsky-Glasberg S, Shimon I, Rubinfeld H. The role of cell lines in the study of neuroendocrine tumors. Neuroendocrinology. 2012;96:173-187. [PMID: 22538498 DOI: 10.1159/000338793] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
139 Yang Y, Lin J, Liu L, Huang S. 18F-FDG PET/CT detected mediastinal small-cell neuroendocrine carcinoma with all cardiac cavities metastases. J Nucl Cardiol 2020. [PMID: 33241475 DOI: 10.1007/s12350-020-02443-3] [Reference Citation Analysis]
140 Rinke A, Ricci S, Bajetta E, Jelic S. 9. Pharmacological Therapy of Neuroendocrine Tumors. Tumori 2010;96:847-57. [DOI: 10.1177/030089161009600538] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
141 Cojocari N, David L. Soft Tissue Primary Neuroendocrine Tumor: A Case Report. Am J Case Rep 2018;19:778-82. [PMID: 29967317 DOI: 10.12659/AJCR.909240] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
142 Park JY, Jeon TJ. Large Cell Neuroendocrine Carcinoma of the Extrahepatic Bile Duct. Korean J Gastroenterol 2018;72:318-21. [PMID: 30642152 DOI: 10.4166/kjg.2018.72.6.318] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
143 Akerström G, Hellman P, Hessman O, Osmak L. Management of midgut carcinoids. J Surg Oncol. 2005;89:161-169. [PMID: 15719373 DOI: 10.1002/jso.20188] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 3.9] [Reference Citation Analysis]
144 Castillo JG, Silvay G. Characterization and Management of Cardiac Tumors. Semin Cardiothorac Vasc Anesth 2010;14:6-20. [DOI: 10.1177/1089253210362596] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
145 Filippi L, Ciorra A, Sardella B, Schillaci O, Bagni O. Sequential Use of (90)Y Microspheres Radioembolization and (177)Lu-Dotatate in Pluri-Metastatic Neuroendocrine Tumors: A Case Report. Nucl Med Mol Imaging 2014;48:321-5. [PMID: 26396640 DOI: 10.1007/s13139-014-0292-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
146 Liu L, Broaddus RR, Yao JC, Xie S, White JA, Wu TT, Hamilton SR, Rashid A. Epigenetic alterations in neuroendocrine tumors: methylation of RAS-association domain family 1, isoform A and p16 genes are associated with metastasis. Mod Pathol. 2005;18:1632-1640. [PMID: 16258509 DOI: 10.1038/modpathol.3800490] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 3.9] [Reference Citation Analysis]
147 Johnbeck CB, Knigge U, Langer SW, Loft A, Berthelsen AK, Federspiel B, Binderup T, Kjaer A. Prognostic Value of 18 F-FLT PET in Patients with Neuroendocrine Neoplasms: A Prospective Head-to-Head Comparison with 18 F-FDG PET and Ki-67 in 100 Patients. J Nucl Med 2016;57:1851-7. [DOI: 10.2967/jnumed.116.174714] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
148 Ito T, Tanaka M, Sasano H, Osamura YR, Sasaki I, Kimura W, Takano K, Obara T, Ishibashi M, Nakao K. Preliminary results of a Japanese nationwide survey of neuroendocrine gastrointestinal tumors. J Gastroenterol. 2007;42:497-500. [PMID: 17671766 DOI: 10.1007/s00535-007-2056-6] [Cited by in Crossref: 83] [Cited by in F6Publishing: 48] [Article Influence: 5.5] [Reference Citation Analysis]
149 Siddiqui MT. Pulmonary neuroendocrine neoplasms: a review of clinicopathologic and cytologic features. Diagn Cytopathol 2010;38:607-17. [PMID: 19937767 DOI: 10.1002/dc.21244] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
150 Fernández KS, Aldrink JH, Ranalli M, Ruymann FB, Caniano DA. Carcinoid tumors in children and adolescents: risk for second malignancies. J Pediatr Hematol Oncol 2015;37:150-3. [PMID: 25374281 DOI: 10.1097/MPH.0000000000000280] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
151 Shi C, Gonzalez RS, Zhao Z, Koyama T, Cornish TC, Hande KR, Walker R, Sandler M, Berlin J, Liu EH. Liver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumors. Am J Clin Pathol 2015;143:398-404. [PMID: 25696798 DOI: 10.1309/AJCPQ55SKOCYFZHN] [Cited by in Crossref: 48] [Cited by in F6Publishing: 22] [Article Influence: 6.9] [Reference Citation Analysis]
152 Ezekian B, Adam MA, Turner MC, Gilmore BF, Freischlag K, Leraas HJ, Mantyh CR, Migaly J. Local excision results in comparable survival to radical resection for early-stage rectal carcinoid. J Surg Res 2018;230:28-33. [PMID: 30100036 DOI: 10.1016/j.jss.2018.04.038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
153 Lim T, Lee J, Kim JJ, Lee JK, Lee KT, Kim YH, Kim KW, Kim S, Sohn TS, Choi DW, Choi SH, Chun HK, Lee WY, Kim KM, Jang KT, Park YS. Gastroenteropancreatic neuroendocrine tumors: incidence and treatment outcome in a single institution in Korea. Asia Pac J Clin Oncol 2011;7:293-9. [PMID: 21884442 DOI: 10.1111/j.1743-7563.2011.01423.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
154 Sisson JC, Yanik GA. Theranostics: evolution of the radiopharmaceutical meta-iodobenzylguanidine in endocrine tumors. Semin Nucl Med 2012;42:171-84. [PMID: 22475426 DOI: 10.1053/j.semnuclmed.2011.11.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
155 Atwal D, Joshi KP, Jeffus S, Ntambi J, Mahmoud F. Well-Differentiated Neuroendocrine Tumor-A Low b-Grade Tumor's Aggressive Course and Dismal Outcome: A Case Report. Perm J 2017;21:16-193. [PMID: 28633725 DOI: 10.7812/TPP/16-193] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
156 Zavras N, Schizas D, Machairas N, Damaskou V, Economopoulos N, Machairas A. Carcinoid syndrome from a carcinoid tumor of the pancreas without liver metastases: A case report and literature review. Oncol Lett 2017;13:2373-6. [PMID: 28454406 DOI: 10.3892/ol.2017.5678] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
157 Roland CL, Starker LF, Kang Y, Chatterjee D, Estrella J, Rashid A, Katz MH, Aloia TA, Lee JE, Dasari A, Yao JC, Fleming JB. Loss of DPC4/SMAD4 expression in primary gastrointestinal neuroendocrine tumors is associated with cancer-related death after resection. Surgery 2017;161:753-9. [PMID: 27816207 DOI: 10.1016/j.surg.2016.09.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
158 Ellis L, Shale MJ, Coleman MP. Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971. Am J Gastroenterol. 2010;105:2563-2569. [PMID: 20823835 DOI: 10.1038/ajg.2010.341] [Cited by in Crossref: 149] [Cited by in F6Publishing: 136] [Article Influence: 12.4] [Reference Citation Analysis]
159 Zhu JG, Zhang ZT, Wu GC, Han W, Wang KL. Synchronous collision neuroendocrine tumor and rectal adenocarcinoma: a case report. Indian J Surg 2015;77:185-7. [PMID: 25972691 DOI: 10.1007/s12262-015-1256-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
160 Agarwal C, Goel S, Stern E, Warner R, Castillo J, Croft L, Lavine R, Zacks J. Carcinoid Heart Disease without Liver Involvement Caused by a Primary Ovarian Carcinoid Tumour. Heart Lung Circ 2015;24:e97-e100. [PMID: 25800541 DOI: 10.1016/j.hlc.2015.02.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
161 Máthé Z, Tagkalos E, Paul A, Molmenti EP, Kóbori L, Fouzas I, Beckebaum S, Sotiropoulos GC. Liver transplantation for hepatic metastases of neuroendocrine pancreatic tumors: a survival-based analysis. Transplantation 2011;91:575-82. [PMID: 21200365 DOI: 10.1097/TP.0b013e3182081312] [Cited by in Crossref: 34] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
162 Valadares LJ, Costa Junior W, Ribeiro HS, Diniz AL, Coimbra FJ, Herman P. Resection of liver metastasis from neuroendocrine tumors: evaluation of results and prognostic factors. Rev Col Bras Cir. 2015;42:25-31. [PMID: 25992697 DOI: 10.1590/0100-69912015001006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
163 Parra-Medina R, Moreno-Lucero P, Jimenez-Moreno J, Parra-Morales AM, Romero-Rojas A. Neuroendocrine neoplasms of gastrointestinal tract and secondary primary synchronous tumors: A systematic review of case reports. Casualty or causality? PLoS One 2019;14:e0216647. [PMID: 31086397 DOI: 10.1371/journal.pone.0216647] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
164 Moore JR, Greenwell B, Nuckolls K, Schammel D, Schisler N, Schammel C, Culumovic P, Mckinley BP, Trocha SD. Neuroendocrine Tumors of the Rectum: A 10-Year Review of Management. The American Surgeon 2011;77:198-200. [DOI: 10.1177/000313481107700221] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
165 Sundling KE, Zhang R, Matkowskyj KA. Pathologic Features of Primary Colon, Rectal, and Anal Malignancies. Cancer Treat Res 2016;168:309-30. [PMID: 29206380 DOI: 10.1007/978-3-319-34244-3_15] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
166 Cao LL, Lu J, Lin JX, Zheng CH, Li P, Xie JW, Wang JB, Chen QY, Lin M, Tu RH, Huang CM. Nomogram based on tumor-associated neutrophil-to-lymphocyte ratio to predict survival of patients with gastric neuroendocrine neoplasms. World J Gastroenterol 2017; 23(47): 8376-8386 [PMID: 29307997 DOI: 10.3748/wjg.v23.i47.8376] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
167 Roberts J, Gonzalez RS, Revetta F, Shi C. Mesenteric tumour deposits arising from small-intestine neuroendocrine tumours are frequently associated with fibrosis and IgG4-expressing plasma cells. Histopathology 2018;73:795-800. [PMID: 29943407 DOI: 10.1111/his.13693] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
168 Masood S, Gupta R, Jaiswal A, Bhardwaj G, Srivastav U. Neuroendocrine Carcinoma of the Colon: Emergency Presentation of a Rare Disease With Poor Biology. Cureus 2021;13:e19582. [PMID: 34926053 DOI: 10.7759/cureus.19582] [Reference Citation Analysis]
169 Lee HS, Moon HS, Kwon IS, Park JH, Kim JS, Kang SH, Lee ES, Kim SH, Sung JK, Lee BS, Jeong HY. Comparison of conventional and modified endoscopic mucosal resection methods for the treatment of rectal neuroendocrine tumors. Surg Endosc 2021;35:6055-65. [PMID: 33094828 DOI: 10.1007/s00464-020-08097-z] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
170 Msaouel P, Galanis E, Koutsilieris M. Somatostatin and somatostatin receptors: implications for neoplastic growth and cancer biology. Expert Opin Investig Drugs 2009;18:1297-316. [PMID: 19678799 DOI: 10.1517/13543780903176399] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
171 Weissferdt A, Tang X, Wistuba II, Moran CA. Comparative immunohistochemical analysis of pulmonary and thymic neuroendocrine carcinomas using PAX8 and TTF-1. Mod Pathol 2013;26:1554-60. [PMID: 23787439 DOI: 10.1038/modpathol.2013.111] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
172 Ricci C, Ingaldi C, Alberici L, Brighi N, Santini D, Mosconi C, Ambrosini V, Campana D, Minni F, Casadei R. Histopathological diagnosis of appendiceal neuroendocrine neoplasms: when to perform a right hemicolectomy? A systematic review and meta-analysis. Endocrine 2019;66:460-6. [DOI: 10.1007/s12020-019-01984-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
173 Pellino G, Marcellinaro R, Candilio G, De Fatico GS, Guadagno E, Campione S, Santangelo G, Reginelli A, Sciaudone G, Riegler G, Canonico S, Selvaggi F. The experience of a referral centre and literature overview of GIST and carcinoid tumours in inflammatory bowel diseases. International Journal of Surgery 2016;28:S133-41. [DOI: 10.1016/j.ijsu.2015.12.051] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
174 Dhali A, Ray S, Dhali GK. Primary Small Cell Neuroendocrine Tumour of Gallbladder Presenting as Pyrexia of Unknown Origin. Cureus 2021;13:e15874. [PMID: 34327099 DOI: 10.7759/cureus.15874] [Reference Citation Analysis]
175 Turshudzhyan A, Rezaizadeh H, Tadros M. Lessons learned: Preventable misses and near-misses of endoscopic procedures. World J Gastrointest Endosc 2022; 14(5): 302-310 [DOI: 10.4253/wjge.v14.i5.302] [Reference Citation Analysis]
176 Pathak S, Dash I, Taylor MR, Poston GJ. The surgical management of neuroendocrine tumour hepatic metastases. Eur J Surg Oncol 2013;39:224-8. [PMID: 23290582 DOI: 10.1016/j.ejso.2012.12.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
177 Zhong DD, Shao LM, Cai JT. Endoscopic mucosal resection vs endoscopic submucosal dissection for rectal carcinoid tumours: a systematic review and meta-analysis. Colorectal Dis. 2013;15:283-291. [PMID: 23083227 DOI: 10.1111/codi.12069] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.5] [Reference Citation Analysis]
178 Williams GT. Endocrine tumours of the gastrointestinal tract-selected topics. Histopathology. 2007;50:30-41. [PMID: 17204019 DOI: 10.1111/j.1365-2559.2006.02570.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
179 Hirai M, Matsumoto K, Ueyama H, Fukushima H, Murakami T, Sasaki H, Nagahara A, Yao T, Watanabe S. A case of neuroendocrine tumor G1 with unique histopathological growth progress. World J Gastrointest Endosc 2013; 5(12): 605-609 [PMID: 24368937 DOI: 10.4253/wjge.v5.i12.605] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
180 Jeon JH, Cheung DY, Lee SJ, Kim HJ, Kim HK, Cho HJ, Lee IK, Kim JI, Park SH, Kim JK. Endoscopic resection yields reliable outcomes for small rectal neuroendocrine tumors. Dig Endosc. 2014;26:556-563. [PMID: 24447261 DOI: 10.1111/den.12232] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
181 Tuna Y, Beyazit Y, Koklu S. Neuroendocrine tumor of the cecum in a young boy diagnosed by colonoscopic examination. Gastroenterol Nurs 2010;33:375-6. [PMID: 20890161 DOI: 10.1097/SGA.0b013e3181f2d4d2] [Reference Citation Analysis]
182 American Joint Committee on Cancer. Neuroendocrine Tumors. AJCC Cancer Staging Manual. New York: Springer; 2010. pp. 181-9. [DOI: 10.1007/978-0-387-88441-7_17] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
183 Stewart SL, Wike JM, Kato I, Lewis DR, Michaud F. A population-based study of colorectal cancer histology in the United States, 1998-2001. Cancer. 2006;107:1128-1141. [PMID: 16802325 DOI: 10.1002/cncr.22010] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 4.1] [Reference Citation Analysis]
184 Aamir MA, Sahebally SM, Gyorffy H, Aremu M. Extra-pulmonary primary small-cell neuroendocrine carcinoma arising from the duodenum: rare tumor, unusual location. Clin Case Rep 2017;5:2117-20. [PMID: 29225868 DOI: 10.1002/ccr3.1267] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
185 Saxena A, Chua TC, Zhao J, Morris DL. Liver-directed therapy for neuroendocrine neoplasm hepatic metastasis prolongs survival following progression after initial surgery. J Surg Oncol 2012;105:342-50. [PMID: 22006355 DOI: 10.1002/jso.22114] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
186 Galanopoulos M, Toumpanakis C. The Problem of Appendiceal Carcinoids. Endocrinol Metab Clin North Am 2018;47:661-9. [PMID: 30098722 DOI: 10.1016/j.ecl.2018.04.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
187 Yun SP, Shin N, Seo HI. Clinical outcomes of small cell neuroendocrine carcinoma and adenocarcinoma of the gallbladder. World J Gastroenterol 2015; 21(1): 269-275 [PMID: 25574101 DOI: 10.3748/wjg.v21.i1.269] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
188 Kenney B, Singh G, Salem RR, Paterno F, Robert ME, Jain D. Pseudointraductal papillary mucinous neoplasia caused by microscopic periductal endocrine tumors of the pancreas: a report of 3 cases. Hum Pathol 2011;42:1034-41. [PMID: 21292301 DOI: 10.1016/j.humpath.2010.09.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
189 Giammarile F, Billotey C, Lombard-bohas C, Le Bars D, Bournaud C, Masson S, Walter T, Houzard C, Scoazec J, Hervieu V, Vuillez J, Cornu C, Janier M, Borson-chazot F. 18F-FLT and 18F-FDG positron emission tomography for the imaging of advanced well-differentiated gastro-entero-pancreatic endocrine tumours. Nuclear Medicine Communications 2011;32:91-7. [DOI: 10.1097/mnm.0b013e3283412143] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
190 Montoriol PF, Boudinaud C. Ovarian metastases from ileal neuroendocrine tumour: Multimodality imaging. J Med Imaging Radiat Oncol 2019;63:349-51. [PMID: 30585699 DOI: 10.1111/1754-9485.12846] [Reference Citation Analysis]
191 Il Kim D, Il Seo H, Lee JY, Kim HS, Han KT. Curative Resection of Combined Neuroendocrine Carcinoma and Adenocarcinoma of the Gallbladder. Tumori 2011;97:815-8. [DOI: 10.1177/030089161109700623] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
192 Fukami Y, Kurumiya Y, Mizuno K, Sekoguchi E, Kobayashi S, Ito A, Tomida A, Onishi S, Shirotsuki R, Okubo K. A 12-mm carcinoid tumor of the minor duodenal papilla with lymph node metastases. Jpn J Clin Oncol. 2013;43:74-77. [PMID: 23136240 DOI: 10.1093/jjco/hys185] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
193 Srirajaskanthan R, Toumpanakis C, Meyer T, Caplin ME. Review article: future therapies for management of metastatic gastroenteropancreatic neuroendocrine tumours. Aliment Pharmacol Ther. 2009;29:1143-1154. [PMID: 19298583 DOI: 10.1111/j.1365-2036.2009.03988.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
194 Srisajjakul S, Prapaisilp P, Bangchokdee S. Imaging features of unusual lesions and complications associated with ovarian mature cystic teratoma. Clinical Imaging 2019;57:115-23. [DOI: 10.1016/j.clinimag.2019.05.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
195 Lopes Dias J, Cunha TM, Gomes FV, Callé C, Félix A. Neuroendocrine tumours of the female genital tract: a case-based imaging review with pathological correlation. Insights Imaging 2015;6:43-52. [PMID: 25592289 DOI: 10.1007/s13244-014-0378-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
196 Crea N, Pata G, Di Betta E, Titi A, Mittempergher F. High Incidence of Appendix Carcinoid Tumors Among Candidates for Bariatric Surgery: Diagnostic and Therapeutic Implications. OBES SURG 2011;21:151-6. [DOI: 10.1007/s11695-010-0112-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
197 Caobelli F, Pizzocaro C, Quartuccio N, Guerra UP. Unusual Widespread Metastatic Subcutaneous Lesions in a Patient With Ileal Carcinoid Evidenced by 68Ga-DOTATOC PET/CT. Clinical Nuclear Medicine 2014;39:391-2. [DOI: 10.1097/rlu.0000000000000377] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
198 Zeichner SB, Cusnir M, Francavilla M, Hirzel A. Typical bronchial carcinoid metastasizing to the brain: a case presentation. Case Rep Oncol 2011;4:602-10. [PMID: 22291640 DOI: 10.1159/000335557] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
199 Prasad V, Steffen IG, Pavel M, Denecke T, Tischer E, Apostolopoulou K, Pascher A, Arsenic R, Brenner W. Somatostatin receptor PET/CT in restaging of typical and atypical lung carcinoids. EJNMMI Res 2015;5:53. [PMID: 26458908 DOI: 10.1186/s13550-015-0130-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
200 Tsai HJ, Wu CC, Tsai CR, Lin SF, Chen LT, Chang JS. The epidemiology of neuroendocrine tumors in Taiwan: a nation-wide cancer registry-based study. PLoS One. 2013;8:e62487. [PMID: 23614051 DOI: 10.1371/journal.pone.0062487] [Cited by in Crossref: 81] [Cited by in F6Publishing: 77] [Article Influence: 9.0] [Reference Citation Analysis]
201 Curran T, Tulin-Silver S, Patel K, Ward S, Schneiderman M, Harpaz N, Schwartz M, Itzkowitz S, Warner RR, Kim MK. Prognostic clinicopathologic factors in longitudinally followed patients with metastatic small bowel carcinoid tumors. Pancreas 2011;40:1253-7. [PMID: 21975435 DOI: 10.1097/MPA.0b013e318225483c] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
202 In‘t Hof KH, van der Wal HC, Kazemier G, Lange JF. Carcinoid tumour of the appendix: an analysis of 1,485 consecutive emergency appendectomies. J Gastrointest Surg. 2008;12:1436-1438. [PMID: 18521695 DOI: 10.1007/s11605-008-0545-4] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 3.9] [Reference Citation Analysis]
203 Folkert IW, Sinnamon AJ, Concors SJ, Bennett BJ, Fraker DL, Mahmoud NN, Metz DC, Stashek KM, Roses RE. Grade is a Dominant Risk Factor for Metastasis in Patients with Rectal Neuroendocrine Tumors. Ann Surg Oncol 2020;27:855-63. [DOI: 10.1245/s10434-019-07848-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
204 Jernman J, Välimäki MJ, Louhimo J, Haglund C, Arola J. The Novel WHO 2010 Classification for Gastrointestinal Neuroendocrine Tumours Correlates Well with the Metastatic Potential of Rectal Neuroendocrine Tumours. Neuroendocrinology 2012;95:317-24. [DOI: 10.1159/000333035] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 4.5] [Reference Citation Analysis]
205 Lee HS, Chen M, Kim JH, Kim WH, Ahn S, Maeng K, Allegra CJ, Kaye FJ, Hochwald SN, Zajac-Kaye M. Analysis of 320 gastroenteropancreatic neuroendocrine tumors identifies TS expression as independent biomarker for survival. Int J Cancer 2014;135:128-37. [PMID: 24347111 DOI: 10.1002/ijc.28675] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
206 Zitzmann K, De Toni EN, Brand S, Göke B, Meinecke J, Spöttl G, Meyer HH, Auernhammer CJ. The novel mTOR inhibitor RAD001 (everolimus) induces antiproliferative effects in human pancreatic neuroendocrine tumor cells. Neuroendocrinology 2007;85:54-60. [PMID: 17310129 DOI: 10.1159/000100057] [Cited by in Crossref: 113] [Cited by in F6Publishing: 100] [Article Influence: 7.5] [Reference Citation Analysis]
207 Chiramel J, Almond R, Slagter A, Khan A, Wang X, Lim KHJ, Frizziero M, Chakrabarty B, Minicozzi A, Lamarca A, Mansoor W, Hubner RA, Valle JW, McNamara MG. Prognostic importance of lymph node yield after curative resection of gastroenteropancreatic neuroendocrine tumours. World J Clin Oncol 2020; 11(4): 205-216 [PMID: 32355642 DOI: 10.5306/wjco.v11.i4.205] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
208 Kaemmerer D, Träger T, Hoffmeister M, Sipos B, Hommann M, Sänger J, Schulz S, Lupp A. Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancy. Oncotarget 2015;6:27566-79. [PMID: 26259237 DOI: 10.18632/oncotarget.4491] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 5.7] [Reference Citation Analysis]
209 Wei G, Feng X, Wang W, Zhang Y, Zeng Y, Chen M, Chen Y, Chen J, Zhou Z, Li Y. Analysis of risk factors of lymph node metastasis in rectal neuroendocrine neoplasms using multicenter data. Future Oncology 2018;14:1817-23. [DOI: 10.2217/fon-2018-0059] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
210 Kidd M, Modlin IM, Mane SM, Camp RL, Eick GN, Latich I, Zikusoka MN. Utility of molecular genetic signatures in the delineation of gastric neoplasia. Cancer. 2006;106:1480-1488. [PMID: 16502410 DOI: 10.1002/cncr.21758] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
211 Page AJ, Weiss MJ, Pawlik TM. Surgical management of noncolorectal cancer liver metastases: Noncolorectal Liver Metatases. Cancer 2014;120:3111-21. [DOI: 10.1002/cncr.28743] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 6.1] [Reference Citation Analysis]
212 Niu C, Wang S, Guan Q, Ren X, Ji B, Liu Y. Neuroendocrine tumors of the gallbladder. Oncol Lett 2020;19:3381-8. [PMID: 32269610 DOI: 10.3892/ol.2020.11461] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
213 Debnath D, Rees J, Myint F. Are we missing diagnostic opportunities in cases of carcinoid tumours of the appendix? Surgeon. 2008;6:266-272. [PMID: 18939372 DOI: 10.1016/s1479-666x(08)80049-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
214 Pasieka JL, McEwan AJ, Rorstad O. The palliative role of 131I-MIBG and 111In-octreotide therapy in patients with metastatic progressive neuroendocrine neoplasms. Surgery. 2004;136:1218-1226. [PMID: 15657579 DOI: 10.1016/j.surg.2004.06.050] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 3.0] [Reference Citation Analysis]
215 Kantawala KP, Sonavane SK, Menias CO, Pai RK. Atypical Tumors of the Rectum With Pathologic Correlation. Current Problems in Diagnostic Radiology 2011;40:198-207. [DOI: 10.1067/j.cpradiol.2011.01.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
216 Shi M, Fan Z, Xu J, Yang J, Li Y, Gao C, Su P, Wang X, Zhan H. Gastroenteropancreatic neuroendocrine neoplasms G3: Novel insights and unmet needs. Biochim Biophys Acta Rev Cancer 2021;1876:188637. [PMID: 34678439 DOI: 10.1016/j.bbcan.2021.188637] [Reference Citation Analysis]
217 Yamashita S, Tanaka N, Takahashi M, Nagai M, Furuya T, Suzuki Y, Nomura Y. Pancreatic insulinoma combined with glucagon positive cell: A case report. World J Gastrointest Surg 2013; 5(3): 68-72 [PMID: 23556064 DOI: 10.4240/wjgs.v5.i3.68] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
218 Zar N, Garmo H, Holmberg L, Rastad J, Hellman P. Long-term survival of patients with small intestinal carcinoid tumors. World J Surg. 2004;28:1163-1168. [PMID: 15490058 DOI: 10.1007/s00268-004-7610-2] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 2.4] [Reference Citation Analysis]
219 Jiao X, Luan W, Peng X, Liu L, Zhang L, Zhou L. Effects of tumor origins and therapeutic options on the prognosis of hepatic neuroendocrine tumors: A retrospective study. Medicine (Baltimore) 2020;99:e23655. [PMID: 33371100 DOI: 10.1097/MD.0000000000023655] [Reference Citation Analysis]
220 Gu P, Wu J, Newman E, Muggia F. Treatment of liver metastases in patients with neuroendocrine tumors of gastroesophageal and pancreatic origin. Int J Hepatol 2012;2012:131659. [PMID: 22518318 DOI: 10.1155/2012/131659] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
221 Kim MK. Endoscopic ultrasound in gastroenteropancreatic neuroendocrine tumors. Gut Liver 2012;6:405-10. [PMID: 23170141 DOI: 10.5009/gnl.2012.6.4.405] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
222 Banfield A, Green S, Ramage J. Neuroendocrine tumour management: a team approach. British Journal of Hospital Medicine 2005;66:37-42. [DOI: 10.12968/hmed.2005.66.1.17534] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
223 Li J, Wang Y, Han F, Wang Z, Xu L, Tong J. Disadvantage of survival outcomes in widowed patients with colorectal neuroendocrine neoplasm: an analysis of surveillance, epidemiology and end results database. Oncotarget 2016;7:83200-7. [PMID: 27825123 DOI: 10.18632/oncotarget.13078] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
224 Kilickap S, Hayran KM. Epidemiology of Neuroendocrine Tumors. In: Yalcin S, Öberg K, editors. Neuroendocrine Tumours. Berlin: Springer Berlin Heidelberg; 2015. pp. 23-33. [DOI: 10.1007/978-3-662-45215-8_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
225 Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, Caplin M, Delle Fave G, Kaltsas GA, Krenning EP, Moss SF, Nilsson O, Rindi G, Salazar R, Ruszniewski P, Sundin A. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008;9:61-72. [PMID: 18177818 DOI: 10.1016/s1470-2045(07)70410-2] [Cited by in Crossref: 1032] [Cited by in F6Publishing: 431] [Article Influence: 73.7] [Reference Citation Analysis]
226 Chiappetta M, Sperduti I, Ciavarella LP, Leuzzi G, Bria E, Mucilli F, Lococo F, Filosso P, Ratto G, Spaggiari L, Facciolo F, Margaritora S. Prognostic score for survival with pulmonary carcinoids: the importance of associating clinical with pathological characteristics. Interact Cardiovasc Thorac Surg 2020;31:315-23. [PMID: 32747930 DOI: 10.1093/icvts/ivaa114] [Reference Citation Analysis]
227 Nau P, Liu J, Dillhoff M, Forster M, Hazey J, Melvin S. Two cases of small cell carcinoma of the gallbladder. Case Rep Med 2010;2010:453624. [PMID: 20953379 DOI: 10.1155/2010/453624] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
228 Masselli G, Guida M, Laghi F, Polettini E, Gualdi G. Magnetic Resonance of Small Bowel Tumors. Magn Reson Imaging Clin N Am 2020;28:75-88. [PMID: 31753238 DOI: 10.1016/j.mric.2019.08.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
229 Fischer L, Mehrabi A, Büchler MW. [Neuroendocrine tumors of the duodenum and pancreas. Surgical strategy]. Chirurg 2011;82:583-90. [PMID: 21656305 DOI: 10.1007/s00104-011-2069-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
230 Nwosu AC, Jones L, Vora J, Poston GJ, Vinjamuri S, Pritchard DM. Assessment of the efficacy and toxicity of (131)I-metaiodobenzylguanidine therapy for metastatic neuroendocrine tumours. Br J Cancer 2008;98:1053-8. [PMID: 18283308 DOI: 10.1038/sj.bjc.6604273] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
231 Zhou YU, Chen P, Zhong L. Compound gastroenteropancreatic neuroendocrine and gastrointestinal stromal tumors in the stomach: A case report. Oncol Lett 2015;10:2996-8. [PMID: 26722278 DOI: 10.3892/ol.2015.3666] [Reference Citation Analysis]
232 Argenta FF, Pereira PR, Bertolini M, Fratini LM, Saccaro RDO, Sonne L, Driemeier D, Pavarini SP. Carcinoid of the gallbladder in two dogs. Cienc Rural 2020;50:e20190445. [DOI: 10.1590/0103-8478cr20190445] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
233 Ni SJ, Sheng WQ, Du X. Pathologic research update of colorectal neuroendocrine tumors. World J Gastroenterol 2010; 16(14): 1713-1719 [PMID: 20380002 DOI: 10.3748/wjg.v16.i14.1713] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
234 Tapia Rico G, Townsend AR, Klevansky M, Price TJ. Liver metastases resection for gastric and esophageal tumors: is there enough evidence to go down this path? Expert Rev Anticancer Ther. 2016;16:1219-1225. [PMID: 27744727 DOI: 10.1080/14737140.2016.1249858] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
235 Lu C, Zhang Z, Jiang Y, Yang Z, Yang Q, Liao D, Bu H. Primary pure carcinoid tumors of the testis: Clinicopathological and immunophenotypical characteristics of 11 cases. Oncol Lett 2015;9:2017-22. [PMID: 26137005 DOI: 10.3892/ol.2015.3046] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
236 Ehehalt F, Saeger HD, Schmidt CM, Grützmann R. Neuroendocrine tumors of the pancreas. Oncologist. 2009;14:456-467. [PMID: 19411317 DOI: 10.1634/theoncologist.2008-0259] [Cited by in Crossref: 149] [Cited by in F6Publishing: 119] [Article Influence: 11.5] [Reference Citation Analysis]
237 Tsoukalas N, Chatzellis E, Rontogianni D, Alexandraki KI, Boutzios G, Angelousi A, Kaltsas G. Pancreatic carcinoids (serotonin-producing pancreatic neuroendocrine neoplasms): Report of 5 cases and review of the literature. Medicine (Baltimore) 2017;96:e6201. [PMID: 28422824 DOI: 10.1097/MD.0000000000006201] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
238 Slim K, Blay JY, Brouquet A, Chatelain D, Comy M, Delpero JR, Denet C, Elias D, Fléjou JF, Fourquier P, Fuks D, Glehen O, Karoui M, Kohneh-Shahri N, Lesurtel M, Mariette C, Mauvais F, Nicolet J, Perniceni T, Piessen G, Regimbeau JM, Rouanet P, sauvanet A, Schmitt G, Vons C, Lasser P, Belghiti J, Berdah S, Champault G, Chiche L, Chipponi J, Chollet P, De Baère T, Déchelotte P, Garcier JM, Gayet B, Gouillat C, Kianmanesh R, Laurent C, Meyer C, Millat B, Msika S, Nordlinger B, Paraf F, Partensky C, Peschaud F, Pocard M, Sastre B, Scoazec JY, Scotté M, Triboulet JP, Trillaud H, Valleur P. [Digestive oncology: surgical practices]. J Chir (Paris) 2009;146 Suppl 2:S11-80. [PMID: 19435621 DOI: 10.1016/S0021-7697(09)72398-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
239 Hendifar AE, Marchevsky AM, Tuli R. Neuroendocrine Tumors of the Lung: Current Challenges and Advances in the Diagnosis and Management of Well-Differentiated Disease. J Thorac Oncol 2017;12:425-36. [PMID: 27890494 DOI: 10.1016/j.jtho.2016.11.2222] [Cited by in Crossref: 87] [Cited by in F6Publishing: 91] [Article Influence: 14.5] [Reference Citation Analysis]
240 Faggiano A, Ferolla P, Grimaldi F, Campana D, Manzoni M, Davì MV, Bianchi A, Valcavi R, Papini E, Giuffrida D, Ferone D, Fanciulli G, Arnaldi G, Franchi GM, Francia G, Fasola G, Crinò L, Pontecorvi A, Tomassetti P, Colao A. Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian epidemiological study: the NET management study. J Endocrinol Invest 2012;35:817-23. [PMID: 22080849 DOI: 10.3275/8102] [Cited by in F6Publishing: 37] [Reference Citation Analysis]
241 Burkitt MD, Pritchard DM. Review article: Pathogenesis and management of gastric carcinoid tumours. Aliment Pharmacol Ther. 2006;24:1305-1320. [PMID: 17059512 DOI: 10.1111/j.1365-2036.2006.03130.x] [Cited by in Crossref: 104] [Cited by in F6Publishing: 94] [Article Influence: 6.9] [Reference Citation Analysis]
242 Drozdov I, Kidd M, Gustafsson BI, Svejda B, Joseph R, Pfragner R, Modlin IM. Autoregulatory effects of serotonin on proliferation and signaling pathways in lung and small intestine neuroendocrine tumor cell lines. Cancer 2009;115:4934-45. [PMID: 19634160 DOI: 10.1002/cncr.24533] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
243 Capdevila J, Casanovas O, Salazar R, Castellano D, Segura A, Fuster P, Aller J, García-Carbonero R, Jimenez-Fonseca P, Grande E, Castaño JP. Translational research in neuroendocrine tumors: pitfalls and opportunities. Oncogene 2017;36:1899-907. [PMID: 27641330 DOI: 10.1038/onc.2016.316] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
244 Whitney R, Vàlek V, Fages JF, Garcia A, Narayanan G, Tatum C, Hahl M, Martin RC. Transarterial chemoembolization and selective internal radiation for the treatment of patients with metastatic neuroendocrine tumors: a comparison of efficacy and cost. Oncologist. 2011;16:594-601. [PMID: 21508068 DOI: 10.1634/theoncologist.2010-0292] [Cited by in Crossref: 44] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
245 Marotta V, Franzese MD, Del Prete M, Chiofalo MG, Ramundo V, Esposito R, Marciello F, Pezzullo L, Carratù A, Vitale M, Colao A, Faggiano A. Targeted therapy with kinase inhibitors in aggressive endocrine tumors. Expert Opin Pharmacother 2013;14:1187-203. [PMID: 23675883 DOI: 10.1517/14656566.2013.796931] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
246 Al-Harbi O, Shakir M, Al-Brahim N. Gastric carcinoid and obesity: association or coincidence? Report of two cases and literature review. Case Rep Gastrointest Med 2013;2013:848075. [PMID: 23401809 DOI: 10.1155/2013/848075] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
247 Neophytou H, Mathieu A, Monseu M, Roblet D, Boissonot O, Andrieux V, Furudoï A, Donatini G. Upper gastrointestinal haemorrhage due to a small extra-papillary duodenal neuroendocrine tumour expressing somatostatin. Ann Endocrinol (Paris) 2015;76:697-701. [PMID: 26593862 DOI: 10.1016/j.ando.2015.06.002] [Reference Citation Analysis]
248 Johnson A, Wright JP, Zhao Z, Komaya T, Parikh A, Merchant N, Shi C. Cadherin 17 is frequently expressed by 'sclerosing variant' pancreatic neuroendocrine tumour. Histopathology 2015;66:225-33. [PMID: 25307987 DOI: 10.1111/his.12535] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
249 Gonulal B, Bilgic Y, Akbulut S, Karabulut E, Samdanci ET. Management and Survival Analysis of Gastrointestinal Neuroendocrine Tumors by Different Tumor Characteristics: Tertiary Center Experience. J Gastrointest Cancer 2021. [PMID: 34524616 DOI: 10.1007/s12029-021-00709-8] [Reference Citation Analysis]
250 Gustafsson BI, Kidd M, Modlin IM. Neuroendocrine tumors of the diffuse neuroendocrine system. Curr Opin Oncol. 2008;20:1-12. [PMID: 18043250 DOI: 10.1097/cco.0b013e3282f1c595] [Cited by in Crossref: 90] [Cited by in F6Publishing: 41] [Article Influence: 6.4] [Reference Citation Analysis]
251 Sen Gupta P, Grozinsky-glasberg S, Drake WM, Akker SA, Perry L, Grossman AB, Druce MR. Are serotonin metabolite levels related to bone mineral density in patients with neuroendocrine tumours? Clin Endocrinol 2014;80:246-52. [DOI: 10.1111/cen.12270] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
252 Li WY, Liu XD, Li WN, Dong SY, Qu XH, Gong SL, Shao MR, Zhang L. Paraneoplastic Cushing's syndrome associated with bronchopulmonary carcinoid tumor in youth: A case report and review of the literature. Oncol Lett 2016;12:69-72. [PMID: 27347101 DOI: 10.3892/ol.2016.4572] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
253 Weber K, Garman RH, Germann P, Hardisty JF, Krinke G, Millar P, Pardo ID. Classification of Neural Tumors in Laboratory Rodents, Emphasizing the Rat. Toxicol Pathol 2011;39:129-51. [DOI: 10.1177/0192623310392249] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
254 Han J, He Z. Late anastomotic perforation following surgery for gastric neuroendocrine tumor complicated by perforated duodenal ulcer: a case report. J Biomed Res 2013;27:159-62. [PMID: 23554807 DOI: 10.7555/JBR.27.20110109] [Reference Citation Analysis]
255 Kim SH, Park CH, Ki HS, Jun CH, Park SY, Kim HS, Choi SK, Rew JS. Endoscopic treatment of duodenal neuroendocrine tumors. Clin Endosc 2013;46:656-61. [PMID: 24340261 DOI: 10.5946/ce.2013.46.6.656] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
256 Zhao B, Hollandsworth HM, Lopez NE, Parry LA, Abbadessa B, Cosman BC, Ramamoorthy SL, Eisenstein S. Local excision versus radical resection in patients with rectal neuroendocrine tumours: a propensity score match analysis. ANZ J Surg 2020;90:E154-62. [PMID: 32808432 DOI: 10.1111/ans.16221] [Reference Citation Analysis]
257 Choi IS, Estecio MR, Nagano Y, Kim DH, White JA, Yao JC, Issa JP, Rashid A. Hypomethylation of LINE-1 and Alu in well-differentiated neuroendocrine tumors (pancreatic endocrine tumors and carcinoid tumors). Mod Pathol. 2007;20:802-810. [PMID: 17483816 DOI: 10.1038/modpathol.3800825] [Cited by in Crossref: 95] [Cited by in F6Publishing: 91] [Article Influence: 6.3] [Reference Citation Analysis]
258 Hofsli E. Genes involved in neuroendocrine tumor biology. Pituitary 2006;9:165-78. [PMID: 17001466 DOI: 10.1007/s11102-006-0262-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
259 Yan S, Wang Y, Chen X, Zhang Y, Huang Z, Zhao J, Zhou J, Li Z, Bi X, Luo Z, Cai J, Zhao H. Clinical Analysis of 15 Cases of Gallbladder Neuroendocrine Carcinoma and Comparison with Gallbladder Adenocarcinoma Using a Propensity Score Matching. Cancer Manag Res 2020;12:1437-46. [PMID: 32161496 DOI: 10.2147/CMAR.S227501] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
260 Wang L, Tang K, Zhang Q, Li H, Wen Z, Zhang H, Zhang H. Somatostatin receptor-based molecular imaging and therapy for neuroendocrine tumors. Biomed Res Int. 2013;2013:102819. [PMID: 24106690 DOI: 10.1155/2013/102819] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
261 Pelage JP, Fohlen A, Mitry E, Lagrange C, Beauchet A, Rougier P. Chemoembolization of Neuroendocrine Liver Metastases Using Streptozocin and Tris-acryl Microspheres: Embozar (EMBOsphere + ZAnosaR) Study. Cardiovasc Intervent Radiol 2017;40:394-400. [PMID: 28035432 DOI: 10.1007/s00270-016-1535-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
262 Chen SF, Kasajima A, Yazdani S, Chan MS, Wang L, He YY, Gao HW, Sasano H. Clinicopathologic significance of immunostaining of α-thalassemia/mental retardation syndrome X-linked protein and death domain-associated protein in neuroendocrine tumors. Hum Pathol 2013;44:2199-203. [PMID: 23954140 DOI: 10.1016/j.humpath.2013.04.025] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
263 Gopalan S, Raghu V. Unravelling the Mysteries of the Mesentery. Journal of Gastrointestinal and Abdominal Radiology 2021;04:033-48. [DOI: 10.1055/s-0040-1718247] [Reference Citation Analysis]
264 Vawdrey DB, Fitzsimmons S, Veldtman GR, Carpenter JP. Therapeutic pulmonary artery stenting for metastatic bronchial carcinoid. BMJ Case Rep 2013;2013:bcr2013201123. [PMID: 24068381 DOI: 10.1136/bcr-2013-201123] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
265 Kocha W, Maroun J, Kennecke H, Law C, Metrakos P, Ouellet JF, Reid R, Rowsell C, Shah A, Singh S, Van Uum S, Wong R. Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian National Expert Group. Curr Oncol 2010;17:49-64. [PMID: 20567626 DOI: 10.3747/co.v17i3.484] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
266 Grąt M, Remiszewski P, Smoter P, Wronka K, Grąt K, Lewandowski Z, Koperski Ł, Górnicka B, Pacho R, Zborowska H, Patkowski W, Krawczyk M. Outcomes Following Liver Transplantation for Metastatic Neuroendocrine Tumors. Transplantation Proceedings 2014;46:2766-9. [DOI: 10.1016/j.transproceed.2014.09.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
267 Duan X, Zhao M, Zhang S, Xu Z, Mi L, Shi J, Ma X, Liu Y, Li N, Yin X, Han X, Han G, Wang J, Xu J, Yin F. Effects of tumor distance from anal verge on survival outcomes for rectal NENs and lymphatic metastasis risk score for colorectal NENs. Int J Colorectal Dis 2020;35:1255-64. [PMID: 32314191 DOI: 10.1007/s00384-020-03596-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
268 Safford SD, Coleman RE, Gockerman JP, Moore J, Feldman J, Onaitis MW, Tyler DS, Olson JA. Iodine-131 metaiodobenzylguanidine treatment for metastatic carcinoid. Results in 98 patients. Cancer. 2004;101:1987-1993. [PMID: 15455358 DOI: 10.1002/cncr.20592] [Cited by in Crossref: 67] [Cited by in F6Publishing: 53] [Article Influence: 3.7] [Reference Citation Analysis]
269 Zhao ZM, Wang J, Ugwuowo UC, Wang L, Townsend JP. Primary hepatic neuroendocrine carcinoma: report of two cases and literature review. BMC Clin Pathol 2018;18:3. [PMID: 29507528 DOI: 10.1186/s12907-018-0070-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
270 Hassan MM, Phan A, Li D, Dagohoy CG, Leary C, Yao JC. Risk factors associated with neuroendocrine tumors: A U.S.-based case-control study. Int J Cancer. 2008;123:867-873. [PMID: 18491401 DOI: 10.1002/ijc.23529] [Cited by in Crossref: 126] [Cited by in F6Publishing: 107] [Article Influence: 9.0] [Reference Citation Analysis]
271 Fanti S, Ambrosini V, Tomassetti P, Castellucci P, Montini G, Allegri V, Grassetto G, Rubello D, Nanni C, Franchi R. Evaluation of unusual neuroendocrine tumours by means of 68Ga-DOTA-NOC PET. Biomed Pharmacother 2008;62:667-71. [PMID: 18358680 DOI: 10.1016/j.biopha.2008.01.010] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 4.1] [Reference Citation Analysis]
272 Woltering EA, Voros BA, Beyer DT, Thiagarajan R, Ramirez RA, Mamikunian G, Boudreaux JP. Plasma Pancreastatin Predicts the Outcome of Surgical Cytoreduction in Neuroendocrine Tumors of the Small Bowel. Pancreas 2019;48:356-62. [PMID: 30768573 DOI: 10.1097/MPA.0000000000001263] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
273 Bushnell DL, O'Dorisio TM, O'Dorisio MS, Menda Y, Hicks RJ, Van Cutsem E, Baulieu JL, Borson-Chazot F, Anthony L, Benson AB, Oberg K, Grossman AB, Connolly M, Bouterfa H, Li Y, Kacena KA, LaFrance N, Pauwels SA. 90Y-edotreotide for metastatic carcinoid refractory to octreotide. J Clin Oncol. 2010;28:1652-1659. [PMID: 20194865 DOI: 10.1200/jco.2009.22.8585] [Cited by in Crossref: 215] [Cited by in F6Publishing: 83] [Article Influence: 17.9] [Reference Citation Analysis]
274 Cernaianu G, Tannapfel A, Nounla J, Gonzalez-vasquez R, Wiesel T, Tröbs R. Appendiceal carcinoid tumor with lymph node metastasis in a child: case report and review of the literature. Journal of Pediatric Surgery 2010;45:e1-5. [DOI: 10.1016/j.jpedsurg.2010.07.025] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
275 AlSaffar A, Wood S, AlRabiy F, Hamie D, Termos S. A Well-Differentiated Grade-3 Neuroendocrine Tumor in the Ascending Colon: A Case Report. Am J Case Rep 2022;23:e933792. [PMID: 35013091 DOI: 10.12659/AJCR.933792] [Reference Citation Analysis]
276 Genc CG, Klümpen HJ, van Oijen MGH, van Eijck CHJ, Nieveen van Dijkum EJM. A Nationwide Population-Based Study on the Survival of Patients with Pancreatic Neuroendocrine Tumors in The Netherlands. World J Surg 2018;42:490-7. [PMID: 29018912 DOI: 10.1007/s00268-017-4278-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
277 Virgone C, Ferrari A, Chiaravalli S, De Pasquale MD, Inserra A, D'Angelo P, Ogunleye MF, Crocoli A, Vallero S, Cesaro S, Alaggio R, Bisogno G, Dall'Igna P. Extra-appendicular neuroendocrine tumors: A report from the TREP project (2000-2020). Pediatr Blood Cancer 2021;68:e28880. [PMID: 33522705 DOI: 10.1002/pbc.28880] [Reference Citation Analysis]
278 Zacharias DG, Jensen MH, Farley DR. Long-term survival with metastatic carcinoid tumors: a case report and review of the literature. J Surg Educ 2010;67:99-102. [PMID: 20656606 DOI: 10.1016/j.jsurg.2010.02.006] [Reference Citation Analysis]
279 Kunnimalaiyaan M, Traeger K, Chen H. Conservation of the Notch1 signaling pathway in gastrointestinal carcinoid cells. Am J Physiol Gastrointest Liver Physiol 2005;289:G636-42. [PMID: 16160079 DOI: 10.1152/ajpgi.00146.2005] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 3.5] [Reference Citation Analysis]
280 Perren A, Schmitt A, Komminoth P, Pavel M. [Classification of gastro-entero-pancreatic neuroendocrine tumors]. Radiologe 2009;49:198-205. [PMID: 19224191 DOI: 10.1007/s00117-008-1781-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
281 Mocellin S, Nitti D. Gastrointestinal carcinoid: epidemiological and survival evidence from a large population-based study (n = 25 531). Ann Oncol. 2013;24:3040-3044. [PMID: 24050954 DOI: 10.1093/annonc/mdt377] [Cited by in Crossref: 75] [Cited by in F6Publishing: 59] [Article Influence: 8.3] [Reference Citation Analysis]
282 Sappenfield R, Gonzalez IA, Cao D, Chatterjee D. Well-differentiated rectal neuroendocrine tumors: analysis of histology, including insulinoma-associated protein 1 expression, and biologic behavior, involving a large cohort of 94 cases. Hum Pathol 2020;104:66-72. [PMID: 32763255 DOI: 10.1016/j.humpath.2020.07.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
283 Shen Y, Luo X, Guan Q, Cheng L. Development, validation and standardization of urinary 5-hydroxyindoleacetic acid determination by LC-MS/MS for implementation in quality-controlled environments. Journal of Chromatography B 2022. [DOI: 10.1016/j.jchromb.2022.123315] [Reference Citation Analysis]
284 Wang YZ, Greiffenstein P. Ingestion of a foreign body unmasks an asymptomatic small bowel carcinoid tumor. Clin Pract 2012;2:e2. [PMID: 24765401 DOI: 10.4081/cp.2012.e2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
285 Delle Fave G, Capurso G, Annibale B, Panzuto F. Gastric neuroendocrine tumors. Neuroendocrinology. 2004;80 Suppl 1:16-19. [PMID: 15477710 DOI: 10.1159/000080734] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
286 Limbach KE, Pommier SJ, Dewey E, Leon E, Pommier RF. Neuroendocrine metastases to the ovaries are significantly associated with small bowel neuroendocrine tumors and carcinomatosis. Am J Surg 2020;219:795-9. [PMID: 32145918 DOI: 10.1016/j.amjsurg.2020.02.040] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
287 Hodgson N, Koniaris LG, Livingstone AS, Franceschi D. Gastric carcinoids: a temporal increase with proton pump introduction. Surg Endosc. 2005;19:1610-1612. [PMID: 16211437 DOI: 10.1007/s00464-005-0232-4] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 3.5] [Reference Citation Analysis]
288 Mcconnell YJ. Surgical management of rectal carcinoids: trends and outcomes from the Surveillance, Epidemiology, and End Results database (1988 to 2012). The American Journal of Surgery 2016;211:877-85. [DOI: 10.1016/j.amjsurg.2016.01.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
289 Castillo JG, Silvay G, Solís J. Current concepts in diagnosis and perioperative management of carcinoid heart disease. Semin Cardiothorac Vasc Anesth 2013;17:212-23. [PMID: 23171718 DOI: 10.1177/1089253212465475] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
290 Frilling A, Weber F, Cicinnati V, Broelsch C. Role of radiolabeled octreotide therapy in patients with metastatic neuroendocrine neoplasms. Expert Rev Endocrinol Metab 2007;2:517-27. [PMID: 30290419 DOI: 10.1586/17446651.2.4.517] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
291 Bapatla A, Syed A, Mohammed AFS, Jones CV, Ismail R. Type I Gastric Neuroendocrine Tumor Presenting as Acute Upper Gastrointestinal Bleed. Cureus 2021;13:e15343. [PMID: 34094786 DOI: 10.7759/cureus.15343] [Reference Citation Analysis]
292 Park SB, Kim DJ, Kim HW, Choi CW, Kang DH, Kim SJ, Nam HS. Is endoscopic ultrasonography essential for endoscopic resection of small rectal neuroendocrine tumors? World J Gastroenterol 2017; 23(11): 2037-2043 [PMID: 28373770 DOI: 10.3748/wjg.v23.i11.2037] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
293 Tsilimigras DI, Brodt P, Clavien PA, Muschel RJ, D'Angelica MI, Endo I, Parks RW, Doyle M, de Santibañes E, Pawlik TM. Liver metastases. Nat Rev Dis Primers 2021;7:27. [PMID: 33859205 DOI: 10.1038/s41572-021-00261-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
294 Caldarella A, Crocetti E, Paci E. Distribution, incidence, and prognosis in neuroendocrine tumors: a population based study from a cancer registry. Pathol Oncol Res. 2011;17:759-763. [PMID: 21476126 DOI: 10.1007/s12253-011-9382-y] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
295 Rajekar H, Bogammana K, Stubbs RS. Selective internal radiation therapy for gastrointestinal neuroendocrine tumour liver metastases: a new and effective modality for treatment. Int J Hepatol 2011;2011:404916. [PMID: 22164335 DOI: 10.4061/2011/404916] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
296 Saxena A, Chua TC, Perera M, Chu F, Morris DL. Surgical resection of hepatic metastases from neuroendocrine neoplasms: a systematic review. Surg Oncol 2012;21:e131-41. [PMID: 22658833 DOI: 10.1016/j.suronc.2012.05.001] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 7.3] [Reference Citation Analysis]
297 Limbach KE, Condron ME, Bingham AE, Pommier SJ, Pommier RF. Β-Adrenergic agonist administration is not associated with secondary carcinoid crisis in patients with carcinoid tumor. Am J Surg 2019;217:932-6. [PMID: 30635207 DOI: 10.1016/j.amjsurg.2018.12.070] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
298 Liu EH, Solorzano CC, Katznelson L, Vinik AI, Wong R, Randolph G. AACE/ACE disease state clinical review: diagnosis and management of midgut carcinoids. Endocr Pract. 2015;21:534-545. [PMID: 25962092 DOI: 10.4158/ep14464.dsc] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
299 Eriksson J, Norlén O, Ögren M, Garmo H, Ihre-Lundgren C, Hellman P. Primary small intestinal neuroendocrine tumors are highly prevalent and often multiple before metastatic disease develops. Scand J Surg 2021;110:44-50. [PMID: 31587594 DOI: 10.1177/1457496919874484] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
300 Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current Status of Gastrointestinal Carcinoids. Gastroenterology 2005;128:1717-51. [DOI: 10.1053/j.gastro.2005.03.038] [Reference Citation Analysis]
301 Kelly EF, Connelly ZM, Noonan MJ, Gu X, Khater N. Primary Renal Carcinoid: Two Rare Cases at a Single Center. Cureus 2021;13:e13907. [PMID: 33880263 DOI: 10.7759/cureus.13907] [Reference Citation Analysis]
302 Schreckenbach T, Hübert H, Koch C, Bojunga J, Schnitzbauer AA, Bechstein WO, Holzer K. Surgical resection of neuroendocrine tumor liver metastases as part of multimodal treatment strategies: A propensity score matching analysis. European Journal of Surgical Oncology 2019;45:808-15. [DOI: 10.1016/j.ejso.2018.12.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
303 Hanna A, Kim-Kiselak C, Tang R, Metz DC, Yang Z, DeMatteo R, Fraker DL, Roses RE. Gastric Neuroendocrine Tumors: Reappraisal of Type in Predicting Outcome. Ann Surg Oncol 2021. [PMID: 34120268 DOI: 10.1245/s10434-021-10293-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
304 Martz J, Jain S, Vahdat LT, Qin L, Mosquera JM, Antonescu CR, Popa EC. High-grade KIT-negative sarcoma of the small bowel in a patient with chronic myeloid leukemia receiving long-term tyrosine kinase inhibitors. J Clin Oncol 2013;31:e181-5. [PMID: 23439757 DOI: 10.1200/JCO.2012.42.7989] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
305 Zar N, Garmo H, Holmberg L, Hellman P. Risk of second primary malignancies and causes of death in patients with adenocarcinoma and carcinoid of the small intestine. Eur J Cancer. 2008;44:718-725. [PMID: 18207733 DOI: 10.1016/j.ejca.2007.12.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
306 Treglia G, Sadeghi R, Giovinazzo F, Galiandro F, Annunziata S, Muoio B, Kroiss AS. PET with Different Radiopharmaceuticals in Neuroendocrine Neoplasms: An Umbrella Review of Published Meta-Analyses. Cancers (Basel) 2021;13:5172. [PMID: 34680321 DOI: 10.3390/cancers13205172] [Reference Citation Analysis]
307 Phan AT, Öberg K, Choi J, Harrison LH, Hassan MM, Strosberg JR, Krenning EP, Kocha W, Woltering EA, Maples WJ. NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors: Well-Differentiated Neuroendocrine Tumors of the Thorax (Includes Lung and Thymus). Pancreas 2010;39:784-98. [DOI: 10.1097/mpa.0b013e3181ec1380] [Cited by in Crossref: 118] [Cited by in F6Publishing: 50] [Article Influence: 9.8] [Reference Citation Analysis]
308 Caobelli F, Bertagna F, Panarotto MB, Paghera B, Giubbini R. An Unusual Muscular Metastasis in a Patient Affected by Ileal Carcinoid Imaged With a 111In-Pentetreotide SPECT/CT Scan and Confirmed by Biopsy. Clinical Nuclear Medicine 2011;36:696-7. [DOI: 10.1097/rlu.0b013e3182177376] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
309 Zhang X, Cornish TC, Yang L, Bennett TD, Ghosh D, Xing F. Generative Adversarial Domain Adaptation for Nucleus Quantification in Images of Tissue Immunohistochemically Stained for Ki-67. JCO Clin Cancer Inform 2020;4:666-79. [PMID: 32730116 DOI: 10.1200/CCI.19.00108] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
310 Ardill JE. Circulating markers for endocrine tumours of the gastroenteropancreatic tract. Ann Clin Biochem. 2008;45:539-559. [PMID: 18941127 DOI: 10.1258/acb.2008.008039] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
311 de Mestier L, Neuzillet C, Hentic O, Kianmanesh R, Hammel P, Ruszniewski P. Prolonged survival in a patient with neuroendocrine tumor of the cecum and diffuse peritoneal carcinomatosis. Case Rep Gastroenterol. 2012;6:205-210. [PMID: 22649333 DOI: 10.1159/000338740] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
312 Kusne YN, Kosiorek HE, Buras MR, Verona PM, Coppola KE, Rone KA, Cook CB, Karlin NJ. Implications of neuroendocrine tumor and diabetes mellitus on patient outcomes and care: a matched case-control study. Future Sci OA 2021;7:FSO684. [PMID: 34046189 DOI: 10.2144/fsoa-2020-0190] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
313 Do MY, Jang SI, Kang HP, Kim EJ, Lee KJ, Park GE, Lee SJ, Lee DK, Woo SM, Cho JH. Comparison of the Clinical Features and Outcomes of Gallbladder Neuroendocrine Carcinoma with Those of Adenocarcinoma: A Propensity Score-Matched Analysis. Cancers (Basel) 2021;13:4713. [PMID: 34572940 DOI: 10.3390/cancers13184713] [Reference Citation Analysis]
314 Devcic Z, Rosenberg J, Braat AJ, Techasith T, Banerjee A, Sze DY, Lam MG. The efficacy of hepatic 90Y resin radioembolization for metastatic neuroendocrine tumors: a meta-analysis. J Nucl Med 2014;55:1404-10. [PMID: 25012459 DOI: 10.2967/jnumed.113.135855] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 6.3] [Reference Citation Analysis]
315 Gaujoux S, Sauvanet A, Belghiti J. Place of surgical resection in the treatment strategy of gastrointestinal neuroendocrine tumors. Target Oncol 2012;7:153-9. [PMID: 22923166 DOI: 10.1007/s11523-012-0230-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
316 Hayes D, Morgan H, Brown N. New murmur. Heart 2020;106:1926-52. [PMID: 33243785 DOI: 10.1136/heartjnl-2020-317521] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
317 Martini C, Buxbaum S, Rodrigues M, Nilica B, Scarpa L, Holzner B, Virgolini I, Gamper EM. Quality of Life in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors Receiving Peptide Receptor Radionuclide Therapy: Information from a Monitoring Program in Clinical Routine. J Nucl Med. 2018;59:1566-1573. [PMID: 30042164 DOI: 10.2967/jnumed.117.204834] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
318 Tiktinsky E, Horne T, Agranovich S, Lantsberg S. Intramuscular Metastasis of Carcinoid Tumor: A Rare Manifestation. Clinical Nuclear Medicine 2008;33:484-5. [DOI: 10.1097/rlu.0b013e3181779374] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
319 Jacob J, Chargari C, Helissey C, Ferrand FR, Ceccaldi B, Le Moulec S, Bauduceau O, Fayolle M, Védrine L. [Neuroendocrine carcinoma of the digestive tract: a literature review]. Rev Med Interne 2013;34:700-5. [PMID: 23871177 DOI: 10.1016/j.revmed.2013.02.013] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
320 Gao L, Lipka S, Hurtado-Cordovi J, Avezbakiyev B, Zuretti A, Rizvon K, Mustacchia P. Synchronous Duodenal Carcinoid and Adenocarcinoma of the Colon. World J Oncol 2012;3:239-42. [PMID: 29147314 DOI: 10.4021/wjon554w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
321 Soga J. Early-stage carcinoids of the gastrointestinal tract: an analysis of 1914 reported cases. Cancer 2005;103:1587-95. [PMID: 15742328 DOI: 10.1002/cncr.20939] [Cited by in Crossref: 221] [Cited by in F6Publishing: 174] [Article Influence: 13.0] [Reference Citation Analysis]
322 Galm T, Turner N. Primary carcinoid tumour of nasal septum. J Laryngol Otol 2009;123:789-92. [PMID: 18761767 DOI: 10.1017/S0022215108003411] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
323 Randle RW, Northrup SA, Sirintrapun SJ, Lyles DS, Stewart JH 4th. Oncolytic vesicular stomatitis virus as a treatment for neuroendocrine tumors. Surgery 2013;154:1323-29; discussion 1329-30. [PMID: 23973113 DOI: 10.1016/j.surg.2013.04.050] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
324 Massironi S, Del Gobbo A, Cavalcoli F, Fiori S, Conte D, Pellegrinelli A, Milione M, Ferrero S. IMP3 expression in small-intestine neuroendocrine neoplasms: a new predictor of recurrence. Endocrine 2017;58:360-7. [PMID: 28210937 DOI: 10.1007/s12020-017-1249-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
325 Jacobs MA, Weinstein S, Hope TA, Aslam R, Yee J, Coakley F. Neuroendocrine tumors: beyond the abdomen. J Comput Assist Tomogr 2014;38:898-914. [PMID: 25162290 DOI: 10.1097/RCT.0000000000000140] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
326 Strosberg J, Nasir A, Cragun J, Gardner N, Kvols L. Metastatic carcinoid tumor to the ovary: A clinicopathologic analysis of seventeen cases. Gynecologic Oncology 2007;106:65-8. [DOI: 10.1016/j.ygyno.2007.02.034] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
327 Broder MS, Cai B, Chang E, Neary MP. Incidence and prevalence of neuroendocrine tumors of the lung: analysis of a US commercial insurance claims database. BMC Pulm Med 2018;18:135. [PMID: 30103725 DOI: 10.1186/s12890-018-0678-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
328 Goede AC, Caplin ME, Winslet MC. Carcinoid tumour of the appendix. Br J Surg. 2003;90:1317-1322. [PMID: 14598408 DOI: 10.1002/bjs.4375] [Cited by in Crossref: 136] [Cited by in F6Publishing: 99] [Article Influence: 7.2] [Reference Citation Analysis]
329 Merg A, Wirtzfeld D, Wang J, Cheney R, Dunn KB, Rajput A. Viability of Endoscopic and Excisional Treatment of Early Rectal Carcinoids. J Gastrointest Surg 2007;11:893-7. [DOI: 10.1007/s11605-007-0153-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
330 Leong C. Ileal volvulus and its association with carcinoid tumours. Australas Med J. 2012;5:326-328. [PMID: 22848331 DOI: 10.4066/AMJ.2012.1239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
331 Walter D, Harter PN, Battke F, Winkelmann R, Schneider M, Holzer K, Koch C, Bojunga J, Zeuzem S, Hansmann ML, Peveling-Oberhag J, Waidmann O. Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors. Sci Rep 2018;8:3811. [PMID: 29491456 DOI: 10.1038/s41598-018-22115-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
332 Motz BM, Lorimer PD, Boselli D, Hill JS, Salo JC. Optimal Lymphadenectomy in Small Bowel Neuroendocrine Tumors: Analysis of the NCDB. J Gastrointest Surg 2018;22:117-23. [DOI: 10.1007/s11605-017-3524-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
333 Khan MU, Khan S, El-Refaie S, Win Z, Rubello D, Al-Nahhas A. Clinical indications for Gallium-68 positron emission tomography imaging. Eur J Surg Oncol 2009;35:561-7. [PMID: 19201567 DOI: 10.1016/j.ejso.2009.01.007] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 3.8] [Reference Citation Analysis]
334 Wang M, Peng J, Yang W, Chen W, Mo S, Cai S. Prognostic analysis for carcinoid tumours of the rectum: a single institutional analysis of 106 patients. Colorectal Dis. 2011;13:150-153. [PMID: 19863599 DOI: 10.1111/j.1463-1318.2009.02090.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
335 Shi H, Jiang C, Zhang Q, Qi C, Yao H, Lin R. Clinicopathological heterogeneity between primary and metastatic sites of gastroenteropancreatic neuroendocrine neoplasm. Diagn Pathol 2020;15:108. [PMID: 32917216 DOI: 10.1186/s13000-020-01030-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
336 Mcgrath S, Nicklin J. Clinicopathological study of ovarian carcinoid tumours. Aust N Z J Obstet Gynaecol 2016;56:508-13. [DOI: 10.1111/ajo.12503] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
337 Li TT, Qiu F, Qian ZR, Wan J, Qi XK, Wu BY. Classification, clinicopathologic features and treatment of gastric neuroendocrine tumors. World J Gastroenterol 2014; 20(1): 118-125 [PMID: 24415864 DOI: 10.3748/wjg.v20.i1.118] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 45] [Article Influence: 5.9] [Reference Citation Analysis]
338 Dotto J, Mezzetti T, Hui P. Primary or Secondary? Genotyping Confirmation of an Ovarian Primary Carcinoid Tumor: . International Journal of Gynecological Pathology 2008;27:33-6. [DOI: 10.1097/pgp.0b13e318053df4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
339 Valkema R, Pauwels S, Kvols LK, Barone R, Jamar F, Bakker WH, Kwekkeboom DJ, Bouterfa H, Krenning EP. Survival and response after peptide receptor radionuclide therapy with [90Y-DOTA0,Tyr3]octreotide in patients with advanced gastroenteropancreatic neuroendocrine tumors. Semin Nucl Med. 2006;36:147-156. [PMID: 16517236 DOI: 10.1053/j.semnuclmed.2006.01.001] [Cited by in Crossref: 211] [Cited by in F6Publishing: 181] [Article Influence: 13.2] [Reference Citation Analysis]
340 Pikin O, Ryabov A, Sokolov V, Glushko V, Kolbanov K, Telegina L, Amiraliev A, Barmin V. Two-Stage Surgery Without Parenchyma Resection for Endobronchial Carcinoid Tumor. The Annals of Thoracic Surgery 2017;104:1846-51. [DOI: 10.1016/j.athoracsur.2017.06.050] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
341 Wang XY, Chai NL, Linghu EQ, Qiu ST, Li LS, Zou JL, Xiang JY, Li XX. The outcomes of modified endoscopic mucosal resection and endoscopic submucosal dissection for the treatment of rectal neuroendocrine tumors and the value of endoscopic morphology classification in endoscopic resection. BMC Gastroenterol 2020;20:200. [PMID: 32586282 DOI: 10.1186/s12876-020-01340-w] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
342 Valentino J, Evers BM. Recent advances in the diagnosis and treatment of gastrointestinal carcinoids. Adv Surg 2011;45:285-300. [PMID: 21954695 DOI: 10.1016/j.yasu.2011.03.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
343 Lee SW, Lee IS, Cho YK, Park JM, Kim SW, Choi MG, Choi KY, Lee MA, Hong TH, You YK, Jung ES. A case of mixed adenoneuroendocrine carcinoma of the common bile duct: initially diagnosed as cholangiocarcinoma. Korean J Pathol 2014;48:445-8. [PMID: 25588638 DOI: 10.4132/KoreanJPathol.2014.48.6.445] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
344 Sippel RS, Chen H. Carcinoid tumors. Surg Oncol Clin N Am. 2006;15:463-478. [PMID: 16882492 DOI: 10.1016/j.soc.2006.05.002] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
345 Yao JC, Eisner MP, Leary C, Dagohoy C, Phan A, Rashid A, Hassan M, Evans DB. Population-based study of islet cell carcinoma. Ann Surg Oncol. 2007;14:3492-3500. [PMID: 17896148 DOI: 10.1245/s10434-007-9566-6] [Cited by in Crossref: 216] [Cited by in F6Publishing: 181] [Article Influence: 14.4] [Reference Citation Analysis]
346 Natalicchio A, Faggiano A, Zatelli MC, Argentiero A, D'Oronzo S, Marrano N, Beretta GD, Acquati S, Adinolfi V, Di Bartolo P, Danesi R, Ferrari P, Gori S, Morviducci L, Russo A, Tuveri E, Montagnani M, Gallo M, Silvestris N, Giorgino F. Metabolic disorders and gastroenteropancreatic-neuroendocrine tumors (GEP-NETs): How do they influence each other? An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper. Crit Rev Oncol Hematol 2021;:103572. [PMID: 34954047 DOI: 10.1016/j.critrevonc.2021.103572] [Reference Citation Analysis]
347 Motylewska E, Gawronska J, Niedziela A, Melen-Mucha G, Lawnicka H, Komorowski J, Swietoslawski J, Stepien H. Somatostatin Analogs and Tumor Localization Do Not Influence Vitamin D Concentration in Patients with Neuroendocrine Tumors. Nutr Cancer. 2016;68:428-434. [PMID: 27028957 DOI: 10.1080/01635581.2016.1152387] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
348 Dörffel Y, Wermke W. [Contrast medium sonography of neuroendocrine tumors of the gastroenteropancreatic system]. Radiologe 2009;49:206-16. [PMID: 19198796 DOI: 10.1007/s00117-008-1782-y] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
349 Fottner C, Ferrata M, Weber MM. Hormone secreting gastro-entero-pancreatic neuroendocrine neoplasias (GEP-NEN): When to consider, how to diagnose? Rev Endocr Metab Disord. 2017;18:393-410. [PMID: 29256148 DOI: 10.1007/s11154-017-9438-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
350 Calvete O, Reyes J, Zuñiga S, Paumard-Hernández B, Fernández V, Bujanda L, Rodriguez-Pinilla MS, Palacios J, Heine-Suñer D, Banka S, Newman WG, Cañamero M, Pritchard DM, Benítez J. Exome sequencing identifies ATP4A gene as responsible of an atypical familial type I gastric neuroendocrine tumour. Hum Mol Genet 2015;24:2914-22. [PMID: 25678551 DOI: 10.1093/hmg/ddv054] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 6.0] [Reference Citation Analysis]
351 Kooyker AI, Verbeek WH, van den Berg JG, Tesselaar ME, van Leerdam ME. Change in incidence, characteristics and management of colorectal neuroendocrine tumours in the Netherlands in the last decade. United European Gastroenterol J 2020;8:59-67. [PMID: 32213058 DOI: 10.1177/2050640619865113] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
352 Senekjian L, Nirula R, Bellows B, Nelson R. Interval Appendectomy: Finding the Breaking Point for Cost-Effectiveness. Journal of the American College of Surgeons 2016;223:632-43. [DOI: 10.1016/j.jamcollsurg.2016.07.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
353 Veyrie N, Pierre-Kahn N, Hugol D, Servajean S, Berger N, Bethoux JP, Bouillot JL. [Carcinoid tumor from the small bowel]. Ann Chir 2004;129:607-10. [PMID: 15581824 DOI: 10.1016/j.anchir.2004.09.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
354 Halezeroğlu S. Uniportal video-assisted thoracic surgery lobectomy in a patient with carcinoid tumor located at the orifice of the right lower lobe. J Thorac Dis 2017;9:3288-92. [PMID: 29221311 DOI: 10.21037/jtd.2017.07.62] [Reference Citation Analysis]
355 Al-Efraij K, Aljama MA, Kennecke HF. Association of dose escalation of octreotide long-acting release on clinical symptoms and tumor markers and response among patients with neuroendocrine tumors. Cancer Med 2015;4:864-70. [PMID: 25727756 DOI: 10.1002/cam4.435] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
356 Savelli G, Bertagna F, Franco F, Dognini L, Bosio G, Migliorati E, Rodella C, Biasiotto G, Bettinsoli G, Minari C, Zaniboni A, Ferrari C, Tomassetti P, Ferrari V, Giubbini R. Final results of a phase 2A study for the treatment of metastatic neuroendocrine tumors with a fixed activity of 90Y-DOTA-D-Phe1-Tyr3 octreotide. Cancer 2012;118:2915-24. [DOI: 10.1002/cncr.26616] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
357 Fields AC, Saadat LV, Scully RE, Davids JS, Goldberg JE, Bleday R, Melnitchouk N. Local Excision Versus Radical Resection for 1- to 2-cm Neuroendocrine Tumors of the Rectum: A National Cancer Database Analysis. Diseases of the Colon & Rectum 2019;62:417-21. [DOI: 10.1097/dcr.0000000000001210] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
358 Griniatsos J, Michail O. Appendiceal neuroendocrine tumors: Recent insights and clinical implications. World J Gastrointest Oncol 2010; 2(4): 192-196 [PMID: 21160597 DOI: 10.4251/wjgo.v2.i4.192] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
359 Elias D, Sideris L, Liberale G, Ducreux M, Malka D, Lasser P, Duvillard P, Baudin E. Surgical treatment of peritoneal carcinomatosis from well-differentiated digestive endocrine carcinomas. Surgery 2005;137:411-6. [DOI: 10.1016/j.surg.2004.11.007] [Cited by in Crossref: 52] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
360 Lam-himlin D, Montgomery EA. The neoplastic appendix: a practical approach. Diagnostic Histopathology 2011;17:395-403. [DOI: 10.1016/j.mpdhp.2011.06.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
361 Park HY, Kwon MJ, Kang HS, Kim YJ, Kim NY, Kim MJ, Min K, Choi KC, Nam ES, Cho SJ, Park H, Min SK, Seo J, Choe J, Lee HK. Targeted next-generation sequencing of well-differentiated rectal, gastric, and appendiceal neuroendocrine tumors to identify potential targets. Human Pathology 2019;87:83-94. [DOI: 10.1016/j.humpath.2019.02.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
362 Forde PM, Hooker CM, Boikos SA, Petrini I, Giaccone G, Rudin CM, Yang SC, Illei PB, Hann CL, Ettinger DS, Brahmer JR, Kelly RJ. Systemic therapy, clinical outcomes, and overall survival in locally advanced or metastatic pulmonary carcinoid: a brief report. J Thorac Oncol 2014;9:414-8. [PMID: 24518093 DOI: 10.1097/JTO.0000000000000065] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
363 Steffen T, Ebinger SM, Warschkow R, Lüthi C, Schmied BM, Clerici T. Long-Term Survival is not Impaired After the Complete Resection of Neuroendocrine Tumors of the Appendix. World J Surg 2015;39:2670-6. [PMID: 26223340 DOI: 10.1007/s00268-015-3164-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
364 Kojima M, Ikeda K, Saito N, Sakuyama N, Koushi K, Kawano S, Watanabe T, Sugihara K, Ito M, Ochiai A. Neuroendocrine Tumors of the Large Intestine: Clinicopathological Features and Predictive Factors of Lymph Node Metastasis. Front Oncol 2016;6:173. [PMID: 27486567 DOI: 10.3389/fonc.2016.00173] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
365 Zheng BH, Zhang C, Wan WZ, Sun WT, Cheng X, Ni XJ, Ni XL, Suo T, Liu H, Shen S, Liu HB. The clinical and prognostic factors for biliary neuroendocrine neoplasm: a study based on the SEER database. BMC Surg 2022;22:253. [PMID: 35768809 DOI: 10.1186/s12893-022-01689-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
366 Sung HY, Kim SW, Kang WK, Kim SY, Jung CK, Cho YK, Park JM, Lee IS, Choi MG, Chung IS. Long-term prognosis of an endoscopically treated rectal neuroendocrine tumor: 10-year experience in a single institution. Eur J Gastroenterol Hepatol. 2012;24:978-983. [PMID: 22647741 DOI: 10.1097/meg.0b013e3283551e0b] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
367 Meng XF, Pan YW, Wang ZB, Duan WD. Primary hepatic neuroendocrine tumor case with a preoperative course of 26 years: A case report and literature review. World J Gastroenterol 2018; 24(24): 2640-2646 [PMID: 29962820 DOI: 10.3748/wjg.v24.i24.2640] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
368 Arnold R. Endocrine tumours of the gastrointestinal tract. Introduction: definition, historical aspects, classification, staging, prognosis and therapeutic options. Best Pract Res Clin Gastroenterol 2005;19:491-505. [PMID: 16183523 DOI: 10.1016/j.bpg.2005.03.006] [Cited by in Crossref: 57] [Cited by in F6Publishing: 44] [Article Influence: 3.6] [Reference Citation Analysis]
369 Pape UF, Wiedenmann B. Adding interferon-alpha to octreotide slows tumour progression compared with octreotide alone but evidence is lacking for improved survival in people with disseminated midgut carcinoid tumours. Cancer Treat Rev 2003;29:565-9. [PMID: 14585268 DOI: 10.1016/j.ctrv.2003.07.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
370 Shen H, Yu Z, Zhao J, Li XZ, Pan WS. Early diagnosis and treatment of gastrointestinal neuroendocrine tumors. Oncol Lett. 2016;12:3385-3392. [PMID: 27900009 DOI: 10.3892/ol.2016.5062] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
371 Liu KJ, Lv YX, Niu YM, Bu Y. Prognostic value of γ-glutamyl transpeptidase to albumin ratio combined with aspartate aminotransferase to lymphocyte ratio in patients with hepatocellular carcinoma after hepatectomy.Medicine (Baltimore). 2020;99:e23339. [PMID: 33235099 DOI: 10.1097/MD.0000000000023339] [Reference Citation Analysis]
372 Rindi G, Inzani F, Solcia E. Pathology of Gastrointestinal Disorders. Endocrinology and Metabolism Clinics of North America 2010;39:713-27. [DOI: 10.1016/j.ecl.2010.08.009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
373 Wardell S, Mousavi N, Tam JW, Kirkpatrick ID, Maycher B, Jassal DS. Case of the month #166: carcinoid heart disease. Carcinoid syndrome. Can Assoc Radiol J 2010;61:297-8. [PMID: 21074101 DOI: 10.1016/j.carj.2009.11.012] [Reference Citation Analysis]
374 Basile ML, Kuga FS, Del Carlo Bernardi F. Comparation of the quantification of the proliferative index KI67 between eyeball and semi-automated digital analysis in gastro-intestinal neuroendrocrine tumors. Surg Exp Pathol 2019;2. [DOI: 10.1186/s42047-019-0045-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
375 Petursdottir A, Sigurdardottir J, Fridriksson BM, Johnsen A, Isaksson HJ, Hardardottir H, Jonsson S, Gudbjartsson T. Pulmonary carcinoid tumours: incidence, histology, and surgical outcome. A population-based study. Gen Thorac Cardiovasc Surg 2020;68:523-9. [DOI: 10.1007/s11748-019-01261-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
376 Hore T, Poston G. Perspectives on surgical management of neuroendocrine liver metastases. International Journal of Endocrine Oncology 2015;2:67-74. [DOI: 10.2217/ije.14.32] [Reference Citation Analysis]
377 Gerson JN, Witteles RM, Chang DT, Beygui RE, Iagaru AH, Kunz PL. Carcinoid Syndrome Complicating a Pancreatic Neuroendocrine Tumor: A Case Report. Pancreas 2017;46:1381-5. [PMID: 29040196 DOI: 10.1097/MPA.0000000000000932] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
378 O'Connor JM, Marmissolle F, Bestani C, Pesce V, Belli S, Dominichini E, Mendez G, Price P, Giacomi N, Pairola A, Loria FS, Huertas E, Martin C, Patane K, Poleri C, Rosenberg M, Cabanne A, Kujaruk M, Caino A, Zamora V, Mariani J, Dioca M, Parma P, Podesta G, Andriani O, Gondolesi G, Roca E. Observational study of patients with gastroenteropancreatic and bronchial neuroendocrine tumors in Argentina: Results from the large database of a multidisciplinary group clinical multicenter study. Mol Clin Oncol. 2014;2:673-684. [PMID: 25054030 DOI: 10.3892/mco.2014.332] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
379 Graham RPD, Williams NP, West KA. Primary epithelial tumours of the appendix in a black population: A review of cases. World J Gastroenterol 2009; 15(12): 1472-1474 [PMID: 19322920 DOI: 10.3748/wjg.15.1472] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
380 Dogeas E, Chong CCN, Weiss MJ, Ahuja N, Choti MA. Can echogenic appearance of neuroendocrine liver metastases on intraoperative ultrasonography predict tumor biology and prognosis? HPB (Oxford) 2018;20:237-43. [PMID: 29103839 DOI: 10.1016/j.hpb.2017.08.029] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
381 Panarelli N, Tyryshkin K, Wong JJM, Majewski A, Yang X, Scognamiglio T, Kim MK, Bogardus K, Tuschl T, Chen Y, Renwick N. Evaluating gastroenteropancreatic neuroendocrine tumors through microRNA sequencing. Endocrine-Related Cancer 2019;26:47-57. [DOI: 10.1530/erc-18-0244] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
382 Spychalski M, Koptas W, Zelga P, Dziki A. Role of endoscopic submucosal dissection in treatment of rectal gastroenteropancreatic neuroendocrine neoplasms. Prz Gastroenterol 2017;12:17-21. [PMID: 28337231 DOI: 10.5114/pg.2016.64635] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
383 Gerber DE, Paik PK, Dowlati A. Beyond adenocarcinoma: current treatments and future directions for squamous, small cell, and rare lung cancer histologies. Am Soc Clin Oncol Educ Book 2015;:147-62. [PMID: 25993153 DOI: 10.14694/EdBook_AM.2015.35.147] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
384 Moon CM, Huh KC, Jung S, Park DI, Kim WH, Jung HM, Koh S, Kim J, Jung Y, Kim KO, Kim JW, Yang D, Shin JE, Shin SJ, Kim ES, Joo Y. Long-Term Clinical Outcomes of Rectal Neuroendocrine Tumors According to the Pathologic Status After Initial Endoscopic Resection: A KASID Multicenter Study. American Journal of Gastroenterology 2016;111:1276-85. [DOI: 10.1038/ajg.2016.267] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
385 Juchems M. Neuroendokrine Tumoren des Abdomens. Radiologe 2018;58:36-44. [DOI: 10.1007/s00117-017-0332-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
386 Gurusamy KS, Ramamoorthy R, Sharma D, Davidson BR. Liver resection versus other treatments for neuroendocrine tumours in patients with resectable liver metastases. Cochrane Database Syst Rev. 2009;CD007060. [PMID: 19370671 DOI: 10.1002/14651858.cd007060.pub2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
387 O'Toole D, Delle Fave G, Jensen RT. Gastric and duodenal neuroendocrine tumours. Best Pract Res Clin Gastroenterol. 2012;26:719-735. [PMID: 23582915 DOI: 10.1016/j.bpg.2013.01.002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 4.9] [Reference Citation Analysis]
388 Vora M, Lacour RA, Black DR, Turbat-Herrera EA, Gu X. Neuroendocrine tumors in the ovary: histogenesis, pathologic differentiation, and clinical presentation. Arch Gynecol Obstet 2016;293:659-65. [PMID: 26306985 DOI: 10.1007/s00404-015-3865-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
389 Johnson PR. Gastroenteropancreatic neuroendocrine (carcinoid) tumors in children. Seminars in Pediatric Surgery 2014;23:91-5. [DOI: 10.1053/j.sempedsurg.2014.03.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
390 Kidd M, Modlin IM, Eick GN, Champaneria MC. Isolation, functional characterization, and transcriptome of Mastomys ileal enterochromaffin cells. Am J Physiol Gastrointest Liver Physiol 2006;291:G778-91. [PMID: 16455786 DOI: 10.1152/ajpgi.00552.2005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
391 Park HW, Byeon JS, Park YS, Yang DH, Yoon SM, Kim KJ, Ye BD, Myung SJ, Yang SK, Kim JH. Endoscopic submucosal dissection for treatment of rectal carcinoid tumors. Gastrointest Endosc. 2010;72:143-149. [PMID: 20381798 DOI: 10.1016/j.gie.2010.01.040] [Cited by in Crossref: 93] [Cited by in F6Publishing: 83] [Article Influence: 7.8] [Reference Citation Analysis]
392 Yang Z, Wang Z, Duan Y, Xu S. Clinicopathological characteristics and prognosis of resected cases of carcinoid tumors of the lung. Thorac Cancer 2016;7:633-8. [PMID: 27755793 DOI: 10.1111/1759-7714.12377] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
393 Tamagno G, Sheahan K, Skehan SJ, Geoghegan JG, Fennelly D, Collins CD, Maguire D, Traynor O, Brophy DP, Cantwell C, Swan N, McGowan L, O'Toole D, O'Shea D. Initial impact of a systematic multidisciplinary approach on the management of patients with gastroenteropancreatic neuroendocrine tumor. Endocrine. 2013;44:504-509. [PMID: 23471696 DOI: 10.1007/s12020-013-9910-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
394 South CD, Baird MA, Marsh WL Jr. Clinical challenges and images in GI. Ampullary somatostatinoma associated with neurofibromatosis type 1, presenting with iron-deficiency anemia. Gastroenterology 2009;136:51, 368. [PMID: 19063889 DOI: 10.1053/j.gastro.2008.05.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
395 Degnan AJ, Tocchio S, Kurtom W, Tadros SS. Pediatric neuroendocrine carcinoid tumors: Management, pathology, and imaging findings in a pediatric referral center: Degnan et al.. Pediatr Blood Cancer 2017;64:e26477. [DOI: 10.1002/pbc.26477] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
396 Berzaczy D, Giraudo C, Haug AR, Raderer M, Senn D, Karanikas G, Weber M, Mayerhoefer ME. Whole-Body 68Ga-DOTANOC PET/MRI Versus 68Ga-DOTANOC PET/CT in Patients With Neuroendocrine Tumors: A Prospective Study in 28 Patients. Clin Nucl Med 2017;42:669-74. [PMID: 28682844 DOI: 10.1097/RLU.0000000000001753] [Cited by in Crossref: 31] [Cited by in F6Publishing: 11] [Article Influence: 7.8] [Reference Citation Analysis]
397 Hill JS, McPhee JT, McDade TP, Zhou Z, Sullivan ME, Whalen GF, Tseng JF. Pancreatic neuroendocrine tumors: the impact of surgical resection on survival. Cancer. 2009;115:741-751. [PMID: 19130464 DOI: 10.1002/cncr.24065] [Cited by in Crossref: 201] [Cited by in F6Publishing: 187] [Article Influence: 15.5] [Reference Citation Analysis]
398 Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current Status of Gastrointestinal Carcinoids. Gastroenterology 2005;128:1717-51. [DOI: 10.1053/j.gastro.2005.03.038] [Reference Citation Analysis]
399 Alexandraki KI, Karapanagioti A, Karoumpalis I, Boutzios G, Kaltsas GA. Advances and Current Concepts in the Medical Management of Gastroenteropancreatic Neuroendocrine Neoplasms. Biomed Res Int 2017;2017:9856140. [PMID: 29349087 DOI: 10.1155/2017/9856140] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
400 Hibi T, Sano T, Sakamoto Y, Takahashi Y, Uemura N, Ojima H, Shimada K, Kosuge T. Surgery for hepatic neuroendocrine tumors: a single institutional experience in Japan. Jpn J Clin Oncol 2007;37:102-7. [PMID: 17234654 DOI: 10.1093/jjco/hyl140] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
401 Pistilli B, Grana C, Fazio N, Cavaliere A, Ferrari M, Bodei L, Baio S, Scambia G, Paganelli G, Peccatori F. Pregnant with metastatic neuroendocrine tumour of the ovary: what now? Ecancermedicalscience 2012;6:240. [PMID: 22331988 DOI: 10.3332/ecancer.2012.240] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
402 Scherübl H, Cadiot G. Early Gastroenteropancreatic Neuroendocrine Tumors: Endoscopic Therapy and Surveillance. Visc Med 2017;33:332-8. [PMID: 29177161 DOI: 10.1159/000459404] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
403 Kitano M, Davidson GW, Shirley LA, Schmidt CR, Guy GE, Khabiri H, Dowell JD, Shah MH, Bloomston M. Transarterial Chemoembolization for Metastatic Neuroendocrine Tumors With Massive Hepatic Tumor Burden: Is the Benefit Worth the Risk? Ann Surg Oncol 2016;23:4008-15. [DOI: 10.1245/s10434-016-5333-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
404 Soga J. Endocrinocarcinomas (carcinoids and their variants) of the duodenum. An evaluation of 927 cases. J Exp Clin Cancer Res 2003;22:349-63. [PMID: 14582691 [PMID: 14582691 DOI: 10.1016/j.oraloncology.2003.09.017] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
405 Naalla R, Konchada K, Kannappan O, Lingadakai R. Duodenal carcinoid with carcinoid syndrome. BMJ Case Rep. 2014;2014:pii: bcr2013202159. [PMID: 24414187 DOI: 10.1136/bcr-2013-202159] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
406 Kitada T, Masui T, Kasai Y, Uchida Y, Ogiso S, Ito T, Ishii T, Seo S, Katsuragawa H, Uemoto S. A subcentimeter duodenal neuroendocrine neoplasm with a liver metastasis upgraded to G3: a case report. Surg Case Rep 2021;7:72. [PMID: 33742297 DOI: 10.1186/s40792-021-01155-1] [Reference Citation Analysis]
407 De Dosso S, Grande E, Barriuso J, Castellano D, Tabernero J, Capdevila J. The targeted therapy revolution in neuroendocrine tumors: in search of biomarkers for patient selection and response evaluation. Cancer Metastasis Rev. 2013;32:465-477. [PMID: 23589060 DOI: 10.1007/s10555-013-9421-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
408 Wu CL, Yu CC. Amyand's hernia with adenocarcinoid tumor. Hernia 2010;14:423-5. [PMID: 19756915 DOI: 10.1007/s10029-009-0552-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
409 Haynes AB, Deshpande V, Ingkakul T, Vagefi PA, Szymonifka J, Thayer SP, Ferrone CR, Wargo JA, Warshaw AL, Fernández-del Castillo C. Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes. Arch Surg 2011;146:534-8. [PMID: 21576607 DOI: 10.1001/archsurg.2011.102] [Cited by in Crossref: 142] [Cited by in F6Publishing: 132] [Article Influence: 12.9] [Reference Citation Analysis]
410 Shim JR, Kim JR, Park Y, Seo HI. Small-cell neuroendocrine carcinoma arising from an extra-hepatic bile duct: a case report. Gastroenterol Rep (Oxf) 2021;9:380-2. [PMID: 34567573 DOI: 10.1093/gastro/goaa051] [Reference Citation Analysis]
411 Wu J, Srirajaskanthan R, Ramage J. Rectal neuroendocrine tumor: Editorial. Digestive Endoscopy 2014;26:532-3. [DOI: 10.1111/den.12308] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
412 Hatta W, Koike T, Iijima K, Asanuma K, Asano N, Musha H, Inomata Y, Sano T, Endo H, Ikehata A, Horii T, Ohyauchi M, Yokosawa S, Kasajima A, Fujishima F, Sasano H, Nakaya N, Nakamura T, Shimosegawa T. The Risk Factors for Metastasis in Non-Ampullary Duodenal Neuroendocrine Tumors Measuring 20 mm or Less in Diameter. Digestion 2017;95:201-9. [DOI: 10.1159/000459619] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
413 Sakamoto A, Nozawa H, Sonoda H, Hinata M, Ishii H, Emoto S, Anzai H, Yokoyama Y, Murono K, Sasaki K, Kawai K, Ushiku T, Ishihara S. Rectal neuroendocrine tumor with extracapsular lymph node metastasis: a case report. Clin J Gastroenterol 2021. [PMID: 34028785 DOI: 10.1007/s12328-021-01447-x] [Reference Citation Analysis]
414 Samonakis DN, Quaglia A, Joshi NM, Tibballs JM, Nagree A, Triantos CK, Davies N, Standish R, Dhillon AP, Davidson BR, Burroughs AK, Caplin ME. Obstructive jaundice secondary to neuroendocrine tumour in a patient with von Recklinghausen's disease. Eur J Gastroenterol Hepatol 2005;17:1229-32. [PMID: 16215436 DOI: 10.1097/00042737-200511000-00012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
415 Ribeiro FB, Siqueira SAC, Gonçalves MC, Costa ADCL. Disseminated neuroendocrine neoplasm with undetected primary tumor. Autops Case Rep 2012;2:13-20. [PMID: 31528575 DOI: 10.4322/acr.2012.021] [Reference Citation Analysis]
416 Hess GP, Chen CC, Liu Z, Yao JC, Phan AT, Hill JW. Clinical burden of illness in patients with neuroendocrine tumors. Pancreas. 2012;41:1058-1062. [PMID: 22513292 DOI: 10.1097/mpa.0b013e318249d8f7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
417 Malik L, Chua YJ, Butt NS, Yip D. Single institutional series of neuroendocrine tumors managed in the Australian Capital Territory. Asia Pac J Clin Oncol. 2016;12:e133-e140. [PMID: 24164683 DOI: 10.1111/ajco.12121] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
418 de Lima BAM, da Silva RG, Carroll C, Vilhena B, Perez C, Felix R, Carneiro M, Neto LM, Vaisman F, Corbo R, Pujatti PB, Bulzico D. Neutrophil to lymphocyte ratio as a prognosis biomarker of PRRT in NET patients. Endocrine 2022. [PMID: 35829985 DOI: 10.1007/s12020-022-03133-5] [Reference Citation Analysis]
419 Venable ER, Kerr SE, Lopes MBS, Jones KA, Bellizzi AM, Mounajjed T, Raghunathan A, Hamidi O, Halfdanarson TR, Ryder M, Graham RP. Liver metastases from pituitary carcinomas mimicking visceral well-differentiated neuroendocrine tumors: a series of four cases. Diagn Pathol 2020;15:81. [PMID: 32622369 DOI: 10.1186/s13000-020-00997-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
420 Meeker A, Heaphy C. Gastroenteropancreatic endocrine tumors. Molecular and Cellular Endocrinology 2014;386:101-20. [DOI: 10.1016/j.mce.2013.07.015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
421 Day RW, Chang YH, Stucky CC, Gray R, Pockaj B, Wasif N. A Predictive Model for Nodal Metastases in Patients With Appendiceal Cancers. Ann Surg 2021;274:155-61. [PMID: 31361626 DOI: 10.1097/SLA.0000000000003501] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
422 Iwata R, Maruyama M, Ito T, Nakano Y, Kanemura Y, Koike T, Oe S, Yoshimura K, Nonaka M, Nomura S, Sugimoto T, Yamada H, Asai A. Establishment of a tumor sphere cell line from a metastatic brain neuroendocrine tumor. Med Mol Morphol 2017;50:211-9. [PMID: 28516286 DOI: 10.1007/s00795-017-0160-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
423 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2005; 13(21): 2634-2635 [DOI: 10.11569/wcjd.v13.i21.2634] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
424 Alonso-Gordoa T, Capdevila J, Grande E. GEP-NETs update: Biotherapy for neuroendocrine tumours. Eur J Endocrinol. 2015;172:R31-R46. [PMID: 25430657 DOI: 10.1530/eje-14-0354] [Cited by in Crossref: 28] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
425 Castillo JG, Filsoufi F, Adams DH, Raikhelkar J, Zaku B, Fischer GW. Management of patients undergoing multivalvular surgery for carcinoid heart disease: the role of the anaesthetist. Br J Anaesth 2008;101:618-26. [PMID: 18689806 DOI: 10.1093/bja/aen237] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
426 Landry JP, Voros BA, Ramirez RA, Boudreaux JP, Woltering EA, Thiagarajan R. Management of Appendiceal Neuroendocrine Tumors: Metastatic Potential of Small Tumors. Ann Surg Oncol 2021;28:751-7. [PMID: 32691337 DOI: 10.1245/s10434-020-08748-4] [Reference Citation Analysis]
427 Gut P, Czarnywojtek A, Bączyk M, Ziemnicka K, Fischbach J, Wrotkowska E, Ruchała M. Clinical features of gastroenteropancreatic tumours. Prz Gastroenterol 2015;10:127-34. [PMID: 26516377 DOI: 10.5114/pg.2015.52346] [Reference Citation Analysis]
428 Catania C, Botteri E, Barberis M, Conforti F, Toffalorio F, Marinis FD, Boselli S, Noberasco C, Delmonte A, Spitaleri G, Spaggiari L, Rotmensz N, Passaro A, Bazolli B, Alfieri M, Manzotti M, Fumagalli C, Milani A, Pas TD. Molecular features and clinical outcome of lung malignancies in very young people. Future Oncology 2015;11:1211-21. [DOI: 10.2217/fon.15.10] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
429 Kojima M, Chen Y, Ikeda K, Tsukada Y, Takahashi D, Kawano S, Amemiya K, Ito M, Ohki R, Ochiai A. Recommendation of long-term and systemic management according to the risk factors in rectal NETs patients. Sci Rep 2019;9:2404. [PMID: 30787304 DOI: 10.1038/s41598-018-37707-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
430 Sun W, Wu S, Han X, Yang C. Effectiveness of Endoscopic Treatment for Gastrointestinal Neuroendocrine Tumors: A Retrospective Study. Medicine (Baltimore) 2016;95:e3308. [PMID: 27082572 DOI: 10.1097/MD.0000000000003308] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
431 Ameri P, Gatto F, Arvigo M, Villa G, Resmini E, Minuto F, Murialdo G, Ferone D. Somatostatin receptor scintigraphy in thoracic diseases. J Endocrinol Invest 2007;30:889-902. [DOI: 10.1007/bf03349233] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
432 Wang HY, Chen MJ, Yang TL, Chang MC, Chan YJ. Carcinoid tumor of the duodenum and accessory papilla associated with polycythemia vera. World J Gastroenterol 2005; 11(24): 3794-3796 [PMID: 15968742 DOI: 10.3748/wjg.v11.i24.3794] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
433 Bertino EM, Confer PD, Colonna JE, Ross P, Otterson GA. Pulmonary neuroendocrine/carcinoid tumors: a review article. Cancer 2009;115:4434-41. [PMID: 19562772 DOI: 10.1002/cncr.24498] [Cited by in Crossref: 88] [Cited by in F6Publishing: 73] [Article Influence: 6.8] [Reference Citation Analysis]
434 Fornaro R, Frascio M, Sticchi C, De Salvo L, Stabilini C, Mandolfino F, Ricci B, Gianetta E. Appendectomy or right hemicolectomy in the treatment of appendiceal carcinoid tumors? Tumori. 2007;93:587-590. [PMID: 18338494 DOI: 10.1177/030089160709300612] [Cited by in Crossref: 39] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
435 Shapiro R, Eldar S, Sadot E, Papa MZ, Zippel DB. Appendiceal carcinoid at a large tertiary center: pathologic findings and long-term follow-up evaluation. Am J Surg. 2011;201:805-808. [PMID: 21741512 DOI: 10.1016/j.amjsurg.2010.04.016] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
436 Demirci E, Kabasakal L, Toklu T, Ocak M, Şahin OE, Alan-Selcuk N, Araman A. 177Lu-DOTATATE therapy in patients with neuroendocrine tumours including high-grade (WHO G3) neuroendocrine tumours: response to treatment and long-term survival update. Nucl Med Commun 2018;39:789-96. [PMID: 29912750 DOI: 10.1097/MNM.0000000000000874] [Cited by in Crossref: 32] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
437 Nishio M, Hirasawa K, Ozeki Y, Sawada A, Ikeda R, Fukuchi T, Kobayashi R, Makazu M, Sato C, Maeda S. Short- and long-term outcomes of endoscopic submucosal dissection for non-ampullary duodenal neuroendocrine tumors. Ann Gastroenterol 2020;33:265-71. [PMID: 32382229 DOI: 10.20524/aog.2020.0477] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
438 Wang YZ, Chauhan A, Ramirez RA, Beyer DT, Stevens MA, Woltering EA, Boudreaux JP, Anthony L. Does the addition of adjuvant intraoperative tumor bed chemotherapy during midgut neuroendocrine tumor debulking procedures benefit patients? J Gastrointest Oncol 2019;10:928-34. [PMID: 31602331 DOI: 10.21037/jgo.2019.07.05] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
439 Hsiao TH, Wu CC, Tseng HH, Chen JH. Synchronous but separate neuroendocrine tumor and high-grade dysplasia/adenoma of the gall bladder: A case report. World J Clin Cases 2022;10:2322-9. [PMID: 35321155 DOI: 10.12998/wjcc.v10.i7.2322] [Reference Citation Analysis]
440 van Essen M, Krenning EP, Bakker WH, de Herder WW, van Aken MO, Kwekkeboom DJ. Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic origin. Eur J Nucl Med Mol Imaging. 2007;34:1219-1227. [PMID: 17260141 DOI: 10.1007/s00259-006-0355-4] [Cited by in Crossref: 85] [Cited by in F6Publishing: 65] [Article Influence: 5.7] [Reference Citation Analysis]
441 Verdugo AD, Crona J, Starker L, Stålberg P, Åkerström G, Westin G, Hellman P, Björklund P. Global DNA methylation patterns through an array-based approach in small intestinal neuroendocrine tumors. Endocrine-Related Cancer 2014;21:L5-7. [DOI: 10.1530/erc-13-0481] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
442 Galán M, Pagés M, Colomo L. [Progressive dysphagia of 2-years duration in a 78-year-old woman]. Med Clin (Barc) 2008;130:149-55. [PMID: 18279634 DOI: 10.1157/13115771] [Reference Citation Analysis]
443 Dujardin F, Beaussart P, de Muret A, Rosset P, Waynberger E, Mulleman D, de Pinieux G. Primary neuroendocrine tumor of the sacrum: case report and review of the literature. Skeletal Radiol. 2009;38:819-823. [PMID: 19360403 DOI: 10.1007/s00256-009-0693-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
444 Busse FP, Mössner J, Stumvoll M, Kluge R, Schoppmeyer K. Nichtoperative Therapiemöglichkeiten gastroenteropankreatischer neuroendokriner Tumoren. Visc Med 2007;23:158-65. [DOI: 10.1159/000101533] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
445 Fields AC, Mccarty JC, Ma‐pak L, Lu P, Irani J, Goldberg JE, Bleday R, Chan J, Melnitchouk N. New lymph node staging for rectal neuroendocrine tumors. J Surg Oncol 2018;119:156-62. [DOI: 10.1002/jso.25307] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
446 Srirajaskanthan R, Ahmed A, Prachialias A, Srinivasan P, Heaton N, Jervis N, Quaglia A, Vivian G, Ramage JK. ENETS TNM staging predicts prognosis in small bowel neuroendocrine tumours. ISRN Oncol. 2013;2013:420795. [PMID: 23533809 DOI: 10.1155/2013/420795] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
447 Kidd M, Modlin I, Shapiro M, Camp R, Mane S, Usinger W, Murren J. CTGF, intestinal stellate cells and carcinoid fibrogenesis. World J Gastroenterol 2007; 13(39): 5208-5216 [PMID: 17876891 DOI: 10.3748/wjg.v13.i39.5208] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 44] [Article Influence: 3.3] [Reference Citation Analysis]
448 He Y, Zhao F, Han Q, Zhou Y, Zhao S. Prognostic nomogram for predicting long-term cancer-specific survival in patients with lung carcinoid tumors. BMC Cancer 2021;21:141. [PMID: 33557782 DOI: 10.1186/s12885-021-07832-6] [Reference Citation Analysis]
449 Schütte K, Bornschein J, Kuester D, Wieners G, Malfertheiner P. [Fulminant duodenal bleeding as first manifestation of a neuroendocrine carcinoma of the pancreatic head]. Med Klin (Munich) 2010;105:291-5. [PMID: 20455052 DOI: 10.1007/s00063-010-1043-5] [Reference Citation Analysis]
450 Gurusamy KS, Pamecha V, Sharma D, Davidson BR. Palliative cytoreductive surgery versus other palliative treatments in patients with unresectable liver metastases from gastro-entero-pancreatic neuroendocrine tumours. Cochrane Database Syst Rev 2009;:CD007118. [PMID: 19160322 DOI: 10.1002/14651858.CD007118.pub2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
451 Lombardi M, De Lio N, Funel N, Sardella C, Russo D, Urbani C, Rossi G, Campani D, Martino E, Marcocci C, Boggi U, Bogazzi F. Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET. J Endocrinol Invest 2015;38:605-13. [DOI: 10.1007/s40618-014-0219-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
452 Wang Y, Huang K, Chen J, Luo Y, Zhang Y, Jia Y, Xu L, Chen M, Huang B, Ni D, Li ZP, Feng ST. Combined Volumetric and Density Analyses of Contrast-Enhanced CT Imaging to Assess Drug Therapy Response in Gastroenteropancreatic Neuroendocrine Diffuse Liver Metastasis. Contrast Media Mol Imaging 2018;2018:6037273. [PMID: 30510495 DOI: 10.1155/2018/6037273] [Reference Citation Analysis]
453 Lea D, Gudlaugsson EG, Skaland I, Lillesand M, Søreide K, Søreide JA. Digital Image Analysis of the Proliferation Markers Ki67 and Phosphohistone H3 in Gastroenteropancreatic Neuroendocrine Neoplasms: Accuracy of Grading Compared With Routine Manual Hot Spot Evaluation of the Ki67 Index. Appl Immunohistochem Mol Morphol 2021;29:499-505. [PMID: 33758143 DOI: 10.1097/PAI.0000000000000934] [Reference Citation Analysis]
454 Milone F, Pivonello C, Cariati F, Sarnataro M, Ramundo V, Marotta V, Jann H, Pape U, Wiedenmann B, Colao A, Pavel M, Faggiano A. Assessment and clinical implications of RANK/RANKL/OPG pathway as markers of bone tumor progression in patients with NET harboring bone metastases. Biomarkers 2013;18:121-5. [DOI: 10.3109/1354750x.2012.745166] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
455 Shin HD. Diagnosis and Treatment of Rectal Neuroendocrine Tumor. Korean J Med 2014;87:415. [DOI: 10.3904/kjm.2014.87.4.415] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
456 Schimmack S, Svejda B, Lawrence B, Kidd M, Modlin IM. The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors. Langenbecks Arch Surg 2011;396:273-98. [DOI: 10.1007/s00423-011-0739-1] [Cited by in Crossref: 81] [Cited by in F6Publishing: 66] [Article Influence: 7.4] [Reference Citation Analysis]
457 Araujo-Castro M, Pascual-Corrales E, Molina-Cerrillo J, Moreno Mata N, Alonso-Gordoa T. Bronchial Carcinoids: From Molecular Background to Treatment Approach. Cancers (Basel) 2022;14:520. [PMID: 35158788 DOI: 10.3390/cancers14030520] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
458 Faggiano A, Malandrino P, Modica R, Agrimi D, Aversano M, Bassi V, Giordano EA, Guarnotta V, Logoluso FA, Messina E, Nicastro V, Nuzzo V, Sciaraffia M, Colao A. Efficacy and Safety of Everolimus in Extrapancreatic Neuroendocrine Tumor: A Comprehensive Review of Literature. Oncologist 2016;21:875-86. [PMID: 27053503 DOI: 10.1634/theoncologist.2015-0420] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
459 Gupta S. Intra-arterial liver-directed therapies for neuroendocrine hepatic metastases. Semin Intervent Radiol 2013;30:28-38. [PMID: 24436515 DOI: 10.1055/s-0033-1333651] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
460 Taghizadeh-Hesary F, Moradi A, Malekzadeh M. Long-term complete remission of a patient with high grade neuroendocrine carcinoma of ampulla of Vater. BMJ Case Rep 2018;2018:bcr-2018-224845. [PMID: 29950363 DOI: 10.1136/bcr-2018-224845] [Reference Citation Analysis]
461 Belak J, Kudlac M, Zak V, Cavarga I, Kocan P, Böör A, Stebnicky M, Somos A, Tkacova R. Surgical Management of Bronchopulmonary Carcinoid Tumors: Experience over 8 years and Review of the Literature. Tumori 2010;96:84-9. [DOI: 10.1177/030089161009600114] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
462 Duran C, Karanis MIE, Bakdik S, Aslan U, Calik M, Calik SG. Ectopic Cushing's syndrome due to adrenocorticotropic hormone secreting atypical thymic carcinoid tumor. North Clin Istanb 2019;6:85-8. [PMID: 31180388 DOI: 10.14744/nci.2018.53244] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
463 Walsh JC, Schaeffer DF, Kirsch R, Pollett A, Manzoni M, Riddell RH, Albarello L. Ileal “carcinoid” tumors—small size belies deadly intent: high rate of nodal metastasis in tumors ≤1 cm in size. Human Pathology 2016;56:123-7. [DOI: 10.1016/j.humpath.2016.05.023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
464 Alsina M, Marcos-Gragera R, Capdevila J, Buxó M, Ortiz RM, Barretina P, Vilardell L, Brunet J, Beltran M, Izquierdo Á. Neuroendocrine tumors: a population-based study of incidence and survival in Girona Province, 1994-2004. Cancer Epidemiol 2011;35:e49-54. [PMID: 21840785 DOI: 10.1016/j.canep.2011.05.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
465 Guccione L, Gough K, Drosdowsky A, Fisher K, Price T, Pavlakis N, Khasraw M, Wyld D, Ransom D, Kong G, Rogers M, Leyden S, Leyden J, Michael M, Schofield P. Defining the Supportive Care Needs and Psychological Morbidity of Patients With Functioning Versus Nonfunctioning Neuroendocrine Tumors: Protocol for a Phase 1 Trial of a Nurse-Led Online and Phone-Based Intervention. JMIR Res Protoc 2019;8:e14361. [PMID: 31793892 DOI: 10.2196/14361] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
466 Raut CP, Kulke MH, Glickman JN, Swanson RS, Ashley SW. Carcinoid Tumors. Current Problems in Surgery 2006;43:391-450. [DOI: 10.1067/j.cpsurg.2006.03.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
467 Landry CS, Brock G, Scoggins CR, McMasters KM, Martin RC 2nd. A proposed staging system for small bowel carcinoid tumors based on an analysis of 6,380 patients. Am J Surg 2008;196:896-903; discussion 903. [PMID: 19095106 DOI: 10.1016/j.amjsurg.2008.07.042] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
468 Ende AR, Sedarat A, Shah P, Jhala N, Fraker DL, Drebin JA, Metz DC, Kochman ML. Risk factors for aggressive nonfunctional pancreatic neuroendocrine tumors and the role of endoscopic ultrasound guided fine-needle aspiration. Endosc Ultrasound. 2016;5:49-54. [PMID: 26879167 DOI: 10.4103/2303-9027.175897] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
469 Mosquera C, Koutlas NJ, Fitzgerald TL. Localized high-grade gastroenteropancreatic neuroendocrine tumors: Defining prognostic and therapeutic factors for a disease of increasing clinical significance. Eur J Surg Oncol. 2016;42:1471-1477. [PMID: 27528467 DOI: 10.1016/j.ejso.2016.07.137] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
470 Wang YZ, Mayhall G, Anthony LB, Campeau RJ, Boudreaux JP, Woltering EA. Cervical and upper mediastinal lymph node metastasis from gastrointestinal and pancreatic neuroendocrine tumors: true incidence and management. J Am Coll Surg 2012;214:1017-22. [PMID: 22521444 DOI: 10.1016/j.jamcollsurg.2012.02.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
471 Ruszniewski P, Delle Fave G, Cadiot G, Komminoth P, Chung D, Kos-Kudla B, Kianmanesh R, Hochhauser D, Arnold R, Ahlman H, Pauwels S, Kwekkeboom DJ, Rindi G; Frascati Consensus Conference; European neuroendocrine Tumor Society. Well-differentiated gastric tumors/carcinomas. Neuroendocrinology. 2006;84:158-164. [PMID: 17312375 DOI: 10.1159/000098007] [Cited by in Crossref: 103] [Cited by in F6Publishing: 73] [Article Influence: 6.9] [Reference Citation Analysis]
472 Shaheen M, Hassanain M, Aljiffry M, Cabrera T, Chaudhury P, Simoneau E, Kongkaewpaisarn N, Salman A, Rivera J, Jamal M. Predictors of response to radio-embolization (TheraSphere®) treatment of neuroendocrine liver metastasis. HPB (Oxford). 2012;14:60-66. [PMID: 22151453 DOI: 10.1111/j.1477-2574.2011.00405.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
473 Arora S, Soundararajan R, Joshi P, Kumar R, Bal C. Somatostatin Receptor Expressing Bilateral Ovarian Metastases Detected by 68Ga DOTANOC PET/CT. Clinical Nuclear Medicine 2015;40:496-8. [DOI: 10.1097/rlu.0000000000000646] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
474 O'Toole D, Salazar R, Falconi M, Kaltsas G, Couvelard A, de Herder WW, Hyrdel R, Nikou G, Krenning E, Vullierme MP, Caplin M, Jensen R, Eriksson B; Frascati Consensus Conference., European Neuroendocrine Tumor Society. Rare functioning pancreatic endocrine tumors. Neuroendocrinology 2006;84:189-95. [PMID: 17312379 DOI: 10.1159/000098011] [Cited by in Crossref: 89] [Cited by in F6Publishing: 58] [Article Influence: 5.9] [Reference Citation Analysis]
475 Crosby DA, Donohoe CL, Fitzgerald L, Muldoon C, Hayes B, O'Toole D, Reynolds JV. Gastric neuroendocrine tumours. Dig Surg. 2012;29:331-348. [PMID: 23075625 DOI: 10.1159/000342988] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
476 Zou YP, Li WM, Liu HR, Li N. Primary carcinoid tumor of the gallbladder: a case report and brief review of the literature. World J Surg Oncol. 2010;8:12. [PMID: 20175936 DOI: 10.1186/1477-7819-8-12] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
477 Taghavi S, Jayarajan SN, Powers BD, Davey A, Willis AI. Examining rectal carcinoids in the era of screening colonoscopy: a surveillance, epidemiology, and end results analysis. Dis Colon Rectum. 2013;56:952-959. [PMID: 23838863 DOI: 10.1097/dcr.0b013e318291f512] [Cited by in Crossref: 39] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
478 Couvelard A, Sauvanet A. Gastroenteropancreatic neuroendocrine tumors: indications for and pitfalls of frozen section examination. Virchows Arch 2008;453:441-8. [DOI: 10.1007/s00428-008-0678-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
479 Wolin EM. Challenges in the Diagnosis and Management of Well-Differentiated Neuroendocrine Tumors of the Lung (Typical and Atypical Carcinoid): Current Status and Future Considerations. Oncologist 2015;20:1123-31. [PMID: 26306904 DOI: 10.1634/theoncologist.2015-0198] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
480 Komaç Ö, Bengi G, Sağol Ö, Akarsu M. C-reactive protein may be a prognostic factor for the whole gastroenteropancreatic neuroendocrine tumor group. World J Gastrointest Oncol 2019; 11(2): 139-152 [PMID: 30788040 DOI: 10.4251/wjgo.v11.i2.139] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
481 Ito T, Sasano H, Tanaka M, Osamura RY, Sasaki I, Kimura W, Takano K, Obara T, Ishibashi M, Nakao K, Doi R, Shimatsu A, Nishida T, Komoto I, Hirata Y, Nakamura K, Igarashi H, Jensen RT, Wiedenmann B, Imamura M. Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan. J Gastroenterol 2010;45:234-43. [PMID: 20058030 DOI: 10.1007/s00535-009-0194-8] [Cited by in Crossref: 272] [Cited by in F6Publishing: 195] [Article Influence: 22.7] [Reference Citation Analysis]
482 Balmadrid BL, Thomas CM, Coffman CJ, Liddle RA, Fisher DA. Factors associated with survival of veterans with gastrointestinal neuroendocrine tumors. J Cancer Epidemiol 2012;2012:986708. [PMID: 22693504 DOI: 10.1155/2012/986708] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
483 Folkestad O, Wasmuth HH, Mjønes P, Fougner R, Hauso Ø, Fossmark R. Survival and Disease Recurrence in Patients with Duodenal Neuroendocrine Tumours-A Single Centre Cohort. Cancers (Basel) 2021;13:3985. [PMID: 34439140 DOI: 10.3390/cancers13163985] [Reference Citation Analysis]
484 Michael M, Garcia-Carbonero R, Weber MM, Lombard-Bohas C, Toumpanakis C, Hicks RJ. The Antiproliferative Role of Lanreotide in Controlling Growth of Neuroendocrine Tumors: A Systematic Review. Oncologist 2017;22:272-85. [PMID: 28220021 DOI: 10.1634/theoncologist.2016-0305] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
485 Sahani DV, Bonaffini PA, Fernández-Del Castillo C, Blake MA. Gastroenteropancreatic neuroendocrine tumors: role of imaging in diagnosis and management. Radiology 2013;266:38-61. [PMID: 23264526 DOI: 10.1148/radiol.12112512] [Cited by in Crossref: 95] [Cited by in F6Publishing: 68] [Article Influence: 10.6] [Reference Citation Analysis]
486 Tamburrino D, Spoletini G, Partelli S, Muffatti F, Adamenko O, Crippa S, Falconi M. Surgical management of neuroendocrine tumors. Best Pract Res Clin Endocrinol Metab. 2016;30:93-102. [PMID: 26971846 DOI: 10.1016/j.beem.2015.10.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
487 Böttger C, Warth A, Nawroth PP, Isermann B. [Neuroendocrine carcinoma of the lung: a diagnostic and therapeutic challenge]. Med Klin (Munich) 2010;105:237-41. [PMID: 20455040 DOI: 10.1007/s00063-010-1049-z] [Reference Citation Analysis]
488 Tewari A, Palaniswamy SS, Subramanyam P. Brain metastasis from neuroendocrine tumor of the gallbladder: a rare entity. South Asian J Cancer 2013;2:120. [PMID: 24455579 DOI: 10.4103/2278-330X.114106] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
489 Hwang EC, Sagel SS, Brunt EM. Best cases from the AFIP: multiple gastric carcinoids. Radiographics 2009;29:1206-9. [PMID: 19605668 DOI: 10.1148/rg.294085211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
490 Schreiter NF, Brenner W, Nogami M, Buchert R, Huppertz A, Pape U, Prasad V, Hamm B, Maurer MH. Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT for staging enteropancreatic neuroendocrine tumours. Eur J Nucl Med Mol Imaging 2012;39:72-82. [DOI: 10.1007/s00259-011-1935-5] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 5.0] [Reference Citation Analysis]
491 Fendrich V, Bartsch DK. Surgical treatment of gastrointestinal neuroendocrine tumors. Langenbecks Arch Surg. 2011;396:299-311. [PMID: 21279821 DOI: 10.1007/s00423-011-0741-7] [Cited by in Crossref: 51] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
492 Raman M. Testing for Chronic Diarrhea. Adv Clin Chem 2017;79:199-244. [PMID: 28212712 DOI: 10.1016/bs.acc.2016.09.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
493 Gangi A, Siegel E, Barmparas G, Lo S, Jamil LH, Hendifar A, Nissen NN, Wolin EM, Amersi F. Multifocality in Small Bowel Neuroendocrine Tumors. J Gastrointest Surg 2018;22:303-9. [PMID: 29119527 DOI: 10.1007/s11605-017-3586-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
494 Chen WJ, Wu N, Zhou JL, Lin GL, Qiu HZ. Full-thickness excision using transanal endoscopic microsurgery for treatment of rectal neuroendocrine tumors. World J Gastroenterol 2015; 21(30): 9142-9149 [PMID: 26290641 DOI: 10.3748/wjg.v21.i30.9142] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
495 Zagar TM, White RR, Willett CG, Tyler DS, Papavassiliou P, Papalezova KT, Guy CD, Broadwater G, Clough RW, Czito BG. Resected Pancreatic Neuroendocrine Tumors: Patterns of Failure and Disease-Related Outcomes With or Without Radiotherapy. International Journal of Radiation Oncology*Biology*Physics 2012;83:1126-31. [DOI: 10.1016/j.ijrobp.2011.09.041] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
496 Safatle-Ribeiro AV, Ribeiro U Jr, Corbett CE, Iriya K, Kobata CH, Sakai P, Yagi OK, Pinto PE Jr, Zilberstein B, Gama-Rodrigues J. Prognostic value of immunohistochemistry in gastric neuroendocrine (carcinoid) tumors. Eur J Gastroenterol Hepatol. 2007;19:21-28. [PMID: 17206073 DOI: 10.1097/01.meg.0000250582.30737.bd] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
497 Nawarawong N, Pongpruttipan T, Aswakul P, Prachayakul V. Mediastinal small cell carcinoma with liver and bone marrow metastasis, mimicking lymphoma. World J Clin Cases 2015; 3(10): 915-919 [PMID: 26488030 DOI: 10.12998/wjcc.v3.i10.915] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
498 Pape U, Jann H, Müller‐nordhorn J, Bockelbrink A, Berndt U, Willich SN, Koch M, Röcken C, Rindi G, Wiedenmann B. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer 2008;113:256-65. [DOI: 10.1002/cncr.23549] [Cited by in Crossref: 300] [Cited by in F6Publishing: 243] [Article Influence: 21.4] [Reference Citation Analysis]
499 Kim HH, Park SJ, Lee SH, Park HU, Song CS, Park MI, Moon W. Efficacy of endoscopic submucosal resection with a ligation device for removing small rectal carcinoid tumor compared with endoscopic mucosal resection: analysis of 100 cases. Dig Endosc. 2012;24:159-163. [PMID: 22507089 DOI: 10.1111/j.1443-1661.2011.01190.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
500 Zimmermann N, Knief J, Kacprowski T, Lazar-Karsten P, Keck T, Billmann F, Schmid S, Luley K, Lehnert H, Brabant G, Thorns C. MicroRNA analysis of gastroenteropancreatic neuroendocrine tumors and metastases. Oncotarget 2018;9:28379-90. [PMID: 29983867 DOI: 10.18632/oncotarget.25357] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
501 Corrias G, Monti S, Horvat N, Tang L, Basturk O, Saba L, Mannelli L. Imaging features of malignant abdominal neuroendocrine tumors with rare presentation. Clin Imaging 2018;51:59-64. [PMID: 29448120 DOI: 10.1016/j.clinimag.2018.02.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
502 Keck KJ, Maxwell JE, Utria AF, Bellizzi AM, Dillon JS, O'Dorisio TM, Howe JR. The Distal Predilection of Small Bowel Neuroendocrine Tumors. Ann Surg Oncol 2018;25:3207-13. [PMID: 30054825 DOI: 10.1245/s10434-018-6676-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
503 Alvarez-Villegas D, Giménez-Milà M, Sbraga F, Camprubí I, Gil A. Dealing With the Right Side: Carcinoid Heart Disease. J Cardiothorac Vasc Anesth 2022;36:2228-31. [PMID: 35337745 DOI: 10.1053/j.jvca.2022.02.014] [Reference Citation Analysis]
504 Zuetenhorst JM, Taal BG. Metastatic carcinoid tumors: a clinical review. Oncologist 2005;10:123-31. [PMID: 15709214 DOI: 10.1634/theoncologist.10-2-123] [Cited by in Crossref: 152] [Cited by in F6Publishing: 134] [Article Influence: 8.9] [Reference Citation Analysis]
505 Schneider R, Waldmann J, Swaid Z, Ramaswamy A, Fendrich V, Bartsch DK, Schlosser K. Calcitonin-secreting pancreatic endocrine tumors: systematic analysis of a rare tumor entity. Pancreas 2011;40:213-21. [PMID: 21178652 DOI: 10.1097/MPA.0b013e3182015f5d] [Cited by in Crossref: 35] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
506 Oberg K, Jelic S. Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendation for diagnosis, treatment and follow-up. Ann Oncol. 2009;20 Suppl 4:150-153. [PMID: 19454440 DOI: 10.1093/annonc/mdp158] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
507 Sookur PA, Sahdev A, Rockall AG, Isidori AM, Monson JP, Grossman AB, Reznek RH. Imaging in covert ectopic ACTH secretion: a CT pictorial review. Eur Radiol 2009;19:1069-78. [PMID: 19137302 DOI: 10.1007/s00330-008-1274-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
508 Walter T, Bruneton D, Cassier PA, Hervieu V, Pilleul F, Scoazec JY, Chayvialle JA, Lombard-Bohas C. Evaluation of the combination 5-fluorouracil, dacarbazine, and epirubicin in patients with advanced well-differentiated neuroendocrine tumors. Clin Colorectal Cancer 2010;9:248-54. [PMID: 20920998 DOI: 10.3816/CCC.2010.n.037] [Cited by in Crossref: 26] [Cited by in F6Publishing: 5] [Article Influence: 2.4] [Reference Citation Analysis]
509 Terai T, Nakagawa K, Nakamura K, Doi S, Morita K, Ohbayashi C, Sho M. Neuroendocrine tumor arising from the greater omentum treated with laparoscopic tumor resection: a case report. Surg Case Rep 2021;7:132. [PMID: 34061282 DOI: 10.1186/s40792-021-01217-4] [Reference Citation Analysis]
510 Baptiste GG, Postlewait LM, Ethun CG, Le N, McInnis MR, Russell MC, Winer JH, Kooby DA, Staley CA, Maithel SK, Cardona K. Symptomatic presentation as a predictor of recurrence in gastroenteropancreatic neuroendocrine tumors: A single institution experience over 15 years. J Surg Oncol 2016;114:163-9. [PMID: 27157897 DOI: 10.1002/jso.24279] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
511 Pinto MP, Muñoz Medel M, Carrillo D, Retamal IN, Bravo ML, Valenzuela Y, Nervi B, Sánchez C, Galindo H, Ibañez C, Peña J, Balmaceda C, Madrid J, Briones J, Torres J, Nilo F, Guarda FJ, Quintana JC, Orellana P, Mondaca S, Acevedo F, Vicentini D, Cordova-Delgado M, Owen GI, Garrido M. Chilean Registry for Neuroendocrine Tumors: A Latin American Perspective. Horm Cancer 2019;10:3-10. [PMID: 30465145 DOI: 10.1007/s12672-018-0354-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
512 Chi Y, Du F, Zhao H, Wang JW, Cai JQ. Characteristics and long-term prognosis of patients with rectal neuroendocrine tumors. World J Gastroenterol 2014; 20(43): 16252-16257 [PMID: 25473180 DOI: 10.3748/wjg.v20.i43.16252] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
513 Kiratli H, Uzun S, Tarlan B, Ateş D, Baydar DE, Söylemezoğlu F. Renal Carcinoid Tumor Metastatic to the Uvea, Medial Rectus Muscle, and the Contralateral Lacrimal Gland. Ophthalmic Plastic & Reconstructive Surgery 2015;31:e91-3. [DOI: 10.1097/iop.0000000000000112] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
514 Hobbins S, West D, Peake M, Beckett P, Woolhouse I. Patient characteristics, treatment and survival in pulmonary carcinoid tumours: an analysis from the UK National Lung Cancer Audit. BMJ Open 2016;6:e012530. [PMID: 27678543 DOI: 10.1136/bmjopen-2016-012530] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
515 Visouli AN, Darwiche K, Kourtoglou GI, Zarogoulidis P, Mpakas A, Machairiotis N, Stylianaki A, Christofis C, Katsikogiannis N, Tsakiridis K, Courcoutsakis N, Zarogoulidis K. Primary lung carcinoid, a rare cause of paraparesis: report of a case and review of the literature. J Thorac Dis 2012;4 Suppl 1:49-55. [PMID: 23304441 DOI: 10.3978/j.issn.2072-1439.2012.s005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
516 Öksüz MÖ, Winter L, Pfannenberg C, Reischl G, Müssig K, Bares R, Dittmann H. Peptide receptor radionuclide therapy of neuroendocrine tumors with (90)Y-DOTATOC: is treatment response predictable by pre-therapeutic uptake of (68)Ga-DOTATOC? Diagn Interv Imaging 2014;95:289-300. [PMID: 24034971 DOI: 10.1016/j.diii.2013.07.006] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 5.3] [Reference Citation Analysis]
517 Oberg K, Akerström G, Rindi G, Jelic S. Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21 Suppl 5:v223-v227. [PMID: 20555086 DOI: 10.1093/annonc/mdq192] [Cited by in Crossref: 86] [Cited by in F6Publishing: 84] [Article Influence: 7.2] [Reference Citation Analysis]
518 Yang TX, Chua TC, Morris DL. Radioembolization and chemoembolization for unresectable neuroendocrine liver metastases - a systematic review. Surg Oncol 2012;21:299-308. [PMID: 22846894 DOI: 10.1016/j.suronc.2012.07.001] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
519 Chatani PD, Aversa JG, McDonald JD, Khan TM, Keutgen XM, Nilubol N. Preoperative serum chromogranin-a is predictive of survival in locoregional jejuno-ileal small bowel neuroendocrine tumors. Surgery 2021;170:106-13. [PMID: 33814188 DOI: 10.1016/j.surg.2021.01.048] [Reference Citation Analysis]
520 Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063-3072. [PMID: 18565894 DOI: 10.1200/jco.2007.15.4377] [Cited by in Crossref: 2588] [Cited by in F6Publishing: 1164] [Article Influence: 184.9] [Reference Citation Analysis]
521 Kandil E, Noureldine SI, Koffron A, Yao L, Saggi B, Buell JF. Outcomes of laparoscopic and open resection for neuroendocrine liver metastases. Surgery. 2012;152:1225-1231. [PMID: 23068086 DOI: 10.1016/j.surg.2012.08.027] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
522 Chi Y, Gao S, Du F, Wang J, Jiang W, Sun Y, Song Y, He J. Diagnosis, treatment, and prognosis of bronchopulmonary carcinoid: an analysis of 74 patients. Anti-Cancer Drugs 2016;27:54-9. [DOI: 10.1097/cad.0000000000000292] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
523 Postlewait LM, Baptiste GG, Ethun CG, Le N, Cardona K, Russell MC, Willingham FF, Kooby DA, Staley CA, Maithel SK. A 15-year experience with gastric neuroendocrine tumors: Does type make a difference? J Surg Oncol. 2016;114:576-580. [PMID: 27393718 DOI: 10.1002/jso.24369] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
524 Lee SY, Cheow PC, Teo JY, Ooi LL. Surgical treatment of neuroendocrine liver metastases. Int J Hepatol 2012;2012:146590. [PMID: 22319650 DOI: 10.1155/2012/146590] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
525 Van Essen M, Krenning EP, De Jong M, Valkema R, Kwekkeboom DJ. Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours. Acta Oncol 2007;46:723-34. [PMID: 17653893 DOI: 10.1080/02841860701441848] [Cited by in Crossref: 146] [Cited by in F6Publishing: 130] [Article Influence: 9.7] [Reference Citation Analysis]
526 Kwekkeboom DJ, de Herder WW, Kam BL, van Eijck CH, van Essen M, Kooij PP, Feelders RA, van Aken MO, Krenning EP. Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival. J Clin Oncol. 2008;26:2124-2130. [PMID: 18445841 DOI: 10.1200/jco.2007.15.2553] [Cited by in Crossref: 947] [Cited by in F6Publishing: 347] [Article Influence: 67.6] [Reference Citation Analysis]
527 Anderson KL Jr, Mulvihill MS, Speicher PJ, Yerokun BA, Gulack BC, Nussbaum DP, Harpole DH Jr, D'Amico TA, Berry MF, Hartwig MG. Adjuvant Chemotherapy Does Not Confer Superior Survival in Patients With Atypical Carcinoid Tumors. Ann Thorac Surg. 2017;104:1221-1230. [PMID: 28760471 DOI: 10.1016/j.athoracsur.2017.05.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
528 Gupta A, Chazen JL, Phillips CD. Carcinoid tumor metastases to the extraocular muscles: MR imaging and CT findings and review of the literature. AJNR Am J Neuroradiol 2011;32:1208-11. [PMID: 21659479 DOI: 10.3174/ajnr.A2470] [Cited by in Crossref: 27] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
529 Luboldt W, Hartmann H, Wiedemann B, Zöphel K, Luboldt H. Gastroenteropancreatic Neuroendocrine Tumors: Standardizing Therapy Monitoring with 68 Ga-DOTATOC PET/CT Using the Example of Somatostatin Receptor Radionuclide Therapy. Mol Imaging 2010;9:7290.2010.00035. [DOI: 10.2310/7290.2010.00035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
530 Fu Z, Zuo C, Sheehan CE, Patil DT, Lin J, Yang Z, Lee H. Novel Finding of Paired Box 5 (PAX5) Cytoplasmic Staining in Well-differentiated Rectal Neuroendocrine Tumors (Carcinoids) and Its Diagnostic and Potentially Prognostic Utility. Appl Immunohistochem Mol Morphol 2019;27:454-60. [PMID: 29561272 DOI: 10.1097/PAI.0000000000000635] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
531 Abdel-Rahman O. Modified staging system for pulmonary carcinoids on the basis of lung cancer TNM system. Clin Transl Oncol 2018;20:670-7. [PMID: 29022170 DOI: 10.1007/s12094-017-1759-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
532 Patel D, Chan D, Cehic G, Pavlakis N, Price TJ. Systemic therapies for advanced gastroenteropancreatic neuroendocrine tumors. Expert Rev Endocrinol Metab 2016;11:311-27. [PMID: 30058926 DOI: 10.1080/17446651.2016.1199952] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
533 van den Bergh RC, Wolters T, Spaander MC, Schröder FH, van Leenders GJ. Non-prostatic pathology on prostate needle-biopsy - colorectal carcinoid: a case report. Cases J 2009;2:75. [PMID: 19159470 DOI: 10.1186/1757-1626-2-75] [Reference Citation Analysis]
534 Depoilly T, Leroux R, Andrade D, Nicolle R, Dioguardi Burgio M, Marinoni I, Dokmak S, Ruszniewski P, Hentic O, Paradis V, De Mestier L, Perren A, Couvelard A, Cros J. Immunophenotypic and molecular characterization of pancreatic neuroendocrine tumors producing serotonin. Mod Pathol 2022. [PMID: 35739266 DOI: 10.1038/s41379-022-01110-x] [Reference Citation Analysis]
535 Castillo JG, Milla F, Adams DH. Surgical Management of Carcinoid Heart Valve Disease. Seminars in Thoracic and Cardiovascular Surgery 2012;24:254-60. [DOI: 10.1053/j.semtcvs.2012.11.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
536 Haeubl M, Schuerz S, Svejda B, Reith LM, Gruber B, Pfragner R, Schoefberger W. Asymmetrically substituted cationic indole- and fluorene porphyrins inhibit tumor proliferation in small intestinal neuroendocrine tumors and medullary thyroid carcinomas. European Journal of Medicinal Chemistry 2010;45:760-73. [DOI: 10.1016/j.ejmech.2009.11.025] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
537 Mehta JS, Abou-Rayyah Y, Rose GE. Orbital carcinoid metastases. Ophthalmology. 2006;113:466-472. [PMID: 16458966 DOI: 10.1016/j.ophtha.2005.10.051] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 3.4] [Reference Citation Analysis]
538 Nejatollahi SM, Etemad O. Concurrent Occurrence of Tumor in Colon and Small Bowel following Intestinal Obstruction: A Case Report and Review of the Literature. Case Rep Surg 2016;2016:8591697. [PMID: 27200205 DOI: 10.1155/2016/8591697] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
539 Araujo PB, Cheng S, Mete O, Serra S, Morin E, Asa SL, Ezzat S. Evaluation of the WHO 2010 grading and AJCC/UICC staging systems in prognostic behavior of intestinal neuroendocrine tumors. PLoS One 2013;8:e61538. [PMID: 23620762 DOI: 10.1371/journal.pone.0061538] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
540 Hauso O, Gustafsson BI, Kidd M, Waldum HL, Drozdov I, Chan AK, Modlin IM. Neuroendocrine tumor epidemiology: contrasting Norway and North America. Cancer. 2008;113:2655-2664. [PMID: 18853416 DOI: 10.1002/cncr.23883] [Cited by in Crossref: 314] [Cited by in F6Publishing: 298] [Article Influence: 22.4] [Reference Citation Analysis]
541 Knigge U, Hansen C, Stadil F. Interventional treatment of neuroendocrine liver metastases. The Surgeon 2008;6:232-9. [DOI: 10.1016/s1479-666x(08)80033-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 4] [Article Influence: 1.9] [Reference Citation Analysis]
542 Li X, Shao L, Lu X, Yang Z, Ai S, Sun F, Wang M, Guan W, Liu S. Risk factors for lymph node metastasis in gastric neuroendocrine tumor: a retrospective study. BMC Surg 2021;21:174. [PMID: 33789664 DOI: 10.1186/s12893-021-01174-7] [Reference Citation Analysis]
543 Singla S, LeVea CM, Pokuri VK, Attwood KM, Wach MM, Tomaszewski GM, Kuvshinoff B, Iyer R. Ki67 score as a potential predictor in the selection of liver-directed therapies for metastatic neuroendocrine tumors: a single institutional experience. J Gastrointest Oncol 2016;7:441-8. [PMID: 27284478 DOI: 10.21037/jgo.2016.02.02] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
544 Filosso PL, Guerrera F, Falco NR, Thomas P, Garcia Yuste M, Rocco G, Welter S, Moreno Casado P, Rendina EA, Venuta F, Ampollini L, Nosotti M, Raveglia F, Rena O, Stella F, Larocca V, Ardissone F, Brunelli A, Margaritora S, Travis WD, Sagan D, Sarkaria I, Evangelista A; ESTS NETs-WG steering committee. Anatomical resections are superior to wedge resections for overall survival in patients with Stage 1 typical carcinoids. Eur J Cardiothorac Surg 2019;55:273-9. [PMID: 30032287 DOI: 10.1093/ejcts/ezy250] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
545 Leong SP, Cady B, Jablons DM, Garcia-Aguilar J, Reintgen D, Jakub J, Pendas S, Duhaime L, Cassell R, Gardner M, Giuliano R, Archie V, Calvin D, Mensha L, Shivers S, Cox C, Werner JA, Kitagawa Y, Kitajima M. Clinical patterns of metastasis. Cancer Metastasis Rev 2006;25:221-32. [PMID: 16770534 DOI: 10.1007/s10555-006-8502-8] [Cited by in Crossref: 92] [Cited by in F6Publishing: 75] [Article Influence: 5.8] [Reference Citation Analysis]
546 Zheng H, Xie HK, Li C, Bao F, Ding JA, Jiang GN, Zhang RX, Chen C. Radical mediastinal nodal removal improves disease-free survival for pulmonary low-grade malignant tumors. Lung Cancer 2012;75:342-7. [PMID: 21840617 DOI: 10.1016/j.lungcan.2011.07.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
547 Crona J, Bjrklund P, Welin S, Kozlovacki G, berg K, Granberg D. Treatment, prognostic markers and survival in thymic neuroendocrine tumours. A study from a single tertiary referral centre. Lung Cancer 2013;79:289-93. [DOI: 10.1016/j.lungcan.2012.12.001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
548 You H, Kandathil A, Beg M, De Blanche L, Kazmi S, Subramaniam RM. Ga-68 DOTATATE PET/CT and F-18 FDG PET/CT in the evaluation of low and intermediate versus high-grade neuroendocrine tumors. Nucl Med Commun 2020;41:1060-5. [PMID: 32732600 DOI: 10.1097/MNM.0000000000001255] [Reference Citation Analysis]
549 Lee SY, Choi YJ, Chang WJ, Shin SW, Kim YH, Kim ST. The role of chemotherapy and/or octreotide in patients with metastatic gastroenteropancreatic and hepatobiliary neuroendocrine carcinoma. J Gastrointest Oncol 2014;5:457-62. [PMID: 25436125 DOI: 10.3978/j.issn.2078-6891.2014.075] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
550 Arnold CN, Sosnowski A, Schmitt-Gräff A, Arnold R, Blum HE. Analysis of molecular pathways in sporadic neuroendocrine tumors of the gastro-entero-pancreatic system. Int J Cancer 2007;120:2157-64. [PMID: 17278096 DOI: 10.1002/ijc.22569] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 3.9] [Reference Citation Analysis]
551 Chambers AJ, Pasieka JL, Dixon E, Rorstad O. The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors. Surgery 2008;144:645-53. [DOI: 10.1016/j.surg.2008.06.008] [Cited by in Crossref: 76] [Cited by in F6Publishing: 63] [Article Influence: 5.4] [Reference Citation Analysis]
552 Reichman O, Sobel JD. Vulvovaginal Pellagra and Lichen Sclerosus Complicating Carcinoid Syndrome. Obstetrics & Gynecology 2009;113:543-5. [DOI: 10.1097/aog.0b013e318191bb51] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
553 Kasumova GG, Tabatabaie O, Eskander MF, Tadikonda A, Ng SC, Tseng JF. National Rise of Primary Pancreatic Carcinoid Tumors: Comparison to Functional and Nonfunctional Pancreatic Neuroendocrine Tumors. J Am Coll Surg 2017;224:1057-64. [PMID: 27965134 DOI: 10.1016/j.jamcollsurg.2016.11.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
554 Massironi S, Partelli S, Petrone MC, Zilli A, Conte D, Falconi M, Arcidiacono PG. Endoscopic ultrasound appearance of pancreatic serotonin-staining neuroendocrine neoplasms. Pancreatology 2018;18:792-8. [DOI: 10.1016/j.pan.2018.08.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
555 Reznek RH. CT/MRI of neuroendocrine tumours. Cancer Imaging 2006;6:S163-77. [PMID: 17114072 DOI: 10.1102/1470-7330.2006.9037] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
556 Markou KD, Goudakos JK, Triaridis S, Televantou D, Hytiroglou P, Nikolaou A. Simultaneous metastatic papillary thyroid carcinoma and carcinoid of the small intestine in the cervical lymph node group. Thyroid 2010;20:1025-8. [PMID: 20718681 DOI: 10.1089/thy.2009.0438] [Reference Citation Analysis]
557 Aggeli C, Felekos I, Kazazaki C, Giannopoulos D, Kartalis A, Pitsavos C, Stefanadis C. Echocardiographic imaging of tricuspid and pulmonary valve abnormalities in primary ovarian carcinoid tumor. Cardiovasc Ultrasound 2010;8:37. [PMID: 20813053 DOI: 10.1186/1476-7120-8-37] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
558 Rindi G, Klöppel G, Alhman H, Caplin M, Couvelard A, de Herder WW, Erikssson B, Falchetti A, Falconi M, Komminoth P. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2006;449:395-401. [PMID: 16967267 DOI: 10.1007/s00428-006-0250-1] [Cited by in Crossref: 1023] [Cited by in F6Publishing: 865] [Article Influence: 63.9] [Reference Citation Analysis]
559 Cao LL, Lu J, Lin JX, Zheng CH, Li P, Xie JW, Wang JB, Chen QY, Lin M, Tu RH, Huang CM. Incidence and survival trends for gastric neuroendocrine neoplasms: An analysis of 3523 patients in the SEER database. Eur J Surg Oncol. 2018;44:1628-1633. [PMID: 29983275 DOI: 10.1016/j.ejso.2018.01.082] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
560 Tiktinsky E, Horne T, Agranovich S, Lantsberg S. Intramuscular metastasis of carcinoid tumor: a rare manifestation. Clin Nucl Med 2008;33:565-6. [PMID: 18645381 DOI: 10.1097/RLU.0b013e31817deac3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
561 Castellano D, Capdevila J, Sastre J, Alonso V, Llanos M, García-carbonero R, Manzano Mozo JL, Sevilla I, Durán I, Salazar R. Sorafenib and bevacizumab combination targeted therapy in advanced neuroendocrine tumour: A phase II study of Spanish Neuroendocrine Tumour Group (GETNE0801). European Journal of Cancer 2013;49:3780-7. [DOI: 10.1016/j.ejca.2013.06.042] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 7.3] [Reference Citation Analysis]
562 Albanese G, Harieaswar S, Sampath R. Orbital metastasis from neuroendocrine tumour: Case report and literature review. Eur J Ophthalmol 2021;:11206721211060633. [PMID: 34787007 DOI: 10.1177/11206721211060633] [Reference Citation Analysis]
563 Velikyan I, Sundin A, Eriksson B, Lundqvist H, Sörensen J, Bergström M, Långström B. In vivo binding of [68Ga]-DOTATOC to somatostatin receptors in neuroendocrine tumours — impact of peptide mass. Nuclear Medicine and Biology 2010;37:265-75. [DOI: 10.1016/j.nucmedbio.2009.11.008] [Cited by in Crossref: 85] [Cited by in F6Publishing: 76] [Article Influence: 7.1] [Reference Citation Analysis]
564 Goswamee P, Arunachalam S, Mehta S, Nasim R, Gunning WT, Giovannucci DR. Gastro-Enteropancreatic Neuroendocrine Tumor Cell Dynamics in Liver Microvasculature. Microsc Microanal 2015;21:655-65. [PMID: 25921482 DOI: 10.1017/S1431927615000392] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
565 Komborozos VA. Carcinoid tumours of the small bowel colon and rectum. Hellenic J Surg 2011;83:12-20. [DOI: 10.1007/s13126-011-0003-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
566 Adnan A, Basu S. Rare-Site Primary Soft-Tissue Neuroendocrine Tumor with Metastases and Near-Complete Resolution with 177Lu-DOTATATE: Documenting a Promising Clinical Application of Peptide Receptor Radionuclide Therapy. J Nucl Med Technol 2020;48:36-9. [PMID: 31401619 DOI: 10.2967/jnmt.119.227058] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
567 Greenblatt DY, Vaccaro AM, Jaskula-Sztul R, Ning L, Haymart M, Kunnimalaiyaan M, Chen H. Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells. Oncologist 2007;12:942-51. [PMID: 17766653 DOI: 10.1634/theoncologist.12-8-942] [Cited by in Crossref: 101] [Cited by in F6Publishing: 98] [Article Influence: 6.7] [Reference Citation Analysis]
568 Chen ZZ, Huang W, Wei ZQ. Small-cell neuroendocrine carcinoma of the rectum — a rare tumor type with poor prognosis: A case report and review of literature. World J Clin Cases 2020; 8(23): 6095-6102 [PMID: 33344610 DOI: 10.12998/wjcc.v8.i23.6095] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
569 Gaur P, Leary C, Yao JC. Thymic neuroendocrine tumors: A SEER database analysis of 160 patients. Ann Surg. 2010;251:1117-1121. [PMID: 20485130 DOI: 10.1097/sla.0b013e3181dd4ec4] [Cited by in Crossref: 88] [Cited by in F6Publishing: 33] [Article Influence: 7.3] [Reference Citation Analysis]
570 Lawrence B, Gustafsson BI, Chan A, Svejda B, Kidd M, Modlin IM. The epidemiology of gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin North Am. 2011;40:1-18, vii. [PMID: 21349409 DOI: 10.1016/j.ecl.2010.12.005] [Cited by in Crossref: 497] [Cited by in F6Publishing: 463] [Article Influence: 45.2] [Reference Citation Analysis]
571 Lorenzen AW, O'Dorisio TM, Howe JR. Neuroendocrine tumors arising in Meckel's diverticula: frequency of advanced disease warrants aggressive management. J Gastrointest Surg 2013;17:1084-91. [PMID: 23558715 DOI: 10.1007/s11605-013-2191-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
572 Eftekhari K, Mcclelland CM, Gausas RE, Jian B, Woo J, Volpe NJ, Tamhankar MA. A Case of Extraocular Muscle Enlargement Causing Diplopia: Thinking Beyond Thyroid Eye Disease. Journal of Neuro-Ophthalmology 2013;33:179-82. [DOI: 10.1097/wno.0b013e3182793c1a] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
573 Li G, Tian ML, Bing YT, Tao LY, Wang HY, Jiang B, Yuan CH, Xiu DR. Clinicopathological features and prognosis factors for survival in elderly patients with pancreatic neuroendocrine tumor: A STROBE-compliant article. Medicine (Baltimore) 2019;98:e14576. [PMID: 30882623 DOI: 10.1097/MD.0000000000014576] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
574 Duclos V, Iep A, Gomez L, Goldfarb L, Besson FL. PET Molecular Imaging: A Holistic Review of Current Practice and Emerging Perspectives for Diagnosis, Therapeutic Evaluation and Prognosis in Clinical Oncology. Int J Mol Sci 2021;22:4159. [PMID: 33923839 DOI: 10.3390/ijms22084159] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
575 Chagpar R, Chiang YJ, Xing Y, Cormier JN, Feig BW, Rashid A, Chang GJ, You YN. Neuroendocrine tumors of the colon and rectum: prognostic relevance and comparative performance of current staging systems. Ann Surg Oncol. 2013;20:1170-1178. [PMID: 23212760 DOI: 10.1245/s10434-012-2746-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
576 Shirota T, Nagakawa Y, Sahara Y, Takishita C, Hijikata Y, Hosokawa Y, Nakajima T, Osakabe H, Katsumata K, Tsuchida A. Surgical resection of neuroendocrine tumors of the pancreas (pNETs) by minimally invasive surgery: the laparoscopic approach. Gland Surg 2018;7:12-9. [PMID: 29629315 DOI: 10.21037/gs.2017.11.06] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
577 Baudin E. Gastroenteropancreatic endocrine tumors: clinical characterization before therapy. Nat Rev Endocrinol 2007;3:228-39. [DOI: 10.1038/ncpendmet0425] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
578 Fraenkel M, Kim M, Faggiano A, de Herder WW, Valk GD; Knowledge NETwork. Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature. Endocr Relat Cancer. 2014;21:R153-R163. [PMID: 24322304 DOI: 10.1530/erc-13-0125] [Cited by in Crossref: 139] [Cited by in F6Publishing: 81] [Article Influence: 17.4] [Reference Citation Analysis]
579 Chong S, Lee KS, Kim BT, Choi JY, Yi CA, Chung MJ, Oh DK, Lee JY. Integrated PET/CT of pulmonary neuroendocrine tumors: diagnostic and prognostic implications. AJR Am J Roentgenol 2007;188:1223-31. [PMID: 17449764 DOI: 10.2214/AJR.06.0503] [Cited by in Crossref: 73] [Cited by in F6Publishing: 17] [Article Influence: 4.9] [Reference Citation Analysis]
580 Jiao X, Li Y, Wang H, Liu S, Zhang D, Zhou Y. Clinicopathological features and survival analysis of gastroenteropancreatic neuroendocrine neoplasms: a retrospective study in a single center of China. Chin J Cancer Res 2015;27:258-66. [PMID: 26157322 DOI: 10.3978/j.issn.1000-9604.2015.06.04] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
581 Kidd M, Modlin IM, Mane SM, Camp RL, Eick G, Latich I. The Role of Genetic Markers— NAP1L1, MAGE-D2, and MTA1—in Defining Small-Intestinal Carcinoid Neoplasia. Ann Surg Oncol 2006;13:253-62. [DOI: 10.1245/aso.2006.12.011] [Cited by in Crossref: 80] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
582 Mayo SC, de Jong MC, Pulitano C, Clary BM, Reddy SK, Gamblin TC, Celinksi SA, Kooby DA, Staley CA, Stokes JB, Chu CK, Ferrero A, Schulick RD, Choti MA, Mentha G, Strub J, Bauer TW, Adams RB, Aldrighetti L, Capussotti L, Pawlik TM. Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis. Ann Surg Oncol. 2010;17:3129-3136. [PMID: 20585879 DOI: 10.1245/s10434-010-1154-5] [Cited by in Crossref: 266] [Cited by in F6Publishing: 218] [Article Influence: 22.2] [Reference Citation Analysis]
583 Chaouch MA, Dougaz MW, Ferjaoui W, Gouta EL, Nouira R, Bouasker I, Dziri C. A Case Report of a Primary Neuroendocrine Tumour of the Proximal Common Bile Duct. J Gastrointest Cancer 2019;50:1048-50. [PMID: 30737710 DOI: 10.1007/s12029-019-00208-x] [Reference Citation Analysis]
584 Mohammadi H, Chuong MD, Moeslein FM, Sharma NK. Selective internal radiation therapy for the treatment of inoperable neuroendocrine tumor liver metastases. International Journal of Endocrine Oncology 2016;3:77-83. [DOI: 10.2217/ije.15.33] [Reference Citation Analysis]
585 Tsukagoshi M, Hosouchi Y, Araki K, Mochida Y, Aihara R, Shirabe K, Kuwano H. Neuroendocrine tumor of the ampulla of Vater with distant cystic lymph node metastasis: a case report. Surg Case Rep 2016;2:73. [PMID: 27457078 DOI: 10.1186/s40792-016-0202-1] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
586 Chen Y, Dong Y, Shi J, Zhao L, Filippi L. Clinicopathological, Oncogenic, and 18F-FDG PET/CT Features of Primary Pulmonary Carcinoid in Resection Specimens. Contrast Media & Molecular Imaging 2022;2022:1-10. [DOI: 10.1155/2022/1926797] [Reference Citation Analysis]
587 Fine C, Roquin G, Terrebonne E, Lecomte T, Coriat R, Do Cao C, de Mestier L, Coffin E, Cadiot G, Nicolli P, Lepiliez V, Hautefeuille V, Ramos J, Girot P, Dominguez S, Céphise FV, Forestier J, Hervieu V, Pioche M, Walter T. Endoscopic management of 345 small rectal neuroendocrine tumours: A national study from the French group of endocrine tumours (GTE). United European Gastroenterol J 2019;7:1102-12. [PMID: 31662867 DOI: 10.1177/2050640619861883] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
588 Kulkarni HR, Singh A, Baum RP. Advances in the Diagnosis of Neuroendocrine Neoplasms. Semin Nucl Med 2016;46:395-404. [PMID: 27553465 DOI: 10.1053/j.semnuclmed.2016.06.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
589 Rorstad O. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract. J Surg Oncol. 2005;89:151-160. [PMID: 15719376 DOI: 10.1002/jso.20179] [Cited by in Crossref: 132] [Cited by in F6Publishing: 102] [Article Influence: 7.8] [Reference Citation Analysis]
590 Valentino JD, Li J, Zaytseva YY, Mustain WC, Elliott VA, Kim JT, Harris JW, Campbell K, Weiss H, Wang C, Song J, Anthony L, Townsend CM Jr, Evers BM. Cotargeting the PI3K and RAS pathways for the treatment of neuroendocrine tumors. Clin Cancer Res 2014;20:1212-22. [PMID: 24443523 DOI: 10.1158/1078-0432.CCR-13-1897] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
591 Campana D, Ambrosini V, Pezzilli R, Fanti S, Labate AM, Santini D, Ceccarelli C, Nori F, Franchi R, Corinaldesi R. Standardized uptake values of (68)Ga-DOTANOC PET: a promising prognostic tool in neuroendocrine tumors. J Nucl Med. 2010;51:353-359. [PMID: 20150249 DOI: 10.2967/jnumed.109.066662] [Cited by in Crossref: 108] [Cited by in F6Publishing: 99] [Article Influence: 9.0] [Reference Citation Analysis]
592 Massimino K, Harrskog O, Pommier S, Pommier R. Octreotide LAR and bolus octreotide are insufficient for preventing intraoperative complications in carcinoid patients. J Surg Oncol 2013;107:842-6. [PMID: 23592524 DOI: 10.1002/jso.23323] [Cited by in Crossref: 56] [Cited by in F6Publishing: 42] [Article Influence: 6.2] [Reference Citation Analysis]
593 Boudreaux JP. Surgery for gastroenteropancreatic neuroendocrine tumors (GEPNETS). Endocrinol Metab Clin North Am. 2011;40:163-171, ix. [PMID: 21349417 DOI: 10.1016/j.ecl.2010.12.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
594 Mahmud N, Tomizawa Y, Stashek K, Katona BW, Ginsberg GG, Metz DC. Endoscopic Resection of Duodenal Carcinoid Tumors: A Single-Center Comparison Between Simple Polypectomy and Endoscopic Mucosal Resection. Pancreas 2019;48:60-5. [PMID: 30451799 DOI: 10.1097/MPA.0000000000001197] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
595 Raz DJ, Nelson RA, Grannis FW, Kim JY. Natural history of typical pulmonary carcinoid tumors: a comparison of nonsurgical and surgical treatment. Chest 2015;147:1111-7. [PMID: 25539082 DOI: 10.1378/chest.14-1960] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 4.1] [Reference Citation Analysis]
596 Murray SE, Lloyd RV, Sippel RS, Chen H, Oltmann SC. Postoperative surveillance of small appendiceal carcinoid tumors. Am J Surg 2014;207:342-5; discussion 345. [PMID: 24393285 DOI: 10.1016/j.amjsurg.2013.08.038] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
597 Zhang C, Huang Y, Long J, Yao X, Wang J, Zang S, Qu W, Wang F. Serum chromogranin A for the diagnosis of gastroenteropancreatic neuroendocrine neoplasms and its association with tumour expression. Oncol Lett 2019;17:1497-504. [PMID: 30675205 DOI: 10.3892/ol.2018.9795] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
598 Marrache F, Vullierme MP, Roy C, El Assoued Y, Couvelard A, O'Toole D, Mitry E, Hentic O, Hammel P, Lévy P, Ravaud P, Rougier P, Ruszniewski P. Arterial phase enhancement and body mass index are predictors of response to chemoembolisation for liver metastases of endocrine tumours. Br J Cancer 2007;96:49-55. [PMID: 17164755 DOI: 10.1038/sj.bjc.6603526] [Cited by in Crossref: 65] [Cited by in F6Publishing: 49] [Article Influence: 4.1] [Reference Citation Analysis]
599 Kessler J, Singh G, Ituarte PHG, Allen R, Chang S, Li D. A Comparison of Liver-Directed Therapy and Systemic Therapy for the Treatment of Liver Metastases in Patients with Gastrointestinal Neuroendocrine Tumors: Analysis of the California Cancer Registry. J Vasc Interv Radiol 2021;32:393-402. [PMID: 33358144 DOI: 10.1016/j.jvir.2020.10.019] [Reference Citation Analysis]
600 Herrera-Martínez AD, Gahete MD, Sánchez-Sánchez R, Salas RO, Serrano-Blanch R, Salvatierra Á, Hofland LJ, Luque RM, Gálvez-Moreno MA, Castaño JP. The components of somatostatin and ghrelin systems are altered in neuroendocrine lung carcinoids and associated to clinical-histological features. Lung Cancer 2017;109:128-36. [PMID: 28577942 DOI: 10.1016/j.lungcan.2017.05.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
601 Shimoyama S, Fujishiro M, Takazawa Y. Successful type-oriented endoscopic resection for gastric carcinoid tumors: A case report. World J Gastrointest Endosc 2010; 2(12): 408-412 [PMID: 21191515 DOI: 10.4253/wjge.v2.i12.408] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
602 Neklason DW, VanDerslice J, Curtin K, Cannon-Albright LA. Evidence for a heritable contribution to neuroendocrine tumors of the small intestine. Endocr Relat Cancer 2016;23:93-100. [PMID: 26604321 DOI: 10.1530/ERC-15-0442] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
603 Tanabe Y, Sugawara Y, Nishimura R, Hosokawa K, Kajihara M, Shimizu T, Takahashi T, Sakai S, Sawada S, Yamashita M, Ohtani H. Oncocytic carcinoid tumor of the lung with intense F-18 fluorodeoxyglucose (FDG) uptake in positron emission tomography–computed tomography (PET/CT). Ann Nucl Med 2013;27:781-5. [DOI: 10.1007/s12149-013-0738-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
604 Tzontcheva A. Neuroendocrine Tumors — Laboratory Diagnosis. Journal of Medical Biochemistry 2010;29:254-64. [DOI: 10.2478/v10011-010-0028-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
605 Turner GB, Johnston BT, McCance DR, McGinty A, Watson RG, Patterson CC, Ardill JE. Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours. Gut 2006;55:1586-91. [PMID: 16556667 DOI: 10.1136/gut.2006.092320] [Cited by in Crossref: 79] [Cited by in F6Publishing: 71] [Article Influence: 4.9] [Reference Citation Analysis]
606 Sigel CS. Advances in the cytologic diagnosis of gastroenteropancreatic neuroendocrine neoplasms. Cancer Cytopathol 2018;126:980-91. [PMID: 30485690 DOI: 10.1002/cncy.22073] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
607 Alifieris CE, Griniatsos J, Delis SG, Nikolaou M, Avgoustou C, Panagiotidis MI, Souferi-chronopoulou E, Trafalis DT. Capecitabine, Oxaliplatin, Irinotecan, and Bevacizumab Combination Followed by Pazopanib Plus Capecitabine Maintenance for High-Grade Gastrointestinal Neuroendocrine Carcinomas. American Journal of Clinical Oncology 2020;43:305-10. [DOI: 10.1097/coc.0000000000000668] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
608 Bongiovanni A, Recine F, Riva N, Foca F, Liverani C, Mercatali L, Nicolini S, Pieri F, Amadori D, Ibrahim T. Outcome Analysis of First-line Somatostatin Analog Treatment in Metastatic Pulmonary Neuroendocrine Tumors and Prognostic Significance of 18 FDG-PET/CT. Clin Lung Cancer. 2017;18:415-420. [PMID: 27956089 DOI: 10.1016/j.cllc.2016.11.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
609 Chablaney S, Zator ZA, Kumta NA. Diagnosis and Management of Rectal Neuroendocrine Tumors. Clin Endosc. 2017;50:530-536. [PMID: 29207857 DOI: 10.5946/ce.2017.134] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
610 Barretoa SG, Tionga L, Thomasa T, Traversa E, Williams RS. Incidental Appendiceal Carcinoids: Is Surgery Affecting Their Incidence? World J Oncol. 2012;3:227-230. [PMID: 29147310 DOI: 10.4021/wjon400w] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
611 Kasai Y, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Harun N, Kim M, Warren RS, Bergsland EK, Nakakura EK. Residual tumor volume discriminates prognosis after surgery for neuroendocrine liver metastasis. J Surg Oncol 2019;121:330-6. [DOI: 10.1002/jso.25811] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
612 Arigoni S, Ignjatovic S, Sager P, Betschart J, Buerge T, Wachtl J, Tschuor C, Limani P, Puhan MA, Lesurtel M, Raptis DA, Breitenstein S. Diagnosis and prediction of neuroendocrine liver metastases: a protocol of six systematic reviews. JMIR Res Protoc 2013;2:e60. [PMID: 24366180 DOI: 10.2196/resprot.2890] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
613 Mafficini A, Scarpa A. Genetics and Epigenetics of Gastroenteropancreatic Neuroendocrine Neoplasms. Endocr Rev 2019;40:506-36. [PMID: 30657883 DOI: 10.1210/er.2018-00160] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 20.0] [Reference Citation Analysis]
614 Hu HJ, Zhou RX, Tan YQ, Jing QY, Ma WJ, Yang Q, Wang JK, Wang SJ, Cheng NS, Li FY. Coexisting cancers: a mixture of neuroendocrine carcinoma and adenocarcinoma in the gallbladder: A case report. Medicine (Baltimore) 2016;95:e5281. [PMID: 27858898 DOI: 10.1097/MD.0000000000005281] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
615 Laskaratos F, Caplin M. Treatment challenges in and outside a network setting: Gastrointestinal neuroendocrine tumours. European Journal of Surgical Oncology 2019;45:52-9. [DOI: 10.1016/j.ejso.2018.03.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
616 Poleé IN, Hermans BCM, van der Zwan JM, Bouwense SAW, Dercksen MW, Eskens FALM, Havekes B, Hofland J, Kerkhofs TMA, Klümpen HJ, Latten-Jansen LM, Speel EM, Verburg FA, Walenkamp AME, Geurts SME, de Vos-Geelen J. Long-term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: A population-based study. Eur J Cancer 2022;172:252-63. [PMID: 35803176 DOI: 10.1016/j.ejca.2022.06.003] [Reference Citation Analysis]
617 Kulke MH, Lenz HJ, Meropol NJ, Posey J, Ryan DP, Picus J, Bergsland E, Stuart K, Tye L, Huang X, Li JZ, Baum CM, Fuchs CS. Activity of sunitinib in patients with advanced neuroendocrine tumors. J Clin Oncol. 2008;26:3403-3410. [PMID: 18612155 DOI: 10.1200/jco.2007.15.9020] [Cited by in Crossref: 446] [Cited by in F6Publishing: 162] [Article Influence: 31.9] [Reference Citation Analysis]
618 Han G, Ouyang Y, Long X, Zhou Y, Li M, Liu Y, Kraatz H. (Carboxymethyl-Dextran)-Modified Magnetic Nanoparticles Conjugated to Octreotide for MRI Applications. Eur J Inorg Chem 2010;2010:5455-61. [DOI: 10.1002/ejic.201000715] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
619 Rodrigues G, Prabhu R, Ravi B. Small bowel carcinoid: a rare cause of bowel obstruction. BMJ Case Rep 2013;2013:bcr2013200875. [PMID: 24068379 DOI: 10.1136/bcr-2013-200875] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
620 Chung TP, Hunt SR. Carcinoid and neuroendocrine tumors of the colon and rectum. Clin Colon Rectal Surg 2006;19:45-8. [PMID: 20011309 DOI: 10.1055/s-2006-942343] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
621 Nikou GC, Pazaitou-Panayiotou K, Dimitroulopoulos D, Alexandrakis G, Papakostas P, Vaslamatzis M, Kaldrymidis P, Markussis V, Koumarianou A; “G-NET-Registry” investigators. Results of a prospective multicenter neuroendocrine tumor registry reporting on clinicopathologic characteristics of Greek patients. BMC Endocr Disord 2016;16:8. [PMID: 26872616 DOI: 10.1186/s12902-016-0089-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
622 Pitt SC, Chen H, Kunnimalaiyaan M. Phosphatidylinositol 3-kinase-Akt signaling in pulmonary carcinoid cells. J Am Coll Surg 2009;209:82-8. [PMID: 19651067 DOI: 10.1016/j.jamcollsurg.2009.03.006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
623 Kim HS, Choi JY, Choi DW, Lim HY, Lee JH, Hong SP, Cho YS, Lee KH, Kim BT. Prognostic Value of Volume-Based Metabolic Parameters Measured by (18)F-FDG PET/CT of Pancreatic Neuroendocrine Tumors. Nucl Med Mol Imaging 2014;48:180-6. [PMID: 25177374 DOI: 10.1007/s13139-013-0262-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
624 Yohanathan L, Cleary SP. Minimally Invasive Management of Secondary Liver Cancer. Surg Oncol Clin N Am 2019;28:229-41. [PMID: 30851825 DOI: 10.1016/j.soc.2018.11.003] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
625 Tan Y, Xiao E. Rare hepatic malignant tumors: dynamic CT, MRI, and clinicopathologic features: with analysis of 54 cases and review of the literature. Abdom Imaging 2013;38:511-26. [DOI: 10.1007/s00261-012-9918-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
626 Abou Saleh M, Mansoor E, Anindo M, Isenberg G. Prevalence of Small Intestine Carcinoid Tumors: A US Population-Based Study 2012–2017. Dig Dis Sci 2019;64:1328-34. [DOI: 10.1007/s10620-018-5402-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
627 Modlin IM, Kidd M, Frilling A, Falconi M, Filosso PL, Malczewska A, Kitz A. Molecular Genomic Assessment Using a Blood-based mRNA Signature (NETest) is Cost-effective and Predicts Neuroendocrine Tumor Recurrence With 94% Accuracy. Ann Surg 2021;274:481-90. [PMID: 34183517 DOI: 10.1097/SLA.0000000000005026] [Reference Citation Analysis]
628 Moreira RK, Washington K. Pathology of Gastrointestinal Neuroendocrine Tumors: An Update. Surg Pathol Clin 2010;3:327-47. [PMID: 26839134 DOI: 10.1016/j.path.2010.05.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
629 Konishi T, Watanabe T, Nagawa H, Oya M, Ueno M, Kuroyanagi H, Fujimoto Y, Akiyoshi T, Yamaguchi T, Muto T. Treatment of colorectal carcinoids: A new paradigm. World J Gastrointest Surg 2010; 2(5): 153-156 [PMID: 21160865 DOI: 10.4240/wjgs.v2.i5.153] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
630 Cloyd JM, Omichi K, Mizuno T, Kawaguchi Y, Tzeng CD, Conrad C, Chun YS, Aloia TA, Katz MHG, Lee JE, Halperin D, Yao J, Vauthey JN, Dasari A. Preoperative Fluorouracil, Doxorubicin, and Streptozocin for the Treatment of Pancreatic Neuroendocrine Liver Metastases. Ann Surg Oncol 2018;25:1709-15. [PMID: 29626307 DOI: 10.1245/s10434-018-6468-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
631 Surani S, Tan J, Ahumada A, Surani SS, Sudhakaran S, Varon J. Delayed recurrence of atypical pulmonary carcinoid cluster: a rare occurrence. Case Rep Pulmonol 2014;2014:620814. [PMID: 25506019 DOI: 10.1155/2014/620814] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
632 Folkestad O, Wasmuth HH, Mjønes P, Fougner R, Hauso Ø, Fossmark R. Survival and disease recurrence in patients operated for small intestinal neuroendocrine tumors at a referral hospital. Surg Oncol 2020;35:336-43. [PMID: 32979699 DOI: 10.1016/j.suronc.2020.09.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
633 Grozinsky-Glasberg S, Thomas D, Strosberg JR, Pape UF, Felder S, Tsolakis AV, Alexandraki KI, Fraenkel M, Saiegh L, Reissman P, Kaltsas G, Gross DJ. Metastatic type 1 gastric carcinoid: A real threat or just a myth? World J Gastroenterol 2013; 19(46): 8687-8695 [PMID: 24379587 DOI: 10.3748/wjg.v19.i46.8687] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 45] [Article Influence: 6.0] [Reference Citation Analysis]
634 Shamimi-Noori S, Gonsalves CF, Shaw CM. Metastatic Liver Disease: Indications for Locoregional Therapy and Supporting Data.Semin Intervent Radiol. 2017;34:145-166. [PMID: 28579683 DOI: 10.1055/s-0037-1602712] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
635 de Saint Roman C, Gervaise A, Cinquetti G, Fixot K, Ezanno AC, Sockeel P. [Appendicular mucocele and endocrine tumor]. Presse Med 2012;41:666-9. [PMID: 22100708 DOI: 10.1016/j.lpm.2011.09.017] [Reference Citation Analysis]
636 Srikumar G, Gunawardene A, Kodeda K. Synchronous small bowel neuroendocrine tumour and lymphoma in a centenarian. ANZ J Surg 2020;90:2581-3. [PMID: 32359197 DOI: 10.1111/ans.15952] [Reference Citation Analysis]
637 Saadeh H, Abdullah N, Erashdi M, Sughayer M, Al-Kadi O. Histopathologist-level quantification of Ki-67 immunoexpression in gastroenteropancreatic neuroendocrine tumors using semiautomated method. J Med Imaging (Bellingham) 2020;7:012704. [PMID: 31824983 DOI: 10.1117/1.JMI.7.1.012704] [Reference Citation Analysis]
638 Chen T, Yao LQ, Xu MD, Zhang YQ, Chen WF, Shi Q, Cai SL, Chen YY, Xie YH, Ji Y, Chen SY, Zhou PH, Zhong YS. Efficacy and Safety of Endoscopic Submucosal Dissection for Colorectal Carcinoids. Clin Gastroenterol Hepatol. 2016;14:575-581. [PMID: 26256463 DOI: 10.1016/j.cgh.2015.07.048] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
639 Litvak A, Pietanza MC. Bronchial and Thymic Carcinoid Tumors. Hematol Oncol Clin North Am. 2016;30:83-102. [PMID: 26614370 DOI: 10.1016/j.hoc.2015.09.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
640 Murthy R, Kamat P, Nunez R, Madoff DC, Gupta S, Salem R, Yao JC. Yttrium-90 microsphere radioembolotherapy of hepatic metastatic neuroendocrine carcinomas after hepatic arterial embolization. J Vasc Interv Radiol 2008;19:145-51. [PMID: 18192482 DOI: 10.1016/j.jvir.2007.09.006] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 3.6] [Reference Citation Analysis]
641 Haug AR, Cindea-Drimus R, Auernhammer CJ, Reincke M, Beuschlein F, Wängler B, Uebleis C, Schmidt GP, Spitzweg C, Bartenstein P. Neuroendocrine tumor recurrence: diagnosis with 68Ga-DOTATATE PET/CT. Radiology. 2014;270:517-525. [PMID: 24056402 DOI: 10.1148/radiol.13122501] [Cited by in Crossref: 61] [Cited by in F6Publishing: 50] [Article Influence: 6.8] [Reference Citation Analysis]
642 Naugler WE, Hunt GC. Carcinoid Tumors. In: Faigel DO, Kochman ML, editors. Endoscopic Oncology. Totowa: Humana Press; 2006. pp. 161-72. [DOI: 10.1007/978-1-59745-172-7_15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
643 Khan MS, El-Khouly F, Davies P, Toumpanakis C, Caplin ME. Long-term results of treatment of malignant carcinoid syndrome with prolonged release Lanreotide (Somatuline Autogel). Aliment Pharmacol Ther. 2011;34:235-242. [PMID: 21585408 DOI: 10.1111/j.1365-2036.2011.04693.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 5.6] [Reference Citation Analysis]
644 Hinchliffe E, Allcock RL, Mansoor W, Myers MA. A patient with a metastatic gastroenteropancreatic endocrine carcinoma causing hyperinsulinaemic hypoglycaemia and the carcinoid syndrome. Ann Clin Biochem 2011;48:579-83. [DOI: 10.1258/acb.2011.011068] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
645 Swarts DR, Ramaekers FC, Speel EJ. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities. Biochim Biophys Acta 2012;1826:255-71. [PMID: 22579738 DOI: 10.1016/j.bbcan.2012.05.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 65] [Article Influence: 2.4] [Reference Citation Analysis]
646 Sandblom V, Ståhl I, Hansson C, Olofsson Bagge R, Forssell-Aronsson E. Local treatment of liver metastases by administration of 177Lu-octreotate via isolated hepatic perfusion - A preclinical simulation of a novel treatment strategy. Surg Oncol 2019;29:148-56. [PMID: 31196481 DOI: 10.1016/j.suronc.2019.05.002] [Reference Citation Analysis]
647 Huang W, Bao Y, Luo X, Yao L, Yuan L. Neuroendocrine neoplasms of the ovary: an analysis of clinicopathological characteristics and prognosis with a focus on histological grading. Endocrine 2022. [PMID: 35538309 DOI: 10.1007/s12020-022-03067-y] [Reference Citation Analysis]
648 Wegner RE, Abel S, Horne ZD, Hasan S, Colonias A, Verma V. Stereotactic body radiation therapy versus fractionated radiation therapy for early-stage bronchopulmonary carcinoid. Lung Cancer Manag 2019;8:LMT14. [PMID: 31807142 DOI: 10.2217/lmt-2019-0003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
649 Steinfort DP, Finlay M, Irving LB. Diagnosis of peripheral pulmonary carcinoid tumor using endobronchial ultrasound. Ann Thorac Med 2008;3:146-8. [PMID: 19561897 DOI: 10.4103/1817-1737.43082] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
650 Strate T, Schurr P, Izbicki JR. Reklassifizierung der neuroendokrinen Pankreastumoren und deren Auswirkung auf die operative und präoperative Strategie. Visc Med 2007;23:151-7. [DOI: 10.1159/000100423] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
651 Virgone C, Cecchetto G, Alaggio R, Ferrari A, Bisogno G, Conte M, Inserra A, Fagnani AM, Indolfi P, Salfi N, Dall’igna P. Appendiceal Neuroendocrine Tumours in Childhood: Italian TREP Project. Journal of Pediatric Gastroenterology & Nutrition 2014;58:333-8. [DOI: 10.1097/mpg.0000000000000217] [Cited by in Crossref: 21] [Cited by in F6Publishing: 4] [Article Influence: 2.6] [Reference Citation Analysis]
652 Vootla VR, Daniel M. Abnormal Liver Function Tests in an Anorexia Nervosa Patient and an Atypical Manifestation of Refeeding Syndrome. Case Rep Gastroenterol 2015;9:261-5. [PMID: 26351414 DOI: 10.1159/000437321] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
653 Degnan AJ, Tadros SS, Tocchio S. Pediatric Neuroendocrine Carcinoid Tumors: Review of Diagnostic Imaging Findings and Recent Advances. AJR Am J Roentgenol 2017;208:868-77. [PMID: 28199138 DOI: 10.2214/AJR.16.17287] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
654 Pericleous M, Karpathakis A, Toumpanakis C, Lumgair H, Reiner J, Marelli L, Thirlwell C, Caplin ME. Well-differentiated bronchial neuroendocrine tumors: Clinical management and outcomes in 105 patients. Clin Respir J 2018;12:904-14. [PMID: 28026127 DOI: 10.1111/crj.12603] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
655 Ambrosini V, Tomassetti P, Castellucci P, Campana D, Montini G, Rubello D, Nanni C, Rizzello A, Franchi R, Fanti S. Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours. Eur J Nucl Med Mol Imaging 2008;35:1431-8. [DOI: 10.1007/s00259-008-0769-2] [Cited by in Crossref: 190] [Cited by in F6Publishing: 144] [Article Influence: 13.6] [Reference Citation Analysis]
656 Diets IJ, Nagtegaal ID, Loeffen J, de Blaauw I, Waanders E, Hoogerbrugge N, Jongmans MC. Childhood neuroendocrine tumours: a descriptive study revealing clues for genetic predisposition. Br J Cancer 2017;116:163-8. [PMID: 27959889 DOI: 10.1038/bjc.2016.408] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
657 Kwak MS, Chung SJ, Yang JI, Im JP, Park MJ, Lee C, Kim JS. Long-term Outcome of Small, Incidentally Detected Rectal Neuroendocrine Tumors Removed by Simple Excisional Biopsy Compared With the Advanced Endoscopic Resection During Screening Colonoscopy. Dis Colon Rectum 2018;61:338-46. [PMID: 29369898 DOI: 10.1097/DCR.0000000000000905] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
658 Ishido K, Tanabe S, Higuchi K, Sasaki T, Katada C, Azuma M, Naruke A, Koizumi W, Mikami T. Clinicopathological evaluation of duodenal well-differentiated endocrine tumors. World J Gastroenterol 2010; 16(36): 4583-4588 [PMID: 20857530 DOI: 10.3748/wjg.v16.i36.4583] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
659 Kidd M, Modlin IM, Pfragner R, Eick GN, Champaneria MC, Chan AK, Camp RL, Mane SM. Small bowel carcinoid (enterochromaffin cell) neoplasia exhibits transforming growth factor-beta1-mediated regulatory abnormalities including up-regulation of C-Myc and MTA1. Cancer 2007;109:2420-31. [PMID: 17469181 DOI: 10.1002/cncr.22725] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 2.5] [Reference Citation Analysis]
660 Fujimoto Y, Oya M, Kuroyanagi H, Ueno M, Akiyoshi T, Yamaguchi T, Muto T. Lymph-node metastases in rectal carcinoids. Langenbecks Arch Surg. 2010;395:139-142. [PMID: 19048280 DOI: 10.1007/s00423-008-0438-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
661 Bacchetti S, Bertozzi S, Londero AP, Uzzau A, Pasqual EM. Surgical treatment and survival in patients with liver metastases from neuroendocrine tumors: a meta-analysis of observational studies. Int J Hepatol. 2013;2013:235040. [PMID: 23509630 DOI: 10.1155/2013/235040] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
662 Soga J. Carcinoids of the pancreas: An analysis of 156 cases. Cancer 2005;104:1180-7. [DOI: 10.1002/cncr.21291] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
663 Modlin IM, Kidd M, Latich I, Zikusoka MN, Eick GN, Mane SM, Camp RL. Genetic differentiation of appendiceal tumor malignancy: a guide for the perplexed. Ann Surg 2006;244:52-60. [PMID: 16794389 DOI: 10.1097/01.sla.0000217617.06782.d5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]
664 Izquierdo KM, Humphries MD, Farkas LM. Size Criteria Is Not Sufficient in Selecting Patients for Local Excision Versus Radical Excision for Rectal Neuroendocrine Tumors >2 cm: A National Cancer Database Analysis. Dis Colon Rectum 2021;64:399-408. [PMID: 33651006 DOI: 10.1097/DCR.0000000000001888] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
665 Shin Y, Ha SY, Hyeon J, Lee B, Lee J, Jang KT, Kim KM, Park YS, Park CK. Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases in Korea: A Clinicopathological Analysis of 72 Cases in a Single Institute. Cancer Res Treat. 2015;47:738-746. [PMID: 25687852 DOI: 10.4143/crt.2014.224] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
666 Shogbesan O, Abdulkareem A, Pappachen B, Altomare J. Primary Mesenteric Carcinoid Tumor Presenting with Carcinoid Syndrome. Case Rep Gastroenterol 2018;12:396-401. [PMID: 30186091 DOI: 10.1159/000490522] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
667 Vootla V, Ahmed R, Niazi M, Balar B, Nayudu S. Synchronous Adenocarcinoma of the Colon and Rectal Carcinoid. Case Rep Gastroenterol 2016;10:600-4. [PMID: 27920648 DOI: 10.1159/000450677] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
668 Dasanu CA, Majumder S, Gopal S, Stoica-Mustafa E, Trikudanathan G. Emerging therapeutic options for advanced enteropancreatic neuroendocrine tumors. Expert Opin Pharmacother 2012;13:461-71. [PMID: 22292707 DOI: 10.1517/14656566.2012.656089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
669 Esin E, Oksuzoglu B, Erdur E, Ozgun G, Demirci U. Well differentiated neuroendocrine tumors, a single center experience. Journal of Oncological Sciences 2018;4:119-24. [DOI: 10.1016/j.jons.2018.10.002] [Reference Citation Analysis]
670 Kim BS, Park YS, Yook JH, Oh ST, Kim BS. Differing Clinical Courses and Prognoses in Patients With Gastric Neuroendocrine Tumors Based on the 2010-WHO Classification Scheme. Medicine (Baltimore). 2015;94:e1748. [PMID: 26554772 DOI: 10.1097/md.0000000000001748] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
671 Peng W, Wu J, Fan H, Lu J, Feng J. LncRNA EGOT Promotes Tumorigenesis Via Hedgehog Pathway in Gastric Cancer. Pathol Oncol Res 2019;25:883-7. [PMID: 29209988 DOI: 10.1007/s12253-017-0367-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
672 Raja SG, Bhattacharyya S, Davar J, Dreyfus GD. Surgery for carcinoid heart disease: current outcomes, concerns and controversies. Future Cardiology 2010;6:647-55. [DOI: 10.2217/fca.10.87] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
673 Boudreaux JP, Klimstra DS, Hassan MM, Woltering EA, Jensen RT, Goldsmith SJ, Nutting C, Bushnell DL, Caplin ME, Yao JC; North American Neuroendocrine Tumor Society (NANETS). The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum. Pancreas. 2010;39:753-766. [PMID: 20664473 DOI: 10.1097/mpa.0b013e3181ebb2a5] [Cited by in Crossref: 341] [Cited by in F6Publishing: 135] [Article Influence: 31.0] [Reference Citation Analysis]
674 Zhang M, Zhao P, Shi X, Zhao A, Zhang L, Zhou L. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study. BMC Endocr Disord. 2017;17:39. [PMID: 28705205 DOI: 10.1186/s12902-017-0190-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
675 Lo YH, Tsai MT, Kuo CY, Liu WS, Lee RC, Yeh YC, Li CP, Chen JY, Chao Y. Transcatheter arterial embolization with trisacryl gelatin microspheres (Embosphere(®)) leads to life-threatening tumor lysis syndrome in a rectal carcinoid patient with hepatic metastases. Acta Radiol Short Rep 2012;1:arsr. [PMID: 23986828 DOI: 10.1258/arsr.2012.110011] [Reference Citation Analysis]
676 Lawler M, Johnston B, Van Schaeybroeck S, Salto-tellez M, Wilson R, Dunlop M, Johnston PG. Colorectal Cancer. Abeloff's Clinical Oncology. Elsevier; 2020. pp. 1219-1280.e15. [DOI: 10.1016/b978-0-323-47674-4.00074-8] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
677 Tsang ES, Loree JM, Davies JM, Gill S, Liu D, Ho S, Renouf DJ, Lim HJ, Kennecke HF. Efficacy and Prognostic Factors for Y-90 Radioembolization (Y-90) in Metastatic Neuroendocrine Tumors with Liver Metastases. Can J Gastroenterol Hepatol 2020;2020:5104082. [PMID: 33299824 DOI: 10.1155/2020/5104082] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
678 Tejedor Bravo M, Justo LMA, Lasala JP, Moreira Vicente VF, Ruiz AC, Scapa MDLÁM. Acute Pancreatitis Secondary to Neuroendocrine Pancreatic Tumors: Report of 3 Cases and Literature Review. Pancreas 2012;41:485-9. [DOI: 10.1097/mpa.0b013e318227adef] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
679 Gusani NJ, Marsh JW, Nalesnik MA, Tublin ME, Gamblin TC. Carcinoid of the Extra-Hepatic Bile Duct: A Case Report with Long-Term Follow-up and Review of Literature. The American Surgeon 2008;74:87-90. [DOI: 10.1177/000313480807400121] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
680 Del Prete M, Fiore F, Modica R, Marotta V, Marciello F, Ramundo V, Di Sarno A, Carratù A, di Roseto Cde L, Tafuto S, Tatangelo F, Baldelli R, Colao A, Faggiano A; Multidisciplinary Group for NeuroEndocrine Tumors of Naples. Hepatic arterial embolization in patients with neuroendocrine tumors. J Exp Clin Cancer Res 2014;33:43. [PMID: 24887262 DOI: 10.1186/1756-9966-33-43] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
681 Kabir T, Issa M, Starkey G. Rare presentation of a symptomatic primary neuroendocrine tumour of small bowel mesentery. ANZ J Surg 2021;91:E403-4. [PMID: 33159428 DOI: 10.1111/ans.16431] [Reference Citation Analysis]
682 Pathak S, Dash I, Taylor MR, Poston GJ. An overview of the surgical management of hepatic neuroendocrine metastases. Indian J Surg Oncol 2012;3:20-5. [PMID: 23449915 DOI: 10.1007/s13193-012-0133-7] [Reference Citation Analysis]
683 Alexander ES, Soulen MC. Liver Metastases From Noncolorectal Malignancies (Neuroendocrine Tumor, Sarcoma, Melanoma, Breast). The Cancer Journal 2016;22:381-6. [DOI: 10.1097/ppo.0000000000000232] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
684 Frilling A, Sotiropoulos GC, Radtke A, Malago M, Bockisch A, Kuehl H, Li J, Broelsch CE. The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors. Ann Surg 2010;252:850-6. [PMID: 21037441 DOI: 10.1097/SLA.0b013e3181fd37e8] [Cited by in Crossref: 132] [Cited by in F6Publishing: 48] [Article Influence: 11.0] [Reference Citation Analysis]
685 Modlin IM, Shapiro MD, Kidd M. Primary Carcinoid Tumor of the Parotid Gland: A Case Report and Review of the Literature. Ear Nose Throat J 2006;85:533-9. [DOI: 10.1177/014556130608500819] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
686 Avenel P, Mckendrick A, Silapaswan S, Kolachalam R, Kestenberg W, Ferguson L, Jacobs MJ, Goriel Y, Mittal V. Gastrointestinal Carcinoids: An Increasing Incidence of Rectal Distribution. The American Surgeon 2010;76:759-63. [DOI: 10.1177/000313481007600736] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
687 Lepage C, Rachet B, Coleman MP. Survival from malignant digestive endocrine tumors in England and Wales: A population-based study. Gastroenterology. 2007;132:899-904. [PMID: 17383419 DOI: 10.1053/j.gastro.2007.01.006] [Cited by in Crossref: 79] [Cited by in F6Publishing: 75] [Article Influence: 5.3] [Reference Citation Analysis]
688 Fitzgerald TL, Dennis SO, Kachare SD, Vohra NA, Zervos EE. Increasing incidence of duodenal neuroendocrine tumors: Incidental discovery of indolent disease? Surgery. 2015;158:466-471. [PMID: 26013986 DOI: 10.1016/j.surg.2015.03.042] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
689 Lee S, Levine P, Heller SL, Hernandez O, Mercado CL, Chhor CM. Metastatic carcinoid tumor to the breast: report of two cases and review of the literature. Clin Imaging 2017;42:88-92. [PMID: 27907837 DOI: 10.1016/j.clinimag.2016.10.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
690 Bassi R, Arora R, Bhasin S, Khurana N. An unusual case of synchronous carcinoid of ovary and gall bladder. Case Rep Obstet Gynecol 2013;2013:737016. [PMID: 24371533 DOI: 10.1155/2013/737016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
691 Modlin IM, Champaneria MC, Chan AK, Kidd M. A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress. Am J Gastroenterol 2007;102:1464-73. [PMID: 17391319 DOI: 10.1111/j.1572-0241.2007.01185.x] [Cited by in Crossref: 123] [Cited by in F6Publishing: 93] [Article Influence: 8.2] [Reference Citation Analysis]
692 Modlin IM, Latich I, Zikusoka M, Kidd M, Eick G, Chan AKC. Gastrointestinal Carcinoids: The Evolution of Diagnostic Strategies: . Journal of Clinical Gastroenterology 2006;40:572-82. [DOI: 10.1097/00004836-200608000-00003] [Cited by in Crossref: 73] [Cited by in F6Publishing: 51] [Article Influence: 4.6] [Reference Citation Analysis]
693 Schiller LR, Pardi DS, Spiller R, Semrad CE, Surawicz CM, Giannella RA, Krejs GJ, Farthing MJ, Sellin JH. Gastro 2013 APDW/WCOG Shanghai working party report: chronic diarrhea: definition, classification, diagnosis. J Gastroenterol Hepatol 2014;29:6-25. [PMID: 24117999 DOI: 10.1111/jgh.12392] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 5.1] [Reference Citation Analysis]
694 Ko S, Baeg MK, Ko SY, Jung HS. Clinical characteristics, risk factors and outcomes of asymptomatic rectal neuroendocrine tumors. Surg Endosc 2017;31:3864-71. [DOI: 10.1007/s00464-016-5413-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
695 Monier A, Saloum N, Szmigielski W, Alrashid A, Napaki SM. Neuroendocrine tumor of the gallbladder. Pol J Radiol. 2015;80:228-231. [PMID: 26000067 DOI: 10.12659/pjr.893705] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
696 Zhao JY, Zhuang H, Luo Y, Su MG, Xiong ML, Wu YT. Double contrast-enhanced ultrasonography of a small intestinal neuroendocrine tumor: a case report of a recommendable imaging modality. Precis Clin Med 2020;3:147-52. [PMID: 35692609 DOI: 10.1093/pcmedi/pbaa011] [Reference Citation Analysis]
697 Cai W, Ge W, Hu H, Mao J. Rectal NETs and rectosigmoid junction NETs may need to be treated differently. Cancer Med 2020;9:971-9. [PMID: 31840409 DOI: 10.1002/cam4.2779] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
698 Uprety D, Halfdanarson TR, Molina JR, Leventakos K. Pulmonary Neuroendocrine Tumors: Adjuvant and Systemic Treatments. Curr Treat Options Oncol 2020;21:86. [PMID: 32862320 DOI: 10.1007/s11864-020-00786-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
699 Kulke MH, Siu LL, Tepper JE, Fisher G, Jaffe D, Haller DG, Ellis LM, Benedetti JK, Bergsland EK, Hobday TJ, Van Cutsem E, Pingpank J, Oberg K, Cohen SJ, Posner MC, Yao JC. Future directions in the treatment of neuroendocrine tumors: consensus report of the National Cancer Institute Neuroendocrine Tumor clinical trials planning meeting. J Clin Oncol. 2011;29:934-943. [PMID: 21263089 DOI: 10.1200/jco.2010.33.2056] [Cited by in Crossref: 208] [Cited by in F6Publishing: 97] [Article Influence: 18.9] [Reference Citation Analysis]
700 Kwon MJ, Kang HS, Soh JS, Lim H, Kim JH, Park CK, Park HR, Nam ES. Lymphovascular invasion in more than one-quarter of small rectal neuroendocrine tumors. World J Gastroenterol 2016; 22(42): 9400-9410 [PMID: 27895428 DOI: 10.3748/wjg.v22.i42.9400] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
701 Luo Y, Chen J, Huang K, Lin Y, Chen M, Xu L, Li ZP, Feng ST. Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria? BMC Cancer 2017;17:154. [PMID: 28231773 DOI: 10.1186/s12885-017-3150-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
702 Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current Status of Gastrointestinal Carcinoids. Gastroenterology 2005;128:1717-51. [DOI: 10.1053/j.gastro.2005.03.038] [Reference Citation Analysis]
703 Peri M, Fazio N. Clinical Evaluation of Everolimus in the Treatment of Neuroendocrine Tumors of the Lung: Patient Selection and Special Considerations. A Systematic and Critical Review of the Literature. Lung Cancer (Auckl) 2020;11:41-52. [PMID: 32753993 DOI: 10.2147/LCTT.S249928] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
704 Ferolla P, Faggiano A, Avenia N, Milone F, Masone S, Giampaglia F, Puma F, Daddi G, Angeletti G, Lombardi G, Santeusanio F, Colao A. Epidemiology of non-gastroenteropancreatic (neuro)endocrine tumours. Clin Endocrinol (Oxf) 2007;66:1-6. [PMID: 17201794 DOI: 10.1111/j.1365-2265.2006.02739.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
705 Howell DL, O’dorisio MS. Management of Neuroendocrine Tumors in Children, Adolescents, and Young Adults. Journal of Pediatric Hematology/Oncology 2012;34:S64-8. [DOI: 10.1097/mph.0b013e31824e3885] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
706 O'Neill S, Haji A, Ryan S, Clement D, Sarras K, Hayee B, Mulholland N, Ramage JK, Srirajaskanthan R. Nodal metastases in small rectal neuroendocrine tumours. Colorectal Dis 2021. [PMID: 34731512 DOI: 10.1111/codi.15978] [Reference Citation Analysis]
707 Tan MC, Jarnagin WR. Surgical management of non-colorectal hepatic metastasis: Non-Colorectal Metastatectomy. J Surg Oncol 2014;109:8-13. [DOI: 10.1002/jso.23462] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
708